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Summary 
The innate immune system senses pathogens by pattern recognition receptors (PRR) located in 
different cell compartments. Components of the bacterial cell wall and conserved proteins are detected 
by Toll-like receptors (TLRs) on the cell surface, and by NODs or NOD like receptors (NLRs) in the 
cytosol of cells. Viruses are recognized via their nucleic acids by TLRs in the endosome and RIG-I 
like helicases in the cytosol. Even though viral and bacterial DNA possess, with TLR9, a PRR in the 
endosome, the cytosolic type I inducing DNA receptor (DNAR) has as yet remained elusive. In the 
first part of this thesis, the minimal recognition motif for the cytosolic DNAR will be investigated. 
We dissected recognition motifs of short double stranded DNA oligonucleotides (dsODN) in primary 
monocytes and cell lines and identified two different types of immune stimulatory ODN: In addition 
to recognition of long dsDNA, including plasmid DNA, human monocytes detected concatamerized 
short dsODN. Surprisingly, monocytes were also able to recognize short dsODN when harboring 
mismatched terminal G extensions at 5’ and 3’ ends (Gn-dsODN). As determined by gel 
electrophoresis and circular dichroism (CD) spectroscopy under physiological salt and temperature 
conditions, the G extensions of stimulatory G3-dsODN did not form G quartet structures, which 
excluded a polymerization-dependent recognition effect. Fluorescence and FRET-based analysis 
techniques revealed no considerable difference in uptake and degradation between G-ended and C-
ended dsODNs. ShRNA-mediated knock-down experiments revealed involvement of the adaptor 
molecule MITA downstream of the DNAR in dsODN-mediated signaling. Our results define a new 
sequence-dependent recognition motif of short cytosolic dsDNA in human immune cells by an as yet 
unknown DNA receptor.  
Like the genetic material of viruses, nucleic acids of bacteria are recognized by TLRs in the endosome. 
In contrast to exclusively extracellular bacteria, intracellular bacteria have evolved mechanisms to 
escape the endosome and penetrate into the cytosol, where they are accessible to cytosolic PRRs. 
Listeria monocytogenes infection has been linked to cytosolic nucleic acid sensor-dependent type I IFN 
induction. Current knowledge indicates that immune cell type I IFN response to Listeria is processed 
via the bacterial DNA. However, it is tempting to speculate that like DNA, RNA can enter into the 
cytosol. Using a novel, sensitive labeling method, we were able to show cytosolic access of Listeria 
RNA during infection. Furthermore, transfection of bacterial RNA into the cytosol of human 
monocytes or epithelial cells resulted in a type I IFN response, which was dependent on RNA 
phosphorylation. In contrast to monocytes, epithelial cells were not triggered by bacterial DNA, 
providing a non-redundant nucleic acid recognition pathway. Notably, knock-down of RIG-I in 
epithelial cells showed a diminished IFN response to both Listeria RNA and infection. This 
characteristic was only minimally evident in monocytic cells. We conclude that RIG-I mediated 
recognition of Listeria monocytogenes plays a role in infection of non-immune cells lacking a 
mechanism for a direct response to bacterial DNA. 
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Zusammenfassung 
Das angeborene Immunsystem identifiziert Pathogene mittels Pathogenerkennungsrezeptoren (PRR), 
die sich in verschiedenen Zellkompartimenten befinden. Komponenten der Bakterien-Zellwand und 
konservierte Proteine werden durch Toll-ähnliche Rezeptoren (TLRs) auf der Zelloberfläche oder 
durch Nod-ähnliche Rezeptoren (NLR) im Zytosol detektiert. Viren werden über ihre Nukleinsäuren 
von TLRs im Endosom und RIG-I ähnliche Rezeptoren im Zytosol erkannt. Obwohl die Erkennung 
von bakterieller- und viraler DNA durch TLR9 im Endosom gut charakterisiert ist, konnte bisher der 
korrespondierende zytosolische Typ I IFN induzierende DNA-Rezeptor (DNAR) nicht identifiziert 
werden. Im ersten Teil dieser Dissertation wurde das Minimalerkennungsmotif des zytosolischen 
DNAR untersucht. Dabei wurden Monozyten und monozytäre Zelllinien mit doppelsträngigen DNA 
Oligonukleotiden (dsODN) stimuliert und die Typ I IFN-Antwort analysiert. Neben der Erkennung 
von langer DNA, wie z.B. Plasmid-DNA, reagierten Monozyten auf konkatamerisierte kurze 
dsODNs und kurze dsODN, wenn diese ungepaarte Gn-Überhänge (n≥2) aufwiesen (Gn-dsODN). 
Wie durch Gelelektrophorese und Zirkuläre Dichroismus-Spektroskopie gezeigt wurde, bildeten 
immunstimulatorische G3-dsODN keine intermolekularen G-Tetraden aus, was eine Polymerisation 
und somit eine längenabhängige Erkennung ausschließt. Fluoreszenz- und FRET-basierte 
Analysetechniken zeigten keinen deutlichen Unterschied bezüglich Aufnahme und Abbau von 
stimulatorischen G3-dsODN und nicht-stimulatorischen C3-dsODN. ShRNA-vermittelte Knock-
Down-Experimente zeigten die Beteiligung des Adapters MITA aus dem bisher bekannten DNAR-
Signalweg bei Gn-dsODN-induzierter Immunstimulation. Die Gn-dsODN-Struktur stellt somit ein 
neues sequenzabhängiges Erkennungsmotiv des bisher noch nicht identifizierten DNAR dar. 
Ähnlich wie das genetische Material von Viren können bakterielle Nukleinsäuren im Endosom 
erkannt werden. Im Gegensatz zu rein extrazellulären Bakterien haben intrazelluläre Bakterien 
Strategien entwickelt, aus Phagolysosomen ins Zytosol zu entkommen, wo sie für zytosolische PRRs 
erreichbar sind. Listeria monocytogenes Infektionen sind mit Nukleinsäurenabhängiger Typ I IFN 
Induktion assoziiert worden. Bisherige Studien zeigten, dass die Typ I IFN Induktion durch Listerien 
über bakterielle DNA (bacDNA) erfolgt. Der Transfer und die Erkennung von bakterieller RNA 
(bacRNA) sollte jedoch ebenso möglich sein. Mittels einer neuen, sensitiven Visualisierungsmethode 
konnte in dieser Arbeit Listerien bacRNA im Zytosol der Wirtszellen nachgewiesen werden. Die 
Transfektion von bacRNA ins Zytosol von Epithelzellen oder Monozyten induzierte eine Typ I IFN-
Antwort. Jedoch zeigten Epithelzellen im Gegensatz zu Monozyten keine IFN-Antwort auf 
bacDNA. was auf die Erkennung von bacRNA als nichtredundanten Signalweg schließen lässt. Der 
Knock-Down von RIG-I bewirkte eine starke Verminderung der Typ I IFN-Antwort in 
Epithelzellen, jedoch kaum in monozytären Zellen. Dies deutet darauf hin, dass die RIG-I–
vermittelte Erkennung von Listerien vor allem eine wichtige Rolle bei der Infektion von nicht-
Immunzellen ohne einen Mechanismus der zytosolischen DNA-Erkennung spielt. 
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1. Introduction 
 
1.1. The components of the innate immune system 
The function of an organism’s immune response is to protect it from pathogens that would 
otherwise cause disease. Most higher organisms have two immune responses; the adaptive or 
acquired immune response and the innate immune response. Adaptive immunity concerns the 
response and activation of antigen-specific immune cells to the pathogen. It is based on the 
presence of highly specialized lymphocytes. By contrast, the innate immune system recognizes 
pathogens by germ line encoded pattern recognition receptors and defends invading pathogens 
either directly or by activating the adaptive immune response.  
 
1.1.1. Cells of the innate immune system 
The cells of the innate immune system are not subject to the clonal selection process present in 
the adaptive immune system (Forsdyke 1995). Pathogens are recognized by broadly specific 
cells and their receptors, usually within minutes of infection. To be able to do this, the cells of 
the innate immune system must be ubiquitous and present in relatively high numbers 
throughout the organism. Mainly sup-populations of peripheral blood mononuclear cells 
(PBMC) were analyzed in the course of this thesis (see Fig. 1.1.).  
 
1.1.1.1. Peripheral blood mononuclear cells (PBMC) 
PBMC, like all leukocytes, originate in the bone marrow from multipotent hematopoietic stem 
cells (see Fig. 1.1.). They are obtained from full blood samples by ficoll density gradient 
centrifugation.  
PBMCs, as such, do not comprise a clearly defined subpopulation of cells, but include all 
mononuclear cells present in the blood, such as T cells, B cells and NK cells, as well as 
monocytes, eosinophiles, neutrophiles, myeloid dendritic cells (MDC) and plasmacytoid 
dendritic cells (PDCs). For this thesis monocytes and PDC are of special interest. 
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Fig. 1.1: Progenitor cells of the innate immune system. Hematopoetic stem cells give rise to all the lymphocytes 
of the innate and adaptive immune systems (adapted from (Kenneth Murphy 2008)). MLP= myeloid lymphoid 
progenitors, CLP = common lymphoid progenitors 
 
1.1.1.2. Monocytes 
Monocytes are of special interest because of their response to pathogens and pathogen 
associated molecular patterns (PAMP). Monocytes make up about 15- 20% of a PBMC 
population. They reside in the blood and are the precursor cells of macrophages. When in 
culture, addition of macrophage colony stimulating factor (M-CSF) to monocytes will result in 
monocyte differentiation to macrophages. Monocytes migrate throughout the body and are 
phagocytic, but usually differentiate into macrophages when an infection occurs. There are two 
different populations of monocytes; CD14+hi and CD14+lo/CD16+. CD14+hi monocytes 
differentiate into CD14+lo/CD16+ monocytes (Ziegler-Heitbrock 2007). Monocytes, but above 
all macrophages, migrate to sites of infection and help induce inflammation, alerting the 
adaptive immune system by presenting antigens to immature lymphocytes and secreting 
chemokines and cytokines, including IFNα, which will be discussed further on.  
 
1.1.1.3. Plasmacytoid dendritic cells (PDCs) 
PDCs are dendritic cells that accumulate in peripheral lymphoid tissues. They secrete copious 
amounts of type I IFN in response to certain types of DNA or RNA stimulus and are therefore 
of great interest when researching nucleic acid-induced immune responses. They do not play a 
particularly large role in presenting antigens to naive T cells. They express surface markers such 
as blood dendritic cell antigen 2 (BDCA-2) and CD123, but no CD11c or CD14, the markers 
for DCs and monocytes, respectively (Shortman and Liu 2002). They recognize DNA 
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sequences which contain unmethylated CpG dinucleotides (Hartmann and Krieg 2000; Krug, 
Rothenfusser et al. 2001) and GU-containing RNA (Heil et al. 2004, Hornung et al., 2005). 
CpG containing DNA functions as the ligand for Toll-like receptor 9 (TLR9), a receptor 
vigorously expressed in PDCs (Bauer and Wagner 2002). RNA is recognized by TLR7 (Heil et 
al. 2004, Hornung et al., 2005). 
Blocking the PDC-derived IFN response is accomplished by inhibiting endosome maturation, 
the localization of TLR9. Chloroquine halts the early endosome from lowering its pH, thus 
preventing TLR9 and TLR7 from activation (Rutz, Metzger et al. 2004). 
 
1.1.2. Receptors of the innate immune system 
The innate immune response functions as a highly complex combination of cells and their 
associated receptors. As had been mentioned previously, the innate immune system is capable of 
broadly distinguishing bacterial from viral infection: Pattern recognition receptors (PRR) are 
capable of distinguishing and binding to ligands characteristic of pathogens, such as 
components of the cell wall, (e.g. lipopolysaccharide (LPS)) the locomotor system 
(e.g. flagellin), or nucleic acids with unusual structure, modification or location (Kawai and 
Akira). Researching these receptors and their ligands is of great interest precisely because they 
are part of the innate immune system and, therefore, on call practically immediately in the 
event of an infection. Finding out how to be able to use this characteristic for therapeutic 
purposes should be a fascinating endeavor. 
 
1.1.2.1. Toll-like receptors and their ligands 
Toll like receptor localization 
TLRs are members of the TLR-Interleukin (IL)-1 superfamily. They are membrane-spanning 
receptors and reside either on the cell membrane or in cellular compartments such as the 
endosome. TLRs are expressed by most antigen-presenting cells (APCs) of the innate immune 
system, such as monocytes and macrophages, although subpopulations differ concerning which 
TLRs are expressed (Iwasaki and Medzhitov 2004). Ten different TLR genes have been 
discovered in higher organisms, each recognizing a different pathogen-associated molecular 
pattern (PAMP) (see Fig. 1.2.). (Medzhitov and Janeway 2000),(Barton and Medzhitov 2002). 
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Fig. 1.2: Cellular localizations and ligands of TLRs in human cells. TLRs 2, 4 and 5 recognize bacterial 
lipopeptides, TLR4 recognizes LPS and TLR5 flagellin. The endosomally located TLRs 3, 7 8 and 9 
recognize dsRNA, ssRNA and CpG DNA, respectively. 
 
TLRs are comprised of a leucine-rich-repeat (LRR) ectodomain, which represents the receptor 
half of the protein, and a cytoplasmic domain which is homologous to the IL-1 receptor. (Xu, 
Tao et al. 2000).  
 
Toll- like receptors 1, 2, 4, 5 and 6 
TLRs can be classified into two main groups; the receptors that recognize pathogen cell wall 
components such as LPS and flagellin and are themselves located on the cell surface, such as 
TLRs 1, 2, 4, 5 and 6 (see Fig. 1.2.). The second group is composed of TLRs that bind 
to pathogenic nucleic acids and are situated in the endosome, such as TLRs 3, 7, 8, 9. 
(see Fig. 1.2.) (Du, Poltorak et al. 2000). Endosomally located TLRs require endosomal 
maturation in order for them to recognize their ligands (Ahmad-Nejad, Hacker et al. 2002).  
Concerning the cell-surface TLRs, TLR2 binds to lipoteichoic acids (LTA) of gram positive 
and lipoproteins of gram negative bacteria (Dziarski and Gupta 2000). On macrophages, LPS 
is recognized by TLR4, in association with cluster of differentiation (CD) 14 and MD-2 
(Medzhitov, Preston-Hurlburt et al. 1997; Dziarski and Gupta 2000; Rhee and Hwang 2000). 
TLR5 recognizes flagellin. (Hayashi, Smith et al. 2001), while TLR6 usually acts in concert as 
a heterodimer with TLR2 or TLR1. Binding of these ligands to their corresponding receptors 
results in the production of cytokines with very different effects; TLR2 results in tumor necrosis 
factor alpha (TNFα) induction while TLR4 can induce type I IFN as well as TNFα (De Trez, 
Pajak et al. 2005).  
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Toll-like receptors 3, 7, 8 and 9 
In the endosome, TLR3 recognizes double stranded (ds) RNA, which is generated during viral 
infections (Alexopoulou, Holt et al. 2001). TLR3 binds to its ligand as a dimer (Liu, Botos et 
al. 2008). Activation of TLR3 results in induction of type I IFN. This PAMP is quite useful, 
because most viruses produce dsRNA at some point during their replication.  
TLR7 and TLR8 share a high homology in humans. They reside in the endosome of PDCs 
(TLR7) and monocytes (TLR8) (see Fig. 1.2.), respectively (reviewed in (Barchet, 
Wimmenauer et al. 2008)). They are activated by ssRNA (TLRs 7, 8) or dsRNA (TLR7), 
which although also a motif naturally occurring in human cells, avoids autoimmune recognition 
by localization of TLR7 and TLR8 in the endosome. Human TLR7 and TLR8 had been 
shown to recognize the synthetic compound imidazoquinoline, which is similar to guanosine in 
structure (Heil, Ahmad-Nejad et al. 2003). Guanosine and uridine-rich strands, such as occur 
in vesicular stomatitis virus or influenza virus life cycles, are readily recognized by TLR7 and 
TLR8 (Diebold, Kaisho et al. 2004; Heil, Hemmi et al. 2004; Lund, Alexopoulou et al. 2004; 
Hornung, Guenthner-Biller et al. 2005). Activation of TLR 7 results in type I IFN induction. 
Predominantly found in PDCs (Krug, Rothenfusser et al. 2001; Hornung, Rothenfusser et al. 
2002), TLR9 is the only endosomal receptor to recognize DNA (see Fig. 1.3.). It is 
preferentially activated by CG containing DNA motifs (Hemmi, Kaisho et al. 2003). TLR9 is 
recruited to the endosome from the endoplasmatic reticulum (ER); once there, it is 
proteolytically cleaved and activated (Hacker, Mischak et al. 1998; Ahmad-Nejad, Hacker et 
al. 2002) (see Fig. 1.3.). Unmethylated CpG DNA is one of the characteristics of bacterial 
DNA (mammalian cytosine is highly methylated) and therefore an easily recognizable PAMP 
(Heeg, Sparwasser et al. 1998; Hartmann and Krieg 2000). CpG DNA can induce both the 
antiviral cytokine type I IFN, as well as the inflammatory cytokine IL-12 (Krug, Towarowski et 
al. 2001). TLR9 recognition of CpG DNA is, however, not restricted to bacterial CpG DNA; 
virally-produced CpG DNA has also been shown to induce type I IFN in PDCs (Krug, Luker 
et al. 2004). IgG-coupled DNA-based induction of IFN by TLR9 also has a role in 
autoimmune diseases; internalized chromatin binds to TLR9 and is one of the mechanisms 
thought to be involved in systemic lupus erythematosus (SLE) (Boule, Broughton et al. 2004). 
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Fig. 1.3: TLR9 localization and signaling pathway. Originally situated in the ER, TLR9 translocates into the 
endosome. Once bound to CpG-DNA, the IFN signaling pathway is activated, recruiting MyD88, IRAK4 and 
IRAK 1, which in turn activate IRF7 and NFkB. 
 
1.1.2.2. TLR signaling pathways 
There are two main pathways of TLR signaling; the MyD88-depdendent and MyD88-
independent pathway (see Fig. 1.4.).  
 
Fig.1.4: TLR signaling pathways. After a TLR binds to its ligand, two main transcription factors are activated, 
mostly resulting in production of inflammatory cytokines or type I IFN. MyD88 is recruited to the TIR 
domains of TLRs 1, 2, 4, 5 and 6. Once there, it recruits IRAK4, 1 and 2, which phosphorylate TRAF6. This 
leads to ubiquitinylation of TAK1, activation of IKKα and β and dissociation of IkB from NF-κB. TRIF is 
recruited upon TLR3 activation and interacts with TRAF6 and the IKKi/TBK1 complex, resulting in IRF3 
phosphorylation and induction of type I IFN. 
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The MyD88-dependent pathway 
TLR-mediated cytokine induction is dependent on the adaptor protein in the cytoplasm 
relaying the TLR signal (Rifkin, Leadbetter et al. 2005). The main adaptor molecule, MyD88, 
binds to all the TLRs except for TLR3 and, in some cases, TLR4 (see Fig. 1.4.). It starts a 
signaling pathway inducing cytokines such as IFNα, IL-12p40 and IL-6. MyD88 recruits IL-1 
receptor associated kinases (IRAK). IRAK-1, 2 and 4 are of great importance for the MyD88-
dependent pathway (Suzuki, Suzuki et al. 2002); they activate the E3 ligase tumor necrosis 
receptor associated factor 6 (TRAF6). TRAF6 transmits the signal to TGFβ-activated kinase 
(TAK1). Once phosphorylated, TAK1 activates the NFkB pathway via IkB kinase (IKK). A 
protein similar to MyD88, TIR domain containing adaptor protein (TIRAP), has been found 
to function together with MyD88 in TLR 2 and 4 pathways, but not for TLRs 7, 8 and 9, 
affording a tidy signaling specificity for MyD88-dependent TLR pathways (Horng, Barton et 
al. 2002; Kagan and Medzhitov 2006) (see Fig. 1.4.). The endosomal receptors TLRs 7 and 9 
in PDC recruit MyD88, which, after activating the IRAK4-TRAF6 complex, phosphorylates 
IRF7. IRF7, structurally very similar to IRF3, translocates to the nucleus and induces IFNβ 
production (Honda, Yanai et al. 2005) (see Fig. 1.4.).  
 
The TRIF-dependent pathway  
MyD88 is not involved in the TLR3 pathway and only partly involved in the TLR4 pathway; 
MyD88-deficient macrophages showed only a slight delay of the NFκB pathway when 
confronted with LPS (Kawai, Adachi et al. 1999). The TIR-domain containing adaptor protein 
inducing IFNβ (TRIF) is the cornerstone of the MyD88-independent pathway (Yamamoto, 
Sato et al. 2003). TRIF is recruited to TLRs 3 and 4, then recruits Tank binding kinase-1 
(TBK1), which phosphorylates IRF3 (Fitzgerald, McWhirter et al. 2003; Honda and 
Taniguchi 2006). TRIF also recruits TRAF6, together with RIP1; they complex with TAK1, 
activating NFκB. This combines MyD88-independent and dependent pathways (Cusson-
Hermance, Khurana et al. 2005). As TLR4 is part of both the MyD88-dependent and 
independent pathways, it is possible that TLR4 first induces TIRAP-MyD88 signaling at the 
plasma membrane and is then endocytosed and activates TRAM-TRIF signaling from early 
endosomes (Kagan, Su et al. 2008).  
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1.1.2.3. RNA helicases and their ligands 
The innate immune system is comprised not only of membrane-bound TLRs, but also includes 
cytosolic PRRs. Some of the best-known cytosolic nucleic acid receptors are the helicases RIGI 
and Mda-5 (Yoneyama, Kikuchi et al. 2004; Kawai and Akira 2006). They both recognize 
pathogenic RNA in the cytosol, but very different motifs (see Fig. 1.5.). 
 
Fig. 1.5: Cytosolic recognition of RNA. RNA from picornaviruses and the synthetic RNA strand pI:C are 
recognized by Mda-5. Short 5’ triphosphate dsRNA is recognized by RIG-I. Once activated, the CARD 
domains of the helicases associate with IPS-1 and induce either a type I IFN response or result in the 
production of inflammatory cytokines. 
 
RIG-I 
Retinoic acid-inducible gene I possesses two caspase recruitment (CARD)-like domains, which 
are crucial for interaction with adaptor proteins further downstream on the activation pathway. 
They associate with IFNβ stimulator-1 (IPS-1), located on the outer membrane of 
mitochondria. IPS-1, in turn, activates NFkB signaling through Fas-associated death domain 
protein and RIP-1 (Kawai, Takahashi et al. 2005). An alternative signaling pathway includes 
IKKi and TBK-1 in order to phosphorylate IRF3 for IFNβ induction (see Fig. 1.5.). 
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RIG-I is present in its inactive form in the cytosol and is activated only upon presence of 
dsRNA in the cytoplasm. 5’-triphosphorylated dsRNA is vitally necessary for an IFN response. 
5’ triphosphate, uncapped RNA is atypical for the human cell and as such well suited as a 
PAMP. The cellular RNAs nonetheless present in the cytosol carry modifications such as 
pseudouridine and 2’O methyl. They therefore do not activate RIG-I (Hornung, Ellegast et al. 
2006). ATP hydrolysis is needed for the CARD domains to become accessible for IPS-I 
binding (Yoneyama, Kikuchi et al. 2004) (see Fig. 1.6.). Inactive, RIG-I is a monomer; 
hydrolysis leads to dimerization and the possibility of CARD-CARD interactions with IPS-I 
(Kawai, Takahashi et al. 2005) (see Fig. 1.5.). In our lab, it has recently been found that short 
dsRNA with a 5’ triphosphate is preferentially recognized, although the main criterion is base 
pairing at the 5’ triphosphate end and not a complete double-stranded sequence (Schlee, Roth 
et al. 2009). Recent publications have demonstrated that the long dsDNA sequence poly(dA-
dT) is also recognized by RIG-I after having been transcribed into RNA by RNA polymerase 
III (Ablasser, Bauernfeind et al. 2009), therefore planting a long-thought DNA receptor ligand 
firmly into the RIG-I domain. 
 
Fig.1.6 Structure and function of RIG-I. The two CARD domains associate with each other and with IPS-I 
upon ATP-dependent binding of short dsRNA sequences. The C-terminal regulatory domain (CTD) binds 
RNA, but only if it has a 5’ triphosphate. It thus activates the RIG-I ATPase, enabling the CARD domains to 
dimerize and bind to IPS-I. 
 
Mda-5 
Melanoma differentiation associated gene 5 shows a certain amount of homology to RIG-I 
(Yoneyama, Kikuchi et al. 2005) (see Fig. 1.5.). It is the receptor that recognizes RNA from 
viruses which do not possess 5’triphosphorylated genomic RNA, like picornaviruses, which are 
not recognized by RIG-I (Gitlin, Barchet et al. 2006; Kato, Takeuchi et al. 2006). This, along 
with the different ligand motifs concerning either helicase, namely short 5’ triphosphate dsRNA 
for RIG-I and long, intermittently double-stranded picornavirus RNA strands, shows that the 
receptors are by no means to be considered redundant (Kato, Takeuchi et al. 2008). 
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RIG-I and Mda-5 signaling pathways 
RIG-I and Mda-5 share signaling pathways, ending in either induction of type I IFN or 
proinflammatory cytokines (see Fig. 1.5.). Once the RNA ligand of choice is bound to the 
receptor, the CARD domains recruit IPS-1 (Kawai, Takahashi et al. 2005; Meylan, Curran et 
al. 2005; Seth, Sun et al. 2005; Xu, Wang et al. 2005). IPS-1 has a CARD domain, a proline-
rich-region (PRR) and a transmembrane domain at its C-terminal end. IPS-1 is therefore 
permanently located at the mitochondrial membrane. It recruits proteins on the NFkB 
signaling pathway, TRAF6 and TRAF2 (see Fig. 1.7.). Meanwhile, TRAF3 binds to the PRR 
in the middle of IPS-1 and uses ubiquitin to form a scaffold of sorts for the IKKe-TBK1 
complex. This complex phosphorylates IRF3 and 7, ultimately resulting in type I IFN induction 
(see Fig. 1.7.) (Kawai, Takahashi et al. 2005; Meylan, Curran et al. 2005; Xu, Wang et al. 
2005). 
 
Fig 1.7.: Both arms of the signaling pathway of RIG-I/Mda-5 going via IPS-1. Upon binding, TRADD and 
TRAF6/2/3 associate with IPS-1 and recruit NEMO-IKK and NEMO-TBK-1 complexes. This ensures that 
both the NFkB and IRF3/IRF7 pathways are triggered.  
 
1.1.2.5. DNA recognition in the cytosol 
Rotem et al (Rotem, Cox et al. 1963) had discovered an IFN response to murine and yeast 
nucleic acids in chick fibroblasts, a 1963 finding which had not been further investigated until 
the end of the 20th century (Yamamoto, Yamamoto et al. 1992). After multiple groups 
discovered IRF-3 dependent recognition of DNA in the cytosol (Ishii, Coban et al. 2006; 
Stetson and Medzhitov 2006), the spotlight was on the cytosolic DNA receptor. The clinical 
relevance of cytosolic DNA recognition is self-explanatory. Cytosolic DNA can have multiple 
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origins, be it from apoptotic cells (Ishii, Suzuki et al. 2001), DNA viruses or certain types of 
bacteria (Stetson and Medzhitov 2006). Autoimmune responses to self-DNA are linked to 
systemic lupus erythematosus (SLE) (reviewed in (Rahman and Isenberg 2008)). In the past 
years, various components of cytosolic recognition of DNA have been discovered. 
 
Z-DNA binding protein-1 (ZBP-1) 
A type I IFN response dependent on a cytosolic DNA receptor was published in 2007 
(Takaoka, Wang et al. 2007). Originally named ZBP-1, it had been discovered in tumor 
stromal cells and later also localized in immune cells (Schwartz, Behlke et al. 2001; 
Deigendesch, Koch-Nolte et al. 2006). As evidenced in the name, ZBP-1 was found to bind 
Z-form DNA. Z-form DNA possesses a left-handed double helical structure in which its helix 
winds clockwise with very little difference between its minor and major grooves. Some of the 
characteristics of ZBP-1 made it exceedingly interesting as a possible cytosolic DNA receptor: 
it was IFN inducible, it had similar DNA-binding domains to an RNA editing enzyme and had 
multiple C-terminal serine/threonine phosphorylation sites (Fu, Comella et al. 1999; Takaoka, 
Wang et al. 2007). Takaoka et al overexpressed ZBP-1 and could show an IRF-3 dependent 
type I IFN response to B-DNA. B-DNA presents itself as a right-handed double helical 
structure. It is the most common of the three DNA forms A, B and Z. ZBP-1 was 
demonstrated to colocalize with TBK-1 and IRF3. When ZBP-1-siRNA treated cells were 
infected with DNA virus or transfected with poly(dA-dT), the IRF-3 activation and 
subsequent type I IFN induction was reduced. DNA was shown to bind to ZBP-1 irrespective 
of sequence, but lengths below 100bp were poorly recognized (Takaoka, Wang et al. 2007) (see 
Fig. 1.8.).  
All of these discoveries hinted at ZBP-1 being the cytosolic DNA receptor, but two later 
papers disproved this theory. Ishii et al showed that cells from ZBP-1 and MyD88/TRIF 
knockout mice still showed a robust IFN response in answer to B-DNA vaccination or 
transfection, thus rendering ZBP-1 non-essential (Ishii, Kawagoe et al. 2008). Lippmann et al 
overexpressed human ZBP-1 or ZBP-1ΔZα, a splice variant lacking one of the DNA binding 
domains, in human A549 cells. They found no effect on IFNβ production in A549 cells 
infected with bacteria or transfected with poly(dA-dT). Nor did ZBP-1 siRNAs suppress 
IFNβ expression in response to bacterial or poly(dA-dT) stimulation (Lippmann, Rothenburg 
et al. 2008). This finding is of particular interest because both poly(dA-dT) and intracellular 
bacteria are thought to be, in part, recognized via RIG-I (Ablasser, Bauernfeind et al. 2009). 
The latter will be discussed as part of this thesis later on. 
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Fig. 1.8.: ZBP-1/DAI and its signaling, proposed by (Takaoka, Wang et al. 2007). The Zα, Zß and D3 
domains of DAI bind to dsDNA, with the RHIM recruiting RIP3 and RIP1, which in turn initiate the 
NEMO and TBK-1 signaling pathway. RHIM: RIP homotypic interaction motif, RIP: receptor-interacting 
protein kinase 1 
 
DNAses 
Endogenous DNA is not usually found in the cytosol but rather restricted to the nuclear 
envelope or the mitochondria. Exceptions are replication and cell death. Mammalian DNA 
found where it shouldn’t be is digested by the host DNases I, II and III. They degrade DNA 
found in the extracellular space, the endosome and the cytosol (Murai, Yamanaka et al. 1980; 
Mazur and Perrino 1999; Oliveri, Daga et al. 2001). Stabilizing DNA with phosphothioate 
modifications results in heightened type I IFN induction (Haas, Metzger et al. 2008).  
DNaseI is an endonuclease that reduces long chromatin strands in necrotic cells to short, non-
immunogenic dsDNA segments. DNase I deficiency in mice leads to SLE-type symptoms, an 
indication that mutations in the human DNAse I gene are one of the factors in SLE 
(Yasutomo, Horiuchi et al. 2001).  
The endonuclease DNase II is involved in DNA clearance from apoptotic cells and works best 
in an acidic environment. Deficiency of DNase II leads to accumulation of dsDNA in 
macrophages and is lethal in mice. It can, however, be rescued by knocking out the IFN 
receptor 1 (IFNR1). Even with this rescue, though, mice develop symptoms mimicking 
rheumatoid polyarthritis (Yasutomo, Horiuchi et al. 2001). 
The intensely studied exonuclease DNase III (or TREX1) has been tapped as having a 
proofreading function for the human DNA polymerase (reviewed in (Vilaysane and Muruve 
2009)). TREX1 localizes to the ER and regulates accumulation of ssDNA that could initiate 
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an innate immune response to DNA. TREX1-deficient mice developed inflammatory 
myocarditis and cardiomyopathy within months (Morita, Stamp et al. 2004). When bred to 
IRF3 or IFNR1-deficient mice, the TREX1 knockout did not result in medium-term lethality. 
This demonstrated that TREX1 was intimately associated with IRF3-dependent IFN induction 
(Stetson, Ko et al. 2008). Although TREX1 may not be a candidate for the role of cytosolic 
receptor, the connection to IRF3 and the type I IFN response is not to be neglected. 
 
Absent in melanoma 2 (AIM-2) 
In addition to the TLR family and the RIG-I-like helicases (RLH), another family of innate 
receptors has been thoroughly investigated: the nucleotide-binding domain leucine rich repeat 
(NLR) family. NLRs are cytosolic PRRs, but differ from TLRs and RLH in that they do not 
induce a type I IFN response, mediating caspase I activation and NFκB signaling instead. The 
receptor family has certain similar features in its composition: LRRs, signaling and NOD 
domains. Some NLRs bind microbial components (Franchi, Eigenbrod et al. 2009), but most 
NLRs are part of inflammasomes, a collection of complexes that activate caspase 1 to cleave 
pro-IL1 to its active form (reviewed in (Petrilli, Dostert et al. 2007)). AIM-2 recruits the 
caspase-1 protease in response to binding of dsDNA (Burckstummer, Baumann et al. 2009; 
Hornung, Ablasser et al. 2009).  
 
Fig. 1.9.: AIM-2 and cytosolic dsDNA. The AIM-2 inflammasome interacts with dsDNA via its HIN200 
domain. The PYD domain recruits ASC, which in turn associates with Pro-caspase 1. Pro-caspase 1 cleaves 
pro-IL-1β and pro-IL18 to soluble IL-1β and IL-18 
 
AIM-2 is a member of the HIN200 family and expressed in the cytoplasm (see Fig. 1.9.). 
Other HIN2000 family members, such as Ifi16 and IfiX are not cytoplasmic, but rather found 
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in the nucleus (Roberts, Idris et al. 2009). It binds directly to cytoplasmic DNA via its HIN200 
domain, oligomerizes, and recruits the adaptor protein ASC via its PYD domain, thus 
initiating the pro-IL-1β cleavage process (see Fig. 1.9.). Caspase recruitment occurred with 
mammalian, synthetic, viral and bacterial DNA (Hornung, Ablasser et al. 2009) (Fernandes-
Alnemri, Yu et al. 2009). 
 
Mediator of IRF3 activation (MITA)/stimulator of interferon genes (STING) 
Recently, a new adaptor protein has been discovered. Two groups had simultaneously identified 
a membrane protein that could activate IRF3 and, therefore, induce a type I IFN response to 
viral infection. Dubbed either MITA or STING, the protein was found to contain multiple 
transmembrane domains and to colocalize with the RIG-I adaptor protein IPS-1 (Ishikawa and 
Barber 2008; Zhong, Yang et al. 2008). Originally found to interact with IPS-1, it was also 
mentioned that the IFN response to cytosolic dsDNA was also abrogated when MITA was 
inhibited. Further publications then cemented the necessity of MITA presence for cytosolic 
dsDNA-induced IFN (Ishikawa, Ma et al. 2009). 
MITA is an ER resident transmembrane protein. It interacts with IPS-1 and RIG-I, and 
participates in the type I IFN induction pathway (Sun et al., 2009) (see Fig. 1.10.). MITA was 
shown to not be involved in the TLR pathway (Ishikawa and Barber 2008), and did not co-
immunoprecipitate with Mda-5. MITA-deficient cells could not induce type I IFN production 
in response to transfected poly(dA-dT), viral DNA or Listeria monocytogenes (Ishikawa and 
Barber 2008). TBK1-mediated phosphorylation of MITA was critical for virus-triggered 
activation of IRF3 (Zhong, Yang et al. 2008).  
Ishikawa et al found that IFNβ production in MITA-deficient MEFs was abrogated in 
response to oligonucleotide dsDNA containing or lacking CpG sequences, viral DNA and 
L. monocytogenes. MITA–/– macrophages transfected with dsDNA revealed that MITA 
functioned independently of the AIM2 inflammasome. MITA–/– plasmacytoid dendritic cells, 
however, still induced a type I IFN response to exogenous CpG DNA, thus confirming the 
MITA-independent TLR9 response (Ishikawa, Ma et al. 2009). 
The localization of MITA between the ER and the mitochondria would imply MITA to be 
a junction point linking RIG-I and dsDNA-mediated innate immune responses 
(see Fig. 1.10.).  This way it could detect viral RNAs in translation in addition to DNAs, 
inducing antiviral immunity via TBK1. A MITA/TBK1 complex is formed following 
transfection with DNA and then shuttles to endosomal compartments leading to a robust 
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innate immune response (Ishikawa and Barber 2008; Zhong, Yang et al. 2008; Ishikawa, Ma et 
al. 2009).  
Although a role for MITA as the central adaptor protein mediating both intracellular DNA 
and negative-stranded RNA virus IFN responses in all cell types is well established, many 
questions remain unanswered, first and foremost of course the receptor molecule that bridges 
the gap between intracellular DNA detection and type I IFN induction. 
 
Fig. 1.10.: MITA signaling pathways. MITA has been shown to be a transmembrane protein resident in the 
ER. MITA interacts with IPS-1. Interactions of the DNAR, DAI, or a direct interaction with RNA 
polymerase III without going via RIG-I are all hypothetical and currently under investigation. 
 
1.1.3. Clinical relevance of cytokines of the innate immune system 
Cytokines are signaling substances secreted by cells of the immune system, facilitating cellular 
communication. They are immunomodulating agents that are of great interest for their 
therapeutic application, but also for further elucidation of infection pathways. Cytokines can be 
broadly divided into two groups, those that favor cellular immune responses and those that 
favor antibody responses (Cannon 2000). The following section will briefly introduce the 
cytokines of interest in investigating recognition of pathogens and their nucleic acids.  
 
1.1.3.1. Interleukins 1α and 1β 
The proinflammatory chemokine IL-1 was discovered to induce fever, control lymphocytes, 
increase the number of bone marrow cells and cause degeneration of bone joints. It consists of 
two isoforms, IL-1α and IL-1β (March, Mosley et al. 1985; Dinarello 1994). 
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IL-1α  
IL-1α is a pleiotropic cytokine that plays a role in multiple immune responses, inflammatory 
processes, and hematopoiesis. It is manufactured by monocytes and macrophages as a 
proprotein, which is proteolytically processed and released in response to cell injury, inducing 
apoptosis (March, Mosley et al. 1985). 
 
IL-1α in disease 
Polymorphism of the IL-1A genes could be associated with rheumatoid arthritis and 
Alzheimer's disease (Hu, Li et al. 2009), which is of interest because rheumatoid arthritis is also 
associated with TREX1 deficiency and can therefore considered to be affiliated with nucleic 
acid-based disease. IL-1α has also been demonstrated to be essential for maintenance of skin 
barrier function, especially with increasing age (Hu, Wang et al. 2003; Barland, Zettersten et al. 
2004). 
 
IL-1β 
The IL-1β precursor pro-IL-1β is cleaved by the cytosolic caspase 1 (as described for the AIM-
2 inflammasome). A thiol protease splits the product to give mature IL-1β, which is an 
important mediator of the inflammatory response, and is involved in cell proliferation, 
differentiation, and apoptosis (March, Mosley et al. 1985). Synthesis of IL-1β is induced by, 
among others, TLR agonists such as LPS or nucleic acids. The precursor of IL-1β is present in 
the cytosol, but is transported to the lysosome, where it is combined with procaspase-1. Only 
after the active caspase 1 is cleaved from this procaspase-proIL-1β complex can caspase 1, in 
turn, cleave IL-1β into its active form (Dinarello 2005). The whole process is tightly regulated; 
the phospholipase A2 is necessary for the caspase activation in the lysosome, while the 
phospholipase C is needed for lysosomal exocytosis and secretion of IL-1β (Dinarello 2005). 
 
IL-1β in disease 
It stands to reason that a system so tightly regulated as the one of IL-1β results in 
complications when the signaling doesn’t go as planned. Various diseases have been connected 
to aberrant IL-1β levels; allergy and rheumatoid arthritis, to name a few (Buchs, di Giovine et 
al. 2001; Um, Do et al. 2004; Hanninen, Katila et al. 2008). Blocking IL-1β secretion with 
IL-1 receptor antagonists prevents cold-associated acute inflammation in familial cold 
autoinflammatory syndrome (Hoffman, Rosengren et al. 2004), as well as mitigating neonatal 
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onset multisystem inflammatory disease (Lovell, Bowyer et al. 2005; Goldbach-Mansky, 
Dailey et al. 2006). 
 
1.1.3.2. IL-6  
IL-6 is an interleukin that acts as both a pro-inflammatory and anti-inflammatory cytokine; it 
is secreted by macrophages and T cells (Li and He 2006), stimulating immune response to 
tissue damage and leading to inflammation. Concerning the immune response to a foreign 
pathogen, IL-6 has been shown, in mice, to be required for resistance against the bacterium, 
Streptococcus pneumoniae (van der Poll, Keogh et al. 1997). IL-6's role as an anti-
inflammatory cytokine is mediated through its inhibitory effects on TNF-alpha and activation 
of IL-1ra and IL-10. IL-6 is a prominent fever mediator and its acute phase response. It is 
secreted by macrophages in response to PAMPs such as LPS and nucleic acids, inducing 
intracellular signaling cascades that give rise to inflammatory cytokine production (Pauls, 
Senserrich et al. 2007). IL-6 signaling is accomplished when IL-6 binds to its receptor, which is 
composed of CD126 and CD130. As IL-6 interacts with CD126, it triggers CD126 and 
CD130 to form a complex, activating the receptor. CD130 then initiates a signal cascade 
through the Janus kinases (JAK) and Signal Transducers and Activators of Transcription 
(STAT) pathways. 
 
IL-6 in disease 
IL-6 is of great clinical interest because of its involvement in various diseases; diabetes, 
atherosclerosis, SLE, prostate cancer, and rheumatoid arthritis all have been shown to be 
influenced by IL-6 concentration (Tackey, Lipsky et al. 2004; Kristiansen and Mandrup-
Poulsen 2005; Dubinski and Zdrojewicz 2007). The case for blocking of IL-6 in SLE is of 
particular relevance because of the nucleic-acid-associated pathology of SLE. Tackey et al 
showed that IL-6 played a critical role in the B cell hyperactivity and immunopathology of 
human SLE, thus mediating tissue damage. It was proposed that blocking the effect of IL-6 in 
humans may improve lupus by interacting with the auto inflammatory process of SLE both 
systemically and locally. It is also known that metastatic cancer patients have higher levels of 
IL-6 in their blood, doubly putting the spotlight on IL-6 research as therapy against many of 
these diseases (reviewed in (Smolen and Maini 2006)). 
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1.1.3.3. Interferons 
IFNs are cytokines released by cells in response to PAMPs or tumor cells. As cytokines, they 
serve as communication between cells to activate the body’s defense system. They are so named 
because of the function that caused them to be identified in the first place; their ability to 
"interfere" with viral replication within host cells. They do, however, have other functions: 
activating immune cells, such as macrophages; up-regulating antigen presentation to T cells, 
and increasing the ability of uninfected host cells to resist new infection by virus. Type I IFNs 
IFNα, IFNβ and IFNω all bind to the IFNα receptor (IFNAR). Type II IFN IFNγ binds to 
the IFNγ receptor (IFNGR).  
Once a virally infected cell releases IFN, the neighboring cells, in response to IFN, produce 
large amounts of protein kinase R (PKR). PKR phosphorylates the eukaryotic translation 
initiation factor-2 (eIF-2) in response to new viral infections. eIF-2 forms an inactive complex 
with eIF2B, to reduce protein synthesis within the cell. Additionally to PKR, IFN and dsRNA 
also induces and activates RNase L, which cleaves RNA intracellularly to further reduce protein 
synthesis of both viral and host genes (Urisman, Molinaro et al. 2006). Inhibition of protein 
synthesis, when long enough, destroys both the virus and infected host cells. IFNs also induce 
production of interferon-stimulated genes (ISGs), genes that code for hundreds of proteins and 
can generally be classified to have roles in combating viruses. IFNs limit viral spread by 
increasing the activity of antitumor protein p53, which kills virus-infected or cancer cells by 
promoting apoptosis (Pestka 2003). 
Major histocompatibility complex molecules MHC I and MHC II are upregulated in response 
to IFN; higher MHC I expression increases antigen presentation. IFNs also increase 
immunoproteasome activity; the immunoproteasome processes viral peptides for loading onto 
the MHC I molecule, thereby increasing the recognition and killing of infected cells by T cells. 
Meanwhile, higher MHC II expression increases presentation of viral peptides to helper T cells. 
IFNs induction occurs predominantly in response to PAMPs. PAMPs bind to their PRRs, 
which start a signaling cascade ending in induction and release of type I IFNs. 
 
Type I IFNs  
Together with type II IFN, type I IFNs represent one of the most important classes of 
cytokines. They influence a great palette of biological functions, the ones of interest here being 
those affecting the immune system. IFN-α/β affects the development of immunocyte lineages, 
innate immunity, and most aspects of the adaptive immune response. The reason for their wide 
range of effects lies in their receptors. Activating IFNR leads to modulation in expression of 
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hundreds of genes (Der, Zhou et al. 1998) (reviewed in (Pestka 2000).  
Ubiquitously expressed, IFN-α and -β share a heterodimeric receptor composed of IFNAR1 
and IFNAR2 subunits. Both chains are required for signal transduction. Multiple cell types 
display small (200 to 6000) numbers of these high-affinity receptors. Binding of IFNα/β 
results in receptor dimerization, and then to auto- and transphosphorylation of the two 
receptor-associated Janus protein tyrosine kinases (Tyk2 on IFNAR1 and Jak1 on IFNAR2). 
Phosphorylation of the Janus kinases leads to phosphorylation of the cytosolic domain of 
IFNAR1, thus making docking sites for STAT2 (connected with STAT1 on IFNAR2). 
STAT2 is then phosphorylated and serves as a platform for recruitment of STAT1. The 
activated STAT1/STAT2 heterodimers then translocate into the nucleus, where they associate 
with IRF9 to form the heterotrimeric complex IFN-stimulated gene factor 3 (ISGF3). ISGF3 
then binds to upstream regulatory consensus sequences of IFN-α/β-inducible genes, also 
known as ISRE, and initiates transcription (reviewed in (Stark, Kerr et al. 1998)). Most cells 
can produce type I IFNs, although pDCs are considered the main IFNα producing population 
(Colonna, Krug et al. 2002). IFN-α/β activate several other pathways, including transcription 
of genes containing IFN stimulated regulatory elements (ISRE) and Gamma-activated sites 
(GAS) (reviewed in (Platanias 2005)). Negative regulation of type I IFN signaling is 
accomplished by various mechanisms, including receptor internalization and degradation, 
dephosphorylation of Jaks and STATs by several phosphatases, induction of suppressors of 
cytokine signaling (SOCS), and repression of STAT-mediated gene activation by protein 
inhibitors of activated STATs (PIAS)(reviewed in (Theofilopoulos, Baccala et al. 2005)). 
 
Type I IFNs in disease 
Type I interferon (IFN) is produced by the innate immune system in several autoimmune 
diseases, such as systemic lupus erythematosus (SLE), polymyositis, and systemic sclerosis. In 
these diseases, immune complex (IC)-containing DNA or RNA may act as endogenous IFN 
inducers. The abilities of these ICs to reach the endosomes in the plasmacytoid dendritic cells 
(PDC) cause the intracellular toll-like receptor (TLR) to initiate a cascade of transcription 
factors - a critical step in triggering type I IFN production. A special configuration of the 
nucleic acid (NA), such as CpG-rich non-methylated DNA or GU-rich RNA, appears crucial. 
However, other components of the IC, like HMGB1, may also be necessary. Studies regarding 
the genetic background of autoimmune diseases suggest that variants of genes involved in both 
IFN production and response are associated with disease susceptibility. This knowledge is 
important for the development of new therapeutic strategies in autoimmune diseases. Infection 
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induces the production of type I IFNs, resulting in fever and aching muscles. The beneficial 
effects of IFNs, i.e. the induction of IFN-stimulated genes (ISG) in cells with IFNR, have 
been extensively used for therapeutic uses. The TLR7 agonist imidazoquinoline is the main 
ingredient of Aldara cream, which is used for actinic keratosis, basal cell carcinoma, papilloma 
and external genital warts. Instead of inducing IFN production with administration of PRR 
agonists, synthetic IFNs can also be given as antiviral, antiseptic and anticarcinogenic drugs, as 
well as treating autoimmune diseases. IFNβ, for example, is used for treatment of multiple 
sclerosis (Hafler 2004).  
Effects, both detrimental and beneficial, of IFN-α/β in several other autoimmune diseases have 
been reported, such as Sjögren’s syndrome, myasthenia gravis, autoimmune hemolytic anemia, 
thyroiditis, uveitis and Behcet’s disease. IFNβ reportedly inhibited collagen-induced arthritis in 
mice and rhesus monkeys and had some beneficial effects in rheumatoid arthritis and Sjögren’s 
syndrome (Tak, Hart et al. 1999; Cummins, Papas et al. 2003). A negative side effect of IFNα 
treatment is autoimmune hemolytic anemia. Hemolytic anemia was significantly reduced in 
IFNAR1-deficient NZB mice (Andriani, Bibas et al. 1996). It is of great interest that IFNα/β 
have a major effect on a high percentage of autoimmune diseases. They are, therefore, an 
excellent candidate on which to start a treatment (Reviewed in (Biggioggero, Gabbriellini et 
al.)).  
IFN therapy can also be administered as cancer treatment, when accompanying chemotherapy 
and radiation. IFN therapy is most effective for treating hematological malignancy; leukemia 
and lymphomas including hairy cell leukemia, chronic myeloid leukemia, nodular lymphoma 
and cutaneous T-cell lymphoma. Recombinant IFNα is used to treat patients with recurrent 
melanomas as well as in hepatitis B and hepatitis C infections. Some patients with hepatitis 
subjected to IFN therapy have a sustained virological response and can clear the virus. Some 
studies demonstrate giving IFN immediately following infection can prevent chronic 
hepatitis C. Once infected, chronic hepatitis C treatment by IFN is associated with reduced 
hepatocellular carcinoma (Reviewed in (Rong and Perelson). IFN therapy can also cause 
immunosuppression. This manifests itself via neutropenia and can result in uncommon 
infection progression (Bhatti and Berenson 2007).  
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1.2. Response of  the innate immune system to c y tosolic  
pathogens 
 
1.2.1. Viruses 
Viruses are ubiquitous pathogens. The immune system blocks the infectious process of the 
majority of them; however, a small fraction succeeds at evading the host immune response or 
subverting it to their own purposes.  
 
1.2.1.1. DNA Viruses  
DNA viruses, such as Adenoviruses, Herpesviruses, Poxviruses, Parvoviruses, Papovaviruses and 
Hepadnaviruses possess a DNA strand encoding their genome. Their infection pathway follows, 
broadly speaking, a common pathway: The virus attaches to a susceptible cell, mostly through 
recognition of a cell surface receptor or receptors. The virus enters the cells and the gapped 
DNA strand is repaired and translocated to the nucleus in a circular form, CCC DNA 
(Mosevitskaia 1978; Bourne, Dienstag et al. 2007). The negative strand of the CCC DNA is 
then used as the template for RNA polymerase II. RNA polymerase II produces longer RNA 
strands, called the pregenome, and shorter mRNAs. The viral mRNAs are translated in the ER 
and the surface antigens of the virus enter the secretory pathway (reviewed in (Chow and Broker 
1994; Boehmer and Lehman 1997; Sugden 2002). The pregenome RNA is translated at low 
efficiency to produce a reverse transcriptase that binds to the pregenome, synthesizing viral 
DNA fit for packaging. Mature nucleocapsids bud out of the ER and are released by 
exocytosis. 
 
DNA virus evasion strategies of the innate immune response 
DNA viruses, as all viruses, are subject to certain restrictions where their capacities of 
interfering with the immune response are concerned. Their strategies are dependent on 
inhibition of antiviral signaling pathways in the host cell. Karposi’s sarcoma-associated 
herpesvirus encodes a viral homolog of the IRF proteins, vIRF3. This inhibits transcriptional 
IRF7 activity and, therefore, activation of ISGs (Zhu, King et al. 2002). KSHV also encodes 
the K-bZIP, a transcription factor that binds to the regulatory domain of the IFNβ promoter, 
thus competing with IRF3 for the binding site. This results in abrogation of the RANTES and 
CXCL11 response (Lefort, Soucy-Faulkner et al. 2007). The genome of the human 
herpesvirus Epstein-Barr virus encodes the protein BZLF-1. BZLF-1 interacts with IRF7 and 
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therefore inhibits the type I IFN response induction (Hahn, Huye et al. 2005). The vaccinia 
virus VACV encodes the inhibitory proteins A46R and A52R. A46R possesses a homotypic 
TIR domain allowing it to interfere with MyD88, TRIF and TRAM signaling. This obstructs 
IRF3 activation and, therefore, type I IFN induction (Stack, Haga et al. 2005). A52R, on the 
other hand, binds to TRAF6 and IRAK2, both components of the NFκB pathway (Harte, 
Haga et al. 2003; Bonjardim, Ferreira et al. 2009). 
 
1.2.1.2. RNA Viruses 
Recognition of RNA from RNA viruses by RIG-I has been extensively explored and 
investigated. Although a focus of this thesis will be on recognition of bacterial RNA by RIG-I, 
the viral infection mechanism concerning said receptor will be briefly introduced to portray 
possible points of overlap in the signaling pathway between the pathogens. There are various 
types of RNA viruses, divided into the polarity of their RNA. The main groups are dsRNA, 
negative strand RNA and positive strand RNA viruses. The dsRNA viruses include the 
rotavirus and the bluetongue virus. The (-) strand RNA viruses are composed of, among others, 
the measles, mumps, hanta, rabies and influenza viruses. The (+) strand RNA viruses include 
corona, SARS, Hepatitis A, picorna and Hepatitis C viruses. Viruses with a dsRNA genome 
enter the cell using receptor-mediated endocytosis. The virus undergoes proteolytic cleavage 
and subsequently leaves the vacuole. 
 
 
Fig. 1.11: DNA Human cytomegalovirus infection cycle. HCMV enters the host cell and associated PAMPs 
can either activate the NFkB pathway or transcription factor SP1. Viral DNA and mRNA, as well as relevant 
proteins, are released into the cytosol and used for transcription of virion components. Once assembled, the 
virion then exits the host cell (adapted from (Huang and Johnson 2000).  
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Multiple capped viral mRNAs are then synthesized from the core particle and associate with 
newly translated viral proteins. Each of the small mRNAs is a template for negative strand 
synthesis. The mRNAs code for an RNAse-resistant subviral particle that serves as location for 
assembly of additional virus particles. The preformed viral capsid proteins are added at the end 
of the assembly process. The virus exits the cell via lysis.  
The rabies virus reproductive cycle will be briefly explained representing the (-) ssRNA virus 
infection. The virion enters the host cell via receptor mediated endocytosis. It fuses with the 
endosome, releasing the viral nucleocapsid, composed of negative strand RNA, which is copied 
into 5 subgenomic mRNAs by the L and P proteins also contained in the nucleocapsid. The 
mRNAs code for, among others, more L and P proteins. Viral RNA replication is started with 
synthesis of the positive strand RNA of the viral genomic RNA, which is used for further 
production of negative strand RNA, reinitiating the reproductive cycle. Glycosylated viral 
membrane proteins are transported to the host cell membrane, as are nucleocapsids, thus 
enabling budding off of virions from the host cell membrane (reviewed in (Chazal and Gerlier 
2003)). 
 
RNA virus infection evasion of the innate immune response 
Confronted with the broadly responsive innate immune system, viral pathogens have developed 
evasion and inhibition mechanisms allowing them to multiply and survive in theoretically hostile 
environments. Various strategies have been developed, ranging from inhibition of IFN 
synthesis, binding of secreted IFN molecules, interference with IFN-induced proteins or 
obstruction of IFN-dependent signaling (reviewed in (Bonjardim, Ferreira et al. 2009)). The 
viral protein VP35 offers itself as a rival substrate for IKKξ and TBK-1, thus obstructing the 
signaling pathway to IFN induction (Prins, Cardenas et al. 2009). VP35 also induces 
SUMOylation of IRF7, blocking its transfer to the nucleus (reviewed in (Basler and 
Amarasinghe 2009)). The protein VP24, as encoded by the Ebola virus obstructs the nuclear 
import of STAT1. The same protein encoded by the Marburg virus, however, simply blocks 
STAT 1 and 2 phosphorylation (Valmas, Grosch et al. ; Basler and Amarasinghe 2009). 
It was discovered that the flavivirus Hepatitis C encodes a protease complex that targets IPS-I 
for cleavage as part of its immune evasion strategy; bioinformatic analysis revealed that two 
flaviviruses encode a viral product that exhibited strong homology with the amino terminus of 
MITA. This product inhibited the type I IFN response induced by MITA, probably due to 
direct interaction (Ishikawa et al., 2009). 
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Fig. 1.12: Viral evasion techniques. RNA and DNA viruses have both evolved strategies to avoid or block the 
innate immune system. A52, for example, inhibits TRAF6 and IRAK2 signaling, while A46 possesses as TIR 
homology domain and therefore blocks the MyD88 and TRIF pathway  (adapted from (Schroder and Bowie 
2007)). 
 
1.2.2. Bacteria 
Most bacteria are not, like viruses, obligate intracellular pathogens, but those that can, or must, 
replicate intracellularly, are of course of particular interest to intracellular PAMP research. 
TLRs such as TLR2 and 4 cannot induce IFN or IL-1β induction to cytosolic pathogens, while 
RIG-I and the DNAR can readily mount an innate immune response to intracellular pathogens 
such as Legionella pneumophila and Listeria monocytogenes.  
 
1.2.2.1 Legionella pneumophila 
Legionella pneumophila is a gram-negative bacterium. It replicates in host macrophages and 
causes Legionnaires' Disease, a severe kind of pneumonia. L. pneumophila is acid labile, does 
not sporulate, and is a not capsulated rod-like bacteria. In humans, L. pneumophila invades and 
replicates in alveolar macrophages (Horwitz and Silverstein 1980). Macrophage phagocytosis of 
the bacteria can be enhanced by the presence of antibody and complement but is not strictly 
necessary. A pseudopod coils around the bacterium in this unique form of internalization. Once 
phagocytosed, the bacteria surround themselves in a membrane-bound vacuole, preventing 
fusion with lysosomes that would otherwise degrade the pathogen. The bacteria multiply in this 
protected compartment. A Type IVB secretion system known as Icm/Dotis inject effector Ank 
proteins into the host, increasing the bacteria's ability to survive inside the host cell (Isberg, 
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O'Connor et al. 2009): They interfere in the fusion process of the Legionella-containing vacuole 
with the host's degradation endosomes (Pan, Luhrmann et al. 2008). 
 
1.2.2.2. Listeria monocytogenes  
Listeria monocytogenes is a facultative intracellular bacterium that is the causative agent of 
Listeriosis. It is a foodborne pathogen and especially dangerous for immunocompromised 
individuals, such as the elderly, the young, or pregnant women (Ramaswamy, Cresence et al. 
2007).  
Primarily, Listeria infects the host via the intestinal epithelium where the bacteria invade non-
phagocytic cells. Induction of uptake occurs by the binding of listerial internalins (Inl) to host 
cell adhesion factors such as E-cadherin. This, in turn, results in activaton of certain Rho-
GTPases which, then bind and stabilize Wiskott Aldrich Syndrome protein (WASp). WASp 
can serve as an actin nucleation point. Subsequent actin polymerization extends the cell 
membrane around the bacterium, eventually engulfing it (Dykes and Dworaczek 2002). 
L. monocytogenes uses internalins only for invasion of non-phagocytic cells; invasion of 
macrophages, their preferred host cell, does not require internalin use.  
The bacterium must then escape from the phagosome before fusion with a lysosome can occur: 
the three main virulence factors which allow the bacterium to escape are listeriolysin O (LLO - 
encoded by hly) phospholipase A (encoded by plcA) and phospholipase B (plcB) (Leimeister-
Wachter, Haffner et al. 1990) (Schmid, Ng et al. 2005). Briefly, secretion of LLO creates 
holes in the vacuolar membrane and allows the bacterium to escape into the cytoplasm, where it 
can reproduce. 
Once in the cytoplasm, ActA proteins associated with the bacterial cell pole are capable of 
binding the Arp2/3 complex, and thus induce actin nucleation at a specific area of the bacterial 
cell surface. Actin polymerization can then be used by the bacterium for transport, either into 
the extracellular space or directly into another host cell. 
 
Immune recognition of Listeria 
The innate immune response to Listeria infection has been investigated under the aspects of 
Nod1, Nod2 and TLR2 activation. Nod1 and Nod2 were found to be involved in bacterial 
recogniton of TLR ligands such as LPS and LTA. Experiments showed that bacterial clearance 
in mice previously challenged with LPS or E.coli was critically dependent on Nod1 and Nod2 
upon systemic infection with L. monocytogenes  (Kim, Y.G. Immunity 2008). Another group 
investigated the mutation in the Nod2 gene and its role in Crohn’s disease. Nod2-deficient 
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mice were, interestingly, also susceptible to orally administered Listeria:  Recognition of Listeria 
infection in the intestinal tract involves Nod2 (Kobayashi, K.S. 2005). Nod1 involvement of 
the intracellular innate immune response to Listeria was cemented using RNAi and Nod1 
overexpression. Endothelial cells with Nod1 respond to Listeria infection with secretion of IL-8 
in a p38-dependent manner (Opitz, B. 2006). The antimicrobial innate response in mesothelial 
cells, which line the outer surface of interior organs, is regulated by Nod1 and TLR receptors, 
as measured by chemokine output. Park et al infected mesothelial cells with Listeria and 
observed a CXCL1 response dependent on the presence of Nod1 (Park, J.h. 2007). Listeria, 
however, can also induce IFN in an IRF-3 dependent manner bypassing TLR and Nod2. IRF3 
was proposed as a convergence point for immune response signals to Listeria infection, as IRF3-
dependent signal transduction occurred independently of MyD88, TRIF and TRAM 
(Stockinger, S. 2004). Ipaf and Nalp3 were shown to activate caspase 1 in the event of Listeria 
infection. A dose-dependent response to Listeria flagellin via Ipaf. The inflammasome 
component ASC activated caspase 1 in the presence of cytosolic Listeria. (Warren, S.E. 2008, 
Reviewed in Tsuji, N.M. 2004). After comparing host responses to Listeria infection in wt and 
TLR2-deficient mice, it was found that TLR2-deficient mice succumb easier to Listeria 
infection. The response of cytokines such as TNF and IL-12, or the expression of 
costimulatory molecules, was reduced in TLR2-deficient macrophages (Torres, D. 2004). 
 
Fig. 1.13.: Pathways of innate immune recognition to Listeria in macrophages. Listeria enter the cell using 
Internalins. Components of the bacterial cell wall can either interact with TLR2 on the cell membrane or with 
NLRs in the cytosol. Bacterial nucleic acids can interact with AIM-2 or an as yet unknown receptor of the 
TBK-1/IRF3 pathway. 
 
Interestingly, recent investigations have shown Listeria to be sensed by the NLRP3 and AIM2 
inflammasomes in murine macrophages. Listeria-triggered cell death was reduced in cells 
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without AIM2 and NLRP3, indicating a role for sensing of intracellular bacterial DNA in the 
cytosol of macrophages (Kim et al, 2010). 
Investigations in the labs of Decker and Portnoy suggested TLR-independent pathways leading 
to induction of type I IFN in mouse macrophages infected with Listeria monocytogenes 
(O'Riordan, Yi et al. 2002; Stockinger, Materna et al. 2002). Elucidating the host response to 
Listeria had been though to have been explained in 2006, when Decker et al described an IPS-1 
independent response to Listeria. IPS-1 relays signals from RIG-I and Mda-5 to the IRF3 
kinase complex, resulting in a type I IFN response. Using siRNA-mediated knock-down in 
macrophages, it was shown that Listeria infection targeted the IFNβ gene without detectable 
IPS-1 requirement (Soulat, Bauch et al. 2006). Furthermore, type I IFN induction depended 
on cytosolic localization of the bacteria (O'Riordan, Yi et al. 2002; Stockinger, Materna et al. 
2002) but was shown to be Nod2 independent (Stockinger, Reutterer et al. 2004).  
Later on, Medzhitov et al could show that DNA represents the type I IFN inducing agent in 
the lysate of Listeria monocytogenes when transfected into murine monocytes. From their 
experiments, they concluded that intracellular bacteria (L. monocytogenes and L. pneumophila) 
with cytosolic shuttle mechanisms induce a type I interferon response by the recognition of 
bacterial genomic DNA in the cytosol. The transfer of bacterial RNA, however, should also be 
possible in the same way and recognition mechanisms as observed for RNA viruses should be 
triggered by intracellular bacteria. In contrast to eukaryotic RNA, bacterial mRNA is not 
capped but contains 15% 5’triphosphorylated RNA (Bieger and Nierlich 1989), a primary 
requirement for recognition by RIG-I. IL-1β is an indicator for Listeria infection; blocking the 
IL-1R exacerbates murine listeriosis (Havell, Moldawer et al. 1992). Observing the correlation 
of IL-1β and IL-6 induction to the type I IFN response after Listeria infection might help 
characterize the innate immune response to Listeria; IL1 and IL6 collaborate to protect the 
host from Listeria (Dalrymple, Lucian et al. 1995; Liu, Simpson et al. 1995). As will be shown 
in this thesis, evidence exists to suggest that Listeria, like Legionella, also take the RIG-I 
pathway. Maybe not uniquely, but RNA definitely plays a role in the innate immune response.  
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1.3. Aim of this thesis 
PRRs and their signaling pathways will be investigated in this thesis. As it is known that 
components of the bacterial cell wall and conserved proteins are detected by TLRs on the cell 
surface, and by NLRs in the cytosol of cells. Experiments were conceived to investigate the type 
I IFN response to bacterial presence in the cytosol. Listeria are considered the model organism 
for cytosolic invasion by bacteria. To this end, Listeria with and without the ability to enter the 
cytosol were used for infection of cell lines with differing cytosolic nucleic acid receptors. This 
would allow a differentiated approach to infection pathways and provided cell-line specific 
innate immune responses.  
Along with the abovementioned experimental setup to determine bacterial type I IFN 
recognition pathways, another approach was designed to establish the minimal recognition 
motif of cytosolic DNA ligands. In order to allow for experimental readout under controlled 
conditions, synthetic oligonucleotides (ODNs) were constructed with minute differences in 
sequence. With RIG-I so acutely dependent on 3-P ends, it would stand to reason that a 
cytosolic DNA receptor is equally dependent on small changes in sequence for IFN induction. 
This thesis will explore the influence of structure and sequence of short dsODNs on type I IFN 
induction in monocytic cells. 
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2. Mater ials  and Methods 
 
2.1 Materials 
 
2.1.1 Equipment 
Analyzer for Agarose gels  
Cell culture incubators Herasafe KS-15 Thermo, Langenselbold 
Centrifuge 5424 Eppendorf, Hamburg 
Centrifuge 5810R Eppendorf, Hamburg 
Herafreeze HFU 586 Thermo, Langenselbold 
Horizontal Gel Electrophoresis SGE-020-02 CBS Scientific, Del Mar, California 
Horizontal shaker DOS-10L Neolab, Heidelberg  
Lumistar Luminometer BMG Labtech, Offenburg 
Magnetic Stirrer VWR, Batavia, Illinois 
Microplate Reader Apollo 8 LB-912 Berthold Technologies, Bal Wildbad 
Microscope Wllovert 30 Hund, Wetzlar 
pH-meter, digital  
PowerStation 300 Plus Labnet International, Berkshire 
Precision Balance 440-47N Kern, Balingen 
Precision Bench Scale EG-420-3NM Kern, Balingen 
Premium nofrost Liebherr, Kempten 
Shaking Incubator for bacteria 311DS Labnet, Edison, New Jersey 
Spectrophotometer Nanodrop ND-1000 Peqlab, Erlangen 
Sterile Workbench Heracell 240 Thermo, Langenselbold 
Thermal Cycler Px2 Thermo Electron Corporation, 
Langenselbold 
Thermomixer 5350 Eppendorf, Hamburg 
Vertical Blotting System EBX 700 CBS Scientific, Del Mar, California 
Vertical Gel Electrophoresis MGV 202 CBS Scientific, Del Mar, California 
Western Blot developer  
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2.1.2 Chemicals 
Unless otherwise stated, all chemicals were obtained from the following companies; 
DiagonalFluka, Gibco, Invitrogen, Merck, Roche Diagnostic GmbH, Serva, Carl Roth and 
Sigma. Solutions were prepared using deionized water. 
 
2.1.3. Media and antibiotics for bacterial cultures 
Media were sterilized by autoclaving for 20 min at 121°C. 
LB-Mediums  
(Luria-Bertani) 
Bacto-Trypton 10g/L 
Bacto yeast extract 5g/L 
NaCl 10g/L 
pH 7.5 
LB-Agar Bacto-Trypton 10g/L 
Bacto yeast extract 5g/L 
NaCl 10g/L 
Bacto-Agar 15g/L 
pH 7.5 
Columbia Agar Casein-peptone 10g/L 
Meat peptone 5g/L 
Heart Peptone 3g/L 
Yeast extract 5g/L 
NaCl 5g/L 
Corn starch 1g/L 
Agar 15g/L 
pH 7.3 
Antibiotics stock solutions  
filter sterilized 
50µg/mL Ampicillin  1:1000 in LB 
50µg/mL Kanamycin 1:1000 in LB 
50µg/mL Puromycin  1:4000 in RPMI 
HTM medium and agar 100mM      MOPS 
4.82mM     KH2PO4 
11.55mM   Na2HPO4 
1.70mM     MgSO4 
55mM        Glucose 
2.96mM     Thiamine 
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1.33mM     Riboflavine 
2.05mM     Biotine 
24pM         Lipoic acid 
0.1mg/mL  Cysteine 
0.1mg/mL  Methionine 
0.6mg/mL  (NH4)SO4 
15g/L         Agarose 
 
2.1.4. Mediums and Solutions for Cell Culture 
Trypsin/EDTA 0.05% Trypsin/EDTA (w/v) Invitrogen 
PBS 1xPBS (Invitrogen) 
Pharmlyse 10x BD Pharm Lyse Lysing Buffer 
(Pharmingen) 
RPMI Culture Medium 1x RPMI 1640 (Invitrogen) 
2mM Glutamine 
100 U/mL Penicillin 
100 U/mL Streptomycin 
10% Heat-inactivated fetal calf serum (FCS) 
DMEM 1x Dulbecco’s modified Eagles Medium 
(Invitrogen) 
100U/mL Penicillin 
100U/mL Streptomycin 
10% Heat-inactivated FCS 
Opti-MEM Opti-MEM, Invitrogen 
Cryo-medium FCS:DMSO 9:1 (Dimethylsulfoxide, Roth) 
  
2.1.5. Solutions for use in molecular biology 
Plasmid preparations (Jetstar Maxiprep) 
Sol E1 Resuspension 50mM Tris 
10mM EDTA 
100µg/mL RNase A 
pH 8.0 
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Sol E2 Lysis buffer 200mM NaOH 
1% SDS (w/v) 
Sol E3 Neutralization buffer 3.1M C2H7NO2 
pH 5.5 
Sol E4 Equilibration buffer 600mM NaCl 
100mM C2H3NaO2 
0,15% Triton-X 100 
pH 5.0 
Sol E5 Wash buffer 800mM NaCl 
100mM C2H3NaO2 
pH 5.0 
Sol E6 Elution buffer 1250mM NaCl 
100mM Tris 
pH 8.5 
 
Gel extraction(JetQuick Protocol) 
Sol L1 Gel solubilization buffer NaClO4 
C2H3NaO2 
TBE-solubilizer 
Sol L2 Wash buffer EtOH 
NaCl 
EDTA 
Tris/HCl 
Tris Buffer Elution buffer 10mM Tris HCl pH 8.0 
 
DNA Agarose Gel Electrophoresis 
10xTBE 1M Tris-HCl 
890mM Boric acid 
10mM EDTA 
pH 8.0 
6x DNA sample buffer 15% (w/v) Ficoll 
0.25% (w/v) bromophenol blue 
0.25% (w/v) xylene cyanol 
1kb Ladder, 10kb Ladder New England Biolabs, Fermentas 
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Ethidiumbromide solution 10mg/mL in TBE 
 
PCR Purification Kit (Jetquick column) 
Sol H1 Binding buffer Guanidine Hydrochloride 
Isopropanol 
Sol H2 Wash buffer EtOH 
NaCl 
EDTA 
Tris/HCl 
 
2.1.6. Materials in molecular biology 
Unless otherwise stated, all materials used were obtained from Invitrogen (Darmstadt, 
Germany), Roth (Karlsruhe, Germany) and Metabion (Martinsried, Germany)  
 
2.1.7. Bacterial strains 
XL1-Blue  
Listeria monocytogenes 11919  
Listeria monocytogenes 43251 
Listeria monocytogenes Δhly 
Listeria monocytogenes Δprf 
Listeria monocytogenes EGD 
DH10ß 
Sure 
 
 
2.1.8 Cell lines 
HEK 293T Human embryonal kidney fibroblasts with a 
stable integration of the large T-antigen of 
the SV-4 virus. 
Vero African green monkey kidney epithelial cells 
A498 Human epithelial cell kidney carcinoma 
FaDu Human epithelial squamous cell carcinoma.  
HaCat Human ceratinocytes 
NIH 3T3 Mouse embryonic fibroblast cells 
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THP-1 
THP-1 505 
A549 
A549 505 
THP-1 MITA 
THP-1 MITA-Inv 
THP-1 Atg5 
Monocytic cell line 
Monocytic cell line, RIG-I knock-down 
Lung epithelial cell line 
Lung epithelial cell line, RIG-I knock down 
Monocytic cell line, MITA knock-down 
Monocytic cell line, MITA knock-down 
Monocytic cell line, Atg5 knock-down 
 
2.1.9. Primary cell cultures 
Peripheral blood mononuclear cells (PBMCs) Isolated from leukocyte-rich buffy coats of 
healthy blood donors 
Human pDCs  
Human monocytes  
Murine glia cells 
Murine bone marrow-derived dendritic cells 
Isolated from healthy C57/BL6 mice 
 
2.1.10. Plasmids 
The plasmids used in this thesis are listed in Table 2.1. 
 
Table 2.1: Vectors used in this thesis. Fusion proteins, cDNAs with complete reading frames and mutants used for 
eukaryotic gene expression were cloned into MIRTOP and pLuc  
pBKs  
IFNb-gLuc  
IRF 1  
IRF 3  
IRF 7  
RIG-I Flag  
RIG-I GFP  
DAI  
MDA-5  
IPS-1  
pATTR  
pSUPER  
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pLV  
pLKO-MITA 
pLKO-Atg5 
 
  
2.2. Methods used in molecular biology 
Unless otherwise stated, most of the methods described are adapted from those characterized in 
Sambrook et al (2000). 
 
2.2.1. Preparative methods 
2.2.1.1. Isolation of DNA by alkaline lysis 
A reliable and fast way to isolate small amounts of plasmid DNA from E. Coli is alkaline lysis. 
The extracted DNA can be used for restriction analysis and transformations. 
Bacteria from 1.5mL of overnight bacterial cultures (LB supplemented with appropriate 
antibiotics) were pelleted for 30sec at 13,200 rpm at room temperature in an Eppendorf 
Biofuge. The pelleted bacteria were lysed with 200µL lysis buffer. After 5 min at room 
temperature, 150µL neutralization buffer were added and the lysate centrifuged for 15 minutes 
at 13,200 rpm, pelleting denatured proteins and genomic DNA. The clear supernatant was 
transferred to a new Eppendorf tube. Addition of 1mL ice-cold 100% EtOH, followed by 
2min incubation at room temperature, led to DNA precipitation. After centrifugation (of 
10min at 13,200 rpm), the supernatant was discarded and the resulting pellet was washed in 
70% EtOH (v/v) and was then resuspended in 10-20µL H2O-RNase. 
 
2.2.1.2. Isolation of DNA on a preparative scale 
A kit from the Genomed company was used to obtain larger quantities of plasmid DNA. 
Bacteria were cultured overnight in 250mL LB-medium with antibiotics and pelleted for 
15min at 6000rpm (4°C, Eppendorf centrifuge). All traces of medium were carefully removed. 
The pellet was resuspended in 10mL Solution E1 until the suspension was homogenous. 10mL 
of Solution 2 were added and the suspension gently mixed by inversion, then incubated at room 
temperature for 5min. After the incubation period was over, 10mL of solution E3 were added 
and the suspension immediately mixed through multiple inversions until the suspension 
appeared homogenous and no remainders of viscous matter were visible. The mixture was 
centrifuged for 10min at 12,000g. During the last centrifugation step, the columns were 
equilibrated with 30mL solution E4. The supernatant was then applied to the equilibrated 
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column and the lysate allowed to pass through by gravity flow. The flow-through was discarded. 
The column was washed with 60mL of solution E5 and the flow-through discarded. The DNA 
was then eluted with 15mL of solution E6.  
 
2.2.1.3. Isolation of DNA fragments 
To isolate DNA fragments, DNA was digested with restriction enzymes and appropriate 
fragments separated by agarose gel electrophoresis (10V/cm distance between the electrodes). 
The sample was loaded onto an agarose gel and the relevant band excised. The DNA in the gel 
band was then isolated by using the gel extraction protocol from the Genomed company. 
Briefly, the gel slice was transferred into an Eppendorf tube and 300µL solution L1 added for 
every 100mg gel slice, then incubated for at least 15 minutes at 50°C. A JetQuick spin column 
was placed into a 2mL Eppendorf tube and the L1-gel slice mixture loaded onto the silica 
matrix, then centrifuged at 12,000g for 1 minute. The flow-through was discarded and the 
column replaced onto the Eppendorf tube. 500µL of solution L2 were then added to the 
column and then centrifuged for 1minute at 12,000g.  The flow-through was discarded and the 
empty column centrifuged again for 1 minute at 12,000g. The JetQuick spin column was 
placed in a new Eppendorf tube and 50µL sterile water or TE buffer pipetted directly onto the 
silica matrix, then centrifuged at maximum speed for 2 minutes. 
 
2.2.1.4 Phenol-Chloroform extraction of DNA 
1 Vol (up to 700µL) of aqueous DNA solution was pipetted into an Eppendorf tube, with an 
equal volume of phenol:chloroform:isoamyl alcohol (25:24:1) added on top. The mixture was 
then vortexed vigorously to mix the phases. The suspension was centrifuged at top speed for 2 
minutes to separate the phases. The aqueous upper phase was removed to a new tube and an 
equal volume of phenol:chloroform (1:1) added. The suspension was vortexed and centrifuged 
for 2 minutes at top speed. The aqueous phase was then removed to a new tube and the DNA 
precipitated with EtOH. 
 
2.2.1.5. Purification and isolation of DNA from aqueous solutions 
In order to precipitate DNA from an aqueous solution, 0.1Vol 3M sodium acetate (pH 5.2) 
and 2 Vol ice-cold 100% EtOH were added to the solution. The mixture was incubated for 30 
min at -20°C. DNA was precipitated by centrifugation for 15 min at 13,200rpm. The pellet 
was washed with 70% EtOH (v/v), air-dried and subsequently dissolved in an appropriate 
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volume of H2O. Alternatively, to keep the total volume small, 1 Vol of isopropanol was used 
for precipitation. 
 
2.2.2. Analytical methods 
2.2.2.1. DNA restriction digest 
Plasmid restriction digests were performed according to the manufacturer’s instructions. 2 to 10 
units of the restriction enzyme were used per µg DNA. The digest was performed for 1 to 12 
hours at 37°C. 
 
2.2.2.2. Oligo dA-dT elongation  
Oligo dA-dT elongation was performed according to previous publications (Hanaki et al., 
2004). Briefly, 85µL H2O were added to 10µL 10x Klenow fragment buffer, 5U Klenow 
fragment, 1µg dAdT and 200µM each of dATP and dTTP. The mixture was incubated for 4 
hours at 37°C and the DNA extracted with EtOH precipitation. 
 
2.2.2.3 Measurement of DNA concentration 
To determine the concentration and purity of DNA samples, the optical density (OD) was 
measured at 260nm and 280nm. An OD260 corresponds to a concentration of 50µg/mL 
double-stranded DNA. The OD260/280 ration indicates the amount of protein impurities in 
the sample. This ratio should be between 1.8 and 2.0 for pure nucleic acids. 
 
2.2.2.4 Electrophoretic separation of large DNA (> 100bp) fragments 
The preparative and analytical separation of DNA fragments according to size was done by 
agarose gel electrophoresis. In order to obtain an optima DNA separation, agarose 
concentration varied between 0.8% and 2%. 1xTBE was used as gel and electrophoresis buffer. 
The gel was prepared by heating the agarose in 1xTBE buffer and pouring the clear solution 
into a horizontal gel chamber with inserted comb. Ethidiumbromide was added to the still-
fluid solution in a final dilution of 1:2000. Before the samples were loaded onto the gel, they 
were combined with 1/6 vol 6x loading buffer. The gel electrophoresis was run at 10V/cm2 and 
took, depending on the agarose concentration, 1-2 hours. Afterwards the gel was photographed 
on an UV-transilluminator. 
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2.2.2.5. Electrophoretic separation of small (<100bp) DNA fragments 
The analytical separation of synthetic oligonucleotides according to size was done by acrylamide 
gel electrophoresis. In oder to obtain an optimal DNA separation, acrylamide concentration 
varied between 6% and 10%. 1xTBE was used as gel and electrophoresis buffer. The gel was 
prepared by mixing (for an 8% gel) 4mL 30% acrylamide, 1.5mL 10xTBE, 9.5mL H2O, 
150µL 10% APS and 15µL TEMED and pouring the solution into a vertical gel chamber. The 
gel was pre-run for 30min at 200V. The samples were combined with 1/6vol 6x loading buffer 
and the gel was run for 1 hour at 200V. The gel was then stained for 30 minutes with 0.02% 
methylene blue solution (w/v).  
 
2.2.3. Plasmid construction 
2.2.3.1. Phosphorylation of PCR fragments 
To subclone PCR fragments into the desired vector, they were phosphorylated by adding 12µL 
of purified synthetic oligonucleotide to 5x T4 DNA-Polymerase buffer (Boehringer), 2µL 10 x 
PNK (polynucleotide kinase) buffer (Boehringer), 1µL 2mM ATP/1mM dNTPs, 0.5µL PNK 
at 10U/µL (Boehringer) and 0.5µL T4 DNA polymerase (Boehringer). The mixture was 
incubated for 30 min at 37°C, fragments isolated and ligated with the vector. 
 
 2.2.3.2 Ligation of DNA fragments and synthetic oligonucleotides 
DNA ligase catalyzes the ligations of a vector with a passenger fragment. This ATP-dependent 
enzyme covalently joins a 3’ OH end with a 5’ phosphate group, producing a phosphodiester 
bond. In order to insert one or more DNA fragments into a vector, 12µL insert and 5µL vector 
were mixed with 3µL ligation buffer, 5µL T4 DNA ligase (1U/µL), 1.5µL 10mM ATP and 
3µL 50% PEG (polyethylene glycol). The solution was incubated overnight at 16°C. 
Subsequently, the ligated DNA was precipitated by adding 1µg tRNA, 10µL 3M sodium 
acetate (pH 5.2), 275µL -20°C EtOH and 60µL H2O to the ligation mixture. After an 
incubation period of at least two hours at -20°C, the DNA was pelleted for 15 min at 
13,2000rpm, the pellet washed with 150µL 70% EtOH, centrifuged for 5 min at 13,200rpm 
and then dissolved in an appropriate amount of H2O. 
2.2.3.3. Cultivation of bacteria 
E.coli and L.monocytogenes strains were grown overnight at 37°C on LB and Columbia agar 
plates, respectively. A single colony was used to inoculate LB medium in order to obtain 
suspension cultures, and then incubated overnight on a shaker at 220rpm and 37°C. Glycerol 
stocks were prepared for permanent storage at -80°C. To this end, glycerol was added to a final 
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concentration of 20° (v/v) to an overnight culture. In oder to inoculate from glycerol stocks, a 
glass pipette was dipped into the stock solution and then transferred to an appropriate volume 
LB medium, which was then incubated overnight on a shaker at 37°C. 
 
2.2.3.4. Preparation of competent cells for chemical transformation 
As described in Chung et al (1989), an 5mL overnight culture of bacteria was rediluted into 
25mL of fresh LB medium. This suspension was grown to an OD600 of 0.2-0.5, then 
centrifuged for 10 minutes at 3000rpm and 4°C. The supernatant was removed and the pellet 
resuspended in 1/10 volume cold TSS buffer. 100µL aliquots were then pipetted into pre-
chilled Eppendorf tubes and stored at -80°C. 
 
2.2.3.5. Chemical transformation of bacteria 
Chemically competent E.coli were taken out of -80°C storage and defrosted for 5 minutes on 
ice. The desired amount of DNA dissolved in 10µL TE buffer was then added and the bacteria 
incubated for 15 minutes on ice, then heated to 42°C for 90 seconds. The transformed bacterial 
suspension was then resuspended in 1mL LB medium and incubated for 30 minutes at room 
temperature before plating onto LB agar plates. 
 
2.2.4. Enzyme-Linked-Immuno-Sorbent-Assay (ELISA) 
2.2.4.1. Conventional ELISA method 
The ELISA method is used in order to measure cytokines found in the supernatant of 
stimulated cells. 
To this end, a primary antibody is used to coat the 96-well ELISA plate. Cytokines present in 
the examined substrate bind to this antibody. A second antibody, whose Fc domain is coupled 
to a substrate-specific enzyme (peroxidase), binds to the cytokine in question. A colorless 
substrate is added to the well and turns blue in dependence of the concentration of the second 
antibody. The reaction is stopped with 2N H2SO4, which turns the blue substrate yellow. The 
intensity of the coloring is measured with an ELISA reader and allows deductions as to the 
cytokine concentration.  
The ELISA plate was coated with 50µL of diluted primary antibody per well and incubated 
overnight at 4°C. The primary antibody solution was removed and the plate washed with 100µL 
wash buffer (1xPBS with 0.05% Tween-20).  
50µL blocking buffer (10% FCS (v/v) in 1xPBS) were added to the wells in order to block the 
unspecific binding sites and the plate incubated for 30 minutes at room temperature. The plate 
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was washed three times with wash buffer and the samples pipetted into the wells in the desired 
dilution. A serial dilution was performed with a known concentration of the cytokine in 
question and pipetted onto 8 microwells. 
The plate was incubated for two hours at room temperature and then washed three times. The 
conjugated second antibody/HRP solution, diluted in assay buffer, attached to the bound 
cytokine in the microwells. The plate was incubated for one to two hours at room temperature 
and then washed seven times. 
The ELISA was then developed. To this end, 50µL of combined substrate solution A and B 
were pipetted per well and the plate incubated for 20 minutes at room temperature out of the 
light. As soon as the five strongest concentrations of the diluted standard could be seen, the 
reaction was stopped with 50µL 2N H2SO4.  
The intensity of the dye was measured in the ELISA reader at 450 and 570nm. The difference 
in absorption was used to calculate the cytokine concentration in the supernatants used. The 
hIFNa ELISA was performed in a generally similar manner, except for the fact that the 
secondary antibody/HRP conjugate could be added directly to the supernatant.  
 
2.2.4.1. murine IFNa ELISA 
Murine IFNa was measured with a kit made of self-assembled ingredients. The coating 
antibody RMMA-1 was diluted 1:2000 in coating buffer and the plate incubated overnight, 
then washed once with washing buffer and the samples added to the wells. The standard protein 
was diluted to 103U/mL, the plate incubated overnight at 4°C. The next day, the plate was 
washed 3x with wash buffer and the detection antibody (polyclonal rabbit anti-mouse IFNa), 
diluted 1:1000 in assay buffer, pipetted into the microwells. The plate was incubated overnight, 
then washed 15 times. 50µL HRP-conjugated secondary antibody (donkey anti-rabbit, dilution 
1:10000) was added to the wells and the plate incubated overnight. The wells were washed 12x 
and 50µL substrate reagent pipetted per well. 
 
2.3. Cell culture 
 
2.3.1. Cell culture conditions 
All procedures with cell cultures were performed under the laminar hood and using sterile 
utensils. 
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2.3.2. Thawing cells 
Cells stored in liquid nitrogen were transported on dry ice. After rapid thawing in a 37°C water 
bath, the cells were transferred to a sterile 15mL tube. 10mL culture medium was added 
dropwise, the tube then centrifuged to 7 minutes at 400rcf (Eppendorf centrifuge), the pellet 
dissolved in 10mL culture medium and transferred to a 10mL culture dish. 
 
2.3.3. Cell cultivation 
The culture of the abovementioned cell lines occurred at 37°C in a controlled atmosphere at 5% 
CO2. In order to passage confluent cells (Lindl and Bauer, 1989), they were washed once with 
PBS, dissociated from the dish with 2mL 0.5% Trypsin-EDTA and transferred at an adequate 
dilution to new 10cm dishes. HEK 293T, HaCat, RAW and Vero cells were cultured in RPMI 
medium and diluted every 3-4 days. FaDu and A498 cells were cultured in DMEM and diluted 
every 3 days.  
 
2.3.4. Preparation and cultivation of PBMCs  
Isolation of human PBMCs occurred through density gradient centrifugation using Leucosep 
tubes (Greiner Bio-One, Germany). These tubes possess a porous barrier of polyethylene, 
preventing mixture of the sample material with the separation medium. 15mL Biocoll 
sucrose gradient were poured onto the barrier and the tubes then shortly centrifuged so the 
separation medium could pass through. Buffy coats were diluted 1:2 with 0.9% NaCl and 
poured on top of the barrier, then centrifuged for 20 minutes at room temperature and 800g 
with the brake turned off. This resulted in the separation of the Buffy coat into different phases. 
 
Fig. 2.1: Isolation of PBMCs through gradient centrifugation (adapted from Greiner Bio-One GmbH) 
 
The cells contained in the enriched cell fraction were carefully removed with a pipette and 
deposited into a new 50mL centrifuge tube. The volume was filled to 50mL with 0.9% NaCl 
and centrifuged for 15 minutes at 400g and 4°C. The supernatant was removed and the pellet 
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resuspended in 1x Lysis buffer, then incubated for 5 minutes at room temperature. The lysed 
suspension was then filled to 50mL with 0.9% NaCl and centrifuged for 15 minutes at 400g 
and 4°C. The supernatant was removed and the lysis step repeated if erythrocytes remained 
visible. PBMCs were resuspended in 10mL RPMI and counted; 200µL PBMC suspension 
containing 4x105 cells were pipetted per well.  
 
2.3.5. Determination of cell count 
1µL of cell suspension was mixed with 99µL of 0,04% trypan blue in order to determine cell 
vitality. Cell count was obtained using the Neubauer counting chamber. (See Fig. 2.2) The cells 
in 3 1mm squares were counted and the average then multiplied by 106 to obtain the cell 
concentration in 1mL.  
 
Fig. 2.2: Counting chamber. Depth of the chamber is 0.1mm, so  10x number of cells in one 1mm square  
would equal the concentration of cells in 1mm3 (Adapted from Emdiasum, Hatfield) 
 
 
2.3.6. Isolation of plasmacytoid dendritic cells (PDC) from PBMCs 
PDCs were isolated from human Buffy coats using the MACS (magnetic cell sorting, 
Milteyni) system and PDC-specific antibodies. They make up 0.5-1% of the PBMC 
population. 
To this end, 108 PBMCs were resuspended in 150µL MACS buffer (1xPBS, 0.5% PSA, 2mM 
EDTA) together with 50µL FcR blocking reagent and 50µL Anti-BDCA-4 microbeads 
(blood dendritic cell antigen 4). The anti-BDCA-4 microbeads solely recognize CD304, which 
is specifically expressed on PDCs, and the FcR blocking reagent impedes unspecific binding of 
the microbeads.  The suspension was incubated for 15 minutes at 6-12°C and then filled to 
10mL with MACS buffer. The mixture was centrifuged to 7 minutes at 400g and the 
supernatant removed completely. The pellet was resuspended in a final volume of 500µL 
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MACS buffer. During the centrifugation step, the precooled LS columns were placed into the 
magnetic holder and equilibrated by pipetting 3mL MACS buffer onto the matrix.  
The suspension was applied on top of the column and the flow-through, i.e. the CD304-
negative cells, was either discarded or used for further experiments. The column was washed 3 
times with 3ml buffer, the flow-through collected in the same tube as the negative cells. The 
column was then removed from the magnetic holder, 3mL buffer applied on top and the flow-
through collected in a new centrifuge tube. Without the magnetic field keeping the CD304-
positive cells in the column matrix, the PDCs were flushed out. In order to achieve higher 
purity of the resulting cell population, the cell suspension was then loaded onto precooled and 
equilibrated MS columns. The PDCs remaining in the column were washed once with MACS 
buffer, the MS column removed from the magnetic holder and the cells flushed out, then 
resuspended in RPMI medium and counted for viability. 
 
2.3.7. Isolation of monocytes 
Monocyte isolation was performed by depleting the cell fraction from all cells except for 
monocytes using the Monocyte Isolation Kit II. Monoclonal antibodies against CD3, CD7, 
CD16, CD19, CD56, CD123 bound to NK cells, T cells, B cells, dendritic cells and basophile 
granulocytes. This way, all non-monocytes would be kept in the column matrix and the non-
labeled flow-through would contain the monocyte fraction. 107 cells were resuspended in 15µL 
of MACS buffer and mixed with 5µL FcR blocking reagent and 5µL Biotin-antibody cocktail. 
After incubation for 10 minutes at 4-8°C, another 15µL buffer were added, as well as 10µL 
Anti-Biotin microbeads. The suspension was mixed and incubated for 15 minutes at 4-8°C. 
2mL MACS buffer were added and the mixture centrifuged for 7 minutes at 400g and 4°C 
The supernatant was removed and the pellet resuspended in 500µL buffer. 
The precooled LD column was inserted into the magnetic holder and equilibrated with 500µL 
MACS buffer. LD columns are used for depletion isolation of cell populations because they 
have a superior microbead binding area, ensuring a higher purity of the monocyte population. 
The cell suspension was applied to the column and the effluent collected in a centrifuge tube. 
The column was washed twice with 1000µL buffer and the flow-through also collected in the 
same tube. The suspension was centrifuged, the supernatant discarded and the pellet 
resuspended in RPMI medium; a working concentration of 106 cells/mL was used for 
stimulation experiments. 
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2.3.8. Isolation of CD14 negative cells 
CD14 is a surface receptor primarily found on monocytes and macrophages (Lacroix et al). It 
works in cooperation with TLRs in order to recognize bacterial endotoxins. Its specificity of 
location facilitates isolating CD14 negative cell populations. 
To this end, 108 PBMCs were resuspended in 800µL MACS buffer and 200µL CD14 
MicroBeads added. The mixture was then incubated for 15 minutes at 4-8°C. The cells were 
washed by adding 8mL MACS buffer, then centrifuged for 7 minutes at 300g and the 
supernatant removed. The pellet was  resuspended in 1mL buffer and then loaded onto 
equilibrated LD columns. The flow-through consisting of CD14 negative cells was pelleted, 
then resuspended in RPMI medium and counted for viability.  
 
2.3.9. Isolation of murine bone marrow derived dendritic cells (mDCs) 
The hind leg bones of mice were used for obtaining mDCs. Bone marrow cells were isolated 
and differentiated into dendritic cells (DC).  
The knee joint of the hind leg was overstretched, the femur separated from the tibia and fibula. 
The bones were cleaned from any remaining tissue and the epiphyses removed in order to have 
free access to the bone marrow. The bone marrow cells were flushed from the hollow into a 
50mL centrifuge tube using a syringe filled with medium, then pelleted by centrifugation. The 
supernatant was removed , the pellet resuspended in 10mL Lysis buffer and incubated for 5 
minutes at room temperature. 30mL NaCl were added and the suspension centrifuged, the 
pellet resuspended in medium and the cells counted.  
In order to differentiate the cells to DCs, 2x105 cells were pipetted per well in a 6-well plate, 
then incubated for seven days with 3mL medium supplemented with 3% GMCSF 
(Granulocyte-Macrophage Colony Stimulating Factor). After seven days, the cells were 
counted and seeded at a concentration of 2x105 cells per well in a 96-well plate in preparation 
for transfection experiments. 
 
2.4. Transfection and stimulation of cells with transfection reagents 
 
2.4.1. Transfection of DNA and RNA with poly-L-arginin 
Combining RNA with the polycationic polypeptide poly-L-arginine results in easily 
endocytosed particles. The size of the particles is time-dependent; longer incubation times were 
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performed in order to achieve larger particles. DNA or RNA can enter into the endosome and 
initiate TLR recognition.  
Per well in a 96-well microtitre plate, 15µL PBS were combined with 0.18µL 2mg/mLPoly-
L-Arginin. 0.2µg RNA or DNA were added and the solution was pipetted to the cell 
suspension, then incubated for 20-24 hours and analyzed for cytokine content. 
 
2.4.2. Transfection of DNA and RNA with Lipofectamine 
The cationic lipid Lipofectamine binds to DNA and facilitates its entry into the cytosol. 
Transfections were usually carried out in 96-well microtitre plates. Per well, 0.5µL 
Lipofectamine were resuspended in 25µL Opti-MEM and then combined with 0.2µg 
DNA/RNA, also resuspended in 25µL Opti-MEM. The mixture was incubated for 20 
minutes at room temperature, then added to the cell suspension. The supernatants were 
removed after 20-24 hours. 
 
2.5 Flow cytometry analysis 
Fluorescence activated cell sorter (FACS) analysis is of great help where cell populations have 
to be differentiated and counted in a high throughput manner. In FACS analysis, cells can be 
separated and measured according to their size and surface or cytosolic proteins. FACS can 
simultaneously measure various characteristics of different subpopulations in one sample. Cells 
are squeezed through a capillary with an inner diameter of 50 to 100µm. Cells are forced to pass 
through it in single file and are thus available for selective measurement. The FACS laser is 
focused on the middle of the capillary and the light scattered in an acute angle, also called 
forward scatter (FSC). Surface smoothness scatters the light in an obtuse angle, also called 
sideward scatter (SSC). A combination of these two factors allows the gating, or selection, of a 
cell population of the desired size. Coupling the cells or molecules of interest to certain 
fluorochromes such as FITC, PE or FAM allows further distinction via emission of the 
fluorochrome in question. It is detected and converted into a digital signal for the appropriate 
software analysis. In this thesis, the flow cytometer LSRII and the associated software FACS 
Diva and FlowJo were used.  
 
2.6.Fluorescence microscopy 
Fluorescence microscopy is of great help when wanting to analyse the exact localization of cell 
processes. For this thesis cells were fixed for 15 minutes with 4% PFA at 4°C, then washed 
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three times with PBS. If a primary antibody was used the cells were first permeabilized with 
0.1% saponin and 5% BSA in PBS for 30’ at room temperature, then washed with PBS. The 
cells were blocked for 30 minutes with 10% FCS in PBS. After renewed washing with PBS, 
the primary antibody was incubated with the cells overnight at 4°C in a wet box. The next 
morning, the cells were washed with PBS and then incubated with DAPI or Hoechst 33452 
and the appropriate secondary antibody for 20 minutes on ice. The cells were washed 3 times 
with PBS and one time with H2O, then mounted on glass slides and kept away from light until 
the mounting medium had dried.  
 
2.7. Lentiviral transduction of cell lines 
 
2.7.1. Transfection of eukaryotic cells using CaPO3 
HEK cells were used for transfection of the three plasmids containing the viral building blocks. 
The culture medium of the cells used for viral production was changed 30 minutes prior to 
transfection. The cells were then transfected using the BBS-Ca2PO4 method (Chen and 
Okayama 1988). In it, DNA forms crystalline structures with CaPO3, which can be 
endocytosed into the cell, where the DNA is then expressed. For one 10cm dish, 10-12µg 
DNA were diluted with H2O to a final concentration of 2µg/100µL transfection solution. The 
diluted DNA was combined with ice-cold CaCl2 to obtain a 250mM transfection buffer that 
was mixed 1:1 with 2x BBS. This was incubated for 10 min at room temperature and then 
added, drop-wise, to the cells. The medium was replaced the next day.  
 
2.7.2.Production of stable knock down cell lines 
In order to establish polyclonal cell lines constitutively expressing shRNA, cell lines possessing 
the IFN response properties of interest were transduced using a lentiviral vector (A549, THP-
1). The production of a lentiviral vector for transfer of the shRNA expression cassette 
necessitated its insertion into a lentiviral expression plasmid already carrying a puromycin 
cassette. The vector manufacture occurred in the abovementioned HEK293T cells: 6.5µg 
pMDL (encodes the Gag-Pol proteins), 3.5µg pMD.G (encodes the capsid protein VSV-G of 
the VSV, and 2.5µg pRSV-Rev (Rev expression plasmid) were transfected together with 10µg 
of the shRNA vector plasmid (pLKO). Medium was replaced the next day, and the virus-
containing supernatant filtered on day two. 
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For the transduction of the cell lines, 2x106 cells were resuspended in 2mL virus-containing 
RPMI, together with 1:250 diluted polybrene. The cells were seeded in 6-well plates and 
centrifuged for 2 hours at 400g and 30°C. After two days, the cells were washed, the medium 
replaced and puromycin added for selection.  
 
Fig. 2.3: Plasmids used for production of shRNA lentiviral vectors. This system is based on four vectors: a 
gag/pol-expression plasmid, an Env-Plasmid for packaging, a Rev-coding plasmid for optimization of the 
lentiviral export out of the nucleus and the vector genome plasmid. CMV = Cytomegalovirus Promoter, H1 = 
human promoter of rRNA-genes, puro= puromycin resistance, RRE = Rev-responsive element, RSV = Promoter 
of the Rous-Sarkoma Virus, IRES = internal ribosomal entry site, wpre = woodchuck post-transcriptional 
response element for the export of mRNA,   = packaging signal. (Figure kindly supplied by C. Schuberth) 
 
2.8. siRNA-mediated knock-down of THP-1 and A549 cells 
THP-1 cells were electroporated with annealed siRNA sequences containing both sense and 
antisense strands. Sequences were annealed for 1hr.  
 
Table 2.1. List of sequences used for shRNA and siRNA experiments 
Name Sequence 
shRNA  
MITA 1 sense GATCTCCCGCAACAGCATCTATGAGCTTCTTCAAGAGGAAGCTCATAGAT GCTGTTGCTTTTTGGAAA 
MITA 1 
antisense 
AGCTTTTCCAAAAAGCAACAGCATCTATGAGCTTCCTCTTGAAGAAGCTC 
ATAGATGCTGTTGCGGGA 
MITA 2 sense GATCTCCCGCATCAAGGATCGGGTTTACATTCAAGAGTGTAAACCCGATC CTTGATGCTTTTTGGAAA 
MITA 2 
antisense 
AGCTTTTCCAAAAAGCATCAAGGATCGGGTTTACACTCTTGAATGTAAACC 
CGATCCTTGATGCGGGA 
siRNA  
MITA 1 GCAACAGCATCTATGAGCTTCTGGAGAAC 
MITA 2 GTGCAGTGAGCCAGCGGCTGTATATTCTC 
Luciferase sense CGUACGCGGAAUACUUCGATT 
Luciferase 
antisense GAAGUAUUCCGCGUACGTT 
RIG-I sense AATTCATCAGAGATAGTCA 
RIG-I antisense GGAAGAGGTGCAGTATATT 
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10µg RNA were used for 2x106 cells. THP-1 cells were washed with PBS and resuspended in 
Opti-MEM. 10µL RNA was combined with 100µL cell suspension. The electroporator was 
set to 300V, 150µF and 100Ω. After electroporation, cells were rapidly pipetted into 3mL 
RPMI in a 6-well plate. Two hours later, cells were pooled and washed. The next day, cells were 
replated in 96 wells and antibiotics added. Proteins were knocked down in time spans ranging 
from 48 to 72 hours. New medium was added prior to transfection experiments.  
 
2.9. Circular dichroism spectra 
Circular dichroism (CD) is the differential absorption of left- and right-handed circularly 
polarized light. Linearly polarized light is polarized in a certain direction (that is, the magnitude 
of its electric field vector oscillates only in one plane, similar to a sine wave). In circularly 
polarized light, the electric field vector has a constant length, but rotates about its propagation 
direction. Hence it forms a helix in space while propagating. If this is a left-handed helix, the 
light is referred to as left circularly polarized, and vice versa for a right-handed helix. 
Measurements are reported in degrees of ellipticity. This relationship is derived by defining the 
ellipticity of the polarization as: 
 
    tanθ = 
€ 
ER − EL
ER + EL
 
where ER and EL are electric field vectors of the right-circularly and left-circularly polarized 
light, respectively. When ER = EL, θ is 0°, meaning linearly polarized light. When either ER or 
EL is equal to zero, θ is 45° and the light is circularly polarized. It is known that G-tetrads have 
a unique melting curve at 295nm (reviewed in (Huppert 2008)). 
 
Fig. 2.4: Melting curve of G quadruplexes (Adapted from (Huppert 2008)). 
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2.10. HEK-Blue IFNβ reporter cell system 
HEK-Blue™ Cytokine Cells from Invivogen is an engineered HEK293 cell line for detection 
of biologically active cytokines. They are based on the inducible expression of an optimized 
secreted embryonic alkaline phosphatase (SEAP) reporter gene and its quantitative detection 
using QUANTI-Blue™,or pNpp (p-Nitrophenyl Phosphate). HEK-Blue™ cells express the 
SEAP reporter gene under the control of the IFNβ-inducible ISG54 promoter. 
Therefore, in the presence of IFNβ, the ISGF3 pathway is activated, modulating the SEAP 
activity. The amount of SEAP secreted in the cell supernatant can be measured 
spectrometrically with pNpp at 405nm. These cells were generated by stable transfection of 
HEK293 cells with the human STAT2 and IRF9 genes to have a maximally active type I IFN 
signaling pathway. HEK-Blue™ cells are resistant to the selectable markers blasticidin and 
Zeocin™ and are usable for about 30 passages. 
 
2.11. Click-it system for RNA synthesis and infection of Listeria 
Invitrogen has developed a system for tracking and observing nucleotide, sugar, or amino acid 
synthesis. RNA synthesis using ethynyl uridine was used in this thesis.  
 
 
Fig. 2.5: Experimental setup of the Click-it Listeria infection. Listeria were incubated during their log growth 
phase with EU at the appropriate Molarity. EU-labeled Listeria were then allowed to infect host cells for various 
infection time points. Cells were washed and fixed with PMA. Listeria visible under fluorescence microscopy 
were therefore inside the host cells and red fluorescence had to be due to EU staining from Listeria, as host cells 
had not been fed with EU. 
 
Click chemistry describes a class of chemical reactions that label and detect a molecule of 
interest using a two-step procedure. The two-step click reaction involves a copper-catalyzed 
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triazole formation from an azide and an alkyne. One can be used to tag the molecule of 
interest, while the other is used for subsequent detection. The azides and alkynes are inert, 
stable, and extremely small. The label is small enough that tagged ethynyl uridines are 
acceptable substrates for the RNA polymerases (Jao and Salic 2008). In addition to the azide 
and alkyne labeled molecules, copper (I) is required to catalyze the reaction. The click reaction 
can occur at pH values ranging from 3 to 12, at temperatures from room temperature to 37°C. 
In the case of Listeria infection, 100µL of an overnight culture of Listeria were grown in BHI 
dissolved in HTM (20% vol/vol), a minimal medium for Listeria (Tsai and Hodgson 2003). 
20mM EU was added to the medium and the cells grown for 2-4 hours, or until the log phase 
had been attained. The cells were washed once with PBS to remove all traces of non-absorbed 
EU, then resuspended in opti-mem and added to host cells plated on coverslips at differing 
MOIs. After 2-4 hours of infection, the coverslips were washed, fixed with 4%PFA and 
permeabilized. The Alexa fluor 594 azide was resuspended in the click-it reaction cocktail 
(according to manufacturer’s instructions), then added to the coverslips and incubated for 30 
minutes at room temperature. The coverslips were washed with PBS and mounted on 
microscope slides, then let dry overnight. 
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3. Results 
The work to characterize cytosolic recognition of nucleic acids encompasses three categories in 
this thesis (Fig. 3.1). The approaches to determine and detail the mechanisms and recognition 
motifs of cytosolic nucleic acid recognition can be divided into the search for a recognition 
motif, the interaction of PAMPs from pathogens such as Listeria monocytogenes with cytosolic 
receptors and the roles of MITA and autophagy with the type I IFN induction pathway. 
 
Fig. 3.1: Different approaches to characterization of cytosolic recognition of nucleic acids. In this thesis, three 
different methods to further understand cytosolic recognition of nucleic acids were performed. The motif for the 
as yet unknown DNAR will be discussed, as will the effect of RIG-I on the type I IFN and proinflammatory 
cytokine response. The involvement of MITA and autophagy in the monocytic IFNα pathway after transfection 
with nucleic acids will also be investigated. 
 
3.1. Cytosolic recognition of DNA 
Immune recognition of cytosolic nucleic acids plays a central role during the innate immune 
response. Cytosolic dsDNA induces a strong type I IFN response in a TLR9 independent 
manner. The exact mechanisms of the cytosolic dsDNA response, however, are poorly 
determined, the receptor unidentified. Recognition motifs of short dsDNA ODNs were 
analyzed in monocytes, as well as assorted cell lines, and two classes of immune stimulatory 
ODNs characterized. In addition to long dsDNA including plasmid DNA, human monocytes 
detected concatemerized short dsDNA ODNs. Surprisingly, monocytes were also able to 
recognize short dsDNA ODNs harboring mismatched terminal G extensions (a so-called bar-
bell structure). As determined by gel electrophoresis and CD spectroscopy under physiological 
salt and temperature conditions, the G extensions of stimulatory dsODN did not form 
G tetrad structures, which excluded a polymerization dependent effect. The recognition of 
small dsDNA ODNs was restricted to monocytes and monocytic cell lines. This would 
implicate a new sequence-dependent recognition motif of short cytosolic DNA in human 
immune cells. 
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3.1.1. PBMCs recognize DNA dependent of its localization 
Several recent works succeeded in showing the long DNA sequence poly dAdT a ligand for 
RIG-I (type I IFN induction) and AIM-2 (IL-1β induction) (Ablasser, Bauernfeind et al. 
2009; Burckstummer, Baumann et al. 2009; Fernandes-Alnemri, Yu et al. 2009).  
This advance, however, did not shed the expected amount of light on the subject of cytosolic 
dsDNA-type I IFN induction pathway. Although Burckstummer et al performed a proteomic 
approach, the type I IFN DNAR remained elusive. Trying to characterize the DNAR by way 
of its ligand has resulted in confusing discoveries, because the descriptions of possible 
recognition motifs differed in cell lines, organisms or readouts. Suzuki et al had shown in 1999 
that mammalian DNA, bacterial DNA, double-stranded linear DNA polymers, double-
stranded ODNs and double-stranded PTO-modified ODNs induced TLR9-independent 
expression of type I IFN inducible genes in rat thyroid cells after lipofection (Suzuki, Shiratori 
et al. 1999). Seven years later, Medzhitov discovered a minimal length requirement of 25bp in 
dsDNA ODN for type I IFN induction in murine monocytes. Medzhitov et al, however, also 
found a complete inhibition of IFN induction after PTO modification of the ODN backbone 
(modification of only the ends, however, was tolerated) (Stetson and Medzhitov 2006). Ishii et 
al. expanded the definition of immunestimulatory cytosolic DNA to include all B-form DNA, 
as long as it was transfected. Poly dAdT was strongly IFN-inducive (in contrast to pdGdC) in 
MEFs (Ishii, Coban et al. 2006). 
In this work, recognition motifs of dsDNA ODNs and associated polymers in human 
monocytes were dissected. Two different types of immune stimulatory ODN, sequence or 
length dependent, were discovered.  
 
The main part of the cytosolic dsDNA- induced type I IFN response is produced by monocytes. 
One of the first experiments was performed in order to characterize the induction of IFNα in 
different cell populations of human blood. Therefore, different types of DNA were transfected 
in freshly isolated PBMCs before and after depletion of pDCs or monocytes. Transfected A 
type CpG (CpG 2216), genomic DNA (genDNA) and plasmid DNA (pDNA) all induced 
comparable amounts of IFNα in whole PBMCs (see Fig. 3.2 - Fig. 3.4)).  
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Fig. 3.2: The main part of cytosolic dsDNA-induced IFNα is produced by monocytes. PDCs were depleted 
from PBMC and transfected with CpG 2216, genDNA and pDNA. TLR9 activity was blocked in PBMCs 
with chloroquine (CQ). PBMCs with chloroquine showed the same IFNα response as PBMCs with PDC 
depletion. 
 
Fig. 3.3: PDCs supply the IFNα response to CpG. PDCs were isolated from PBMCs and transfected with 
CpG2216, genDNA, pDNA, or medium. Only PDCs that had not been treated with the endosomal 
acidification reagent CQ could respond to CpG2216 stimulation. The bacterial origin of pDNA is visible in the 
IFN response of PDCs to it.  
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Fig. 3.4: Monocytes are the source of cytosolic dsDNA IFNα in PBMCs. PBMCs were stimulated as a whole 
population, or PBMCs were depleted of monocytes using CD14 beads, or the pure monocyte population was 
used. The amount of IFNα produced by PBMCs and monocytes was near identical, while PBMCs depleted of 
CD14+ cells produced IFNα solely in response to TLR9 stimuli.  
 
However, blocking of TLR9 with CQ or depletion of PDCs abrogated the induction of IFNα 
by type A CpG, while the induction of IFNα by genDNA and pDNA was not disturbed. In 
contrast, depletion of monocytes nearly completely abolished the induction of IFNα by 
genDNA, while the induction of IFNα by CpG2216 and pDNA was enhanced. Pure 
monocytes responded with the virtually same amount of IFNα as PBMCs to stimulation with 
genDNA. These experiments clearly show that the presence of monocytes is essential for the 
IFNα response to genDNA. As pDNA contains CpG motifs, pDNA represents both a TLR9 
ligand and a ligand for the DNAR. According to Krieg, mammalian genDNA is not 
recognized by TLR9 due to its modifications (McCluskie and Krieg 2006). Further 
experiments in pure human PDCs show that the induction of IFNα by genDNA is only 
partially sensitive to CQ. This indicates that, similar to monocytes, PDC also recognize DNA 
in a TLR9-independent manner. However, as PDCs are infrequent in PBMCs, TLR9-
independent IFNα from PDC only plays a minor role overall. With this knowledge, further 
experiments were done with CQ-suppressed PBMCs, assured that the IFNα response could be 
interpreted as coming from the monocyte population.  
 
3.1.2. Tandem dsODN are recognized by the DNAR 
So far, dsDNA ODNs, but not ssDNA ODNs, have been tested in only the murine system 
(Stetson and Medzhitov 2006). In order to systematically analyze the innate immune response 
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to dsDNA ODNs in the human system, various synthetic palindromic ODNs of different 
lengths were transfected into human PBMCs. The ODN sequence GC(AT)nGC was used, 
with n=10, 13, 20, 30, 40. IFNα production was analyzed 24h after stimulation. In addition to 
human PBMCs, human cell lines were used, as well as murine bone marrow-derived DCs 
(BMDCs) (see Fig. 3.5).  
 
Fig. 3.5: Length-dependent induction of type I IFN in PBMCs. dsODNs were transfected into cells of 
different origins and different species. A) IFNα ELISA of PBMCs blocked with CQ. A robust IFNα response 
to dsDNA only starts after 84bp. 2x105 PBMCs were plated per well of a 96-well plate and then transfected 
with 0.5µL Lipofectamine complexed with 0.2µg DNA. Supernatants were removed after 24 hours incubation 
and IFNα measured. B) hIP-10 ELISA of human cell lines HEK293T and THP-1. Only THP-1, a 
monocytic cell line derived from professional immune cells, seems to express a DNA recognition system. C) 
PA-gel of the dsDNA. 0.4µg DNA was loaded onto the gel and run for 40 min at 90V. The dsDNA ODNs 
traveled through the gel according to size, but showed various forms of their molecular weight because of their 
palindromic sequence. 
 
PBMCs blocked with CQ were used because it had been established that the use of CQ allows 
for an almost purely monocyte-derived cytokine response (see Fig. 3.2). No considerable 
induction of hIFNα was obtained after transfection of ODN smaller than n=20. Various cell 
lines were tested for their ability to respond to transfection of cytosolic DNA with production 
of type I IFN; THP-1 and HEK 293T cells are shown here exemplarily. Of all the cell lines 
tested, only the monocyte-derived cell line THP-1 mounted a type I IFN response to DNA 
transfection, showing that cytosolic DNA recognition is restricted to certain cell types. As 
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highly repetitive, palindromic sequences could form unpredictable undusual structures, we also 
evaluated length-dependency of type I IFN production for non-palindromic sequences 
(Fig. 3.5D) yielding similar results.  
 
3.1.3. Long DNA sequences are recognized regardless of sequence 
Once the minimal sequence length had been determined, it was tested whether sequence 
specificity was a part of the type I IFN response. 
 
Concatemerized DNA sequences resulting in long dsDNA fragments induce a type I IFN response  
As earlier studies suggested a sequence independent but length dependent mechanism of DNA 
recognition, it was attempted to design small but self-polymerizing ODN. The concept of the 
motif design was to combine a pair of DNA ODNs with self-polymerizing properties. 
Double-stranded DNA ODNs were constructed using overlapping sense and antisense strands 
so that long dsDNA strands would result from hybridization of both ODNs together. 
CAAACCAAAGAATGGCATCATAAATAGTGGAGAGGGTGAAGGTGA (ODNs 
Nr 126) and its counterpart, the antisense strand with the staggered sequence 
TATGATGCCATTCTTTGGTTTGTCACCTTCACCCTCTCCACTATT (ODN Nr 
153) give a concatemerizing double strand with a molecular weight a multiple of the single 
strand. (see Fig. 3.6C).  
The 5’ half of the sense strand hybridizes with the 5’ half of the antisense strand, while the 3’ 
half of the sense strand hybridizes with the 3’ half of the antisense strand. Sequences leading to 
self-hybridization of either sense or antisense ODN had to be avoided. This is why 
nonpalindromic sequences based on the GFP sequence were used. In theory, hybridizing the 
two sequences together would result in a self-replicating dsDNA strand of varying length, while 
using only each ODN by itself would show a single band on a PA gel. The hybridization of 
both ODNs together induced substantial secretion of IFNα, while single ODN did not induce 
IFNα secretion when transfected. After loading the single ODNs, as well as the hybridized 
dsODN mixture, distinct bands were visible for the single ODNs and a long smear, as well as a 
solitary band, were visible for the hybridized ODN mixture, indicating that long dsDNA of a 
high MW had been formed. 
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Fig. 3.6: Concatemerizing ODNs induce type I IFN only when transfected together. IFNα ELISA of PBMCs 
blocked with CQ and stimulated with concatemerizing ODNs. To this end, the sequence 126 and the 
ODN sequence numbers 153 ((TATGATGCCATTCTTTGGTTTGTCACCTTCACCCTCTCCACTATT) 
and its staggered partner (CAAACCAAAGAATGGCATCATAAATAGTGGAGAGGGTGAAGGTGA), 
respectively) concatemerize to large double-stranded DNA strands, which they do not do when single-stranded or 
unhybridized, as can be seen in the PA gel. A) CQ-blocked PBMCs were transfected with either the single 
stranded ODNs or the double-stranded hybridized version. Only the concatemer induces IFNα; ssODNs 
transfected alone do not induce IFNα. B) PA-gel of both ODNs alone and concatemerized. Both ODNs alone 
only gave a single band, while when hybridized together, they result in a smear of DNA with a larger molecular 
weight than either strand alone. 
 
3.1.4. Short DNA sequences need to concatemerize for type I IFN induction 
Single-stranded ODN sequences were designed, with the anti-sense strand giving a 
concatemerizing double strand when hybridized to the corresponding sense strand: 
(AT)6ACGGCT(AT)6 and CG(TA)13GC, together with the C-G-switched pair 
(AT)6AGCCGT(AT)6 and GC(TA)13CG, were hybridized with each other and their 
corresponding strands (Fig. 3.7A). ODNs, when self-hybridized, failed to induce an IFNα 
response; only when hybridized as concatemers without gaps in the strand was an IFNα 
induction visible. In the next step, the ODN sequences were altered to C2(TA)13C2, 
(AT)6AG4T(AT)6, G2(TA)13G2, and (AT)6AC4T(AT)6 (Fig. 3.7B). Transfection of the self-
hybridized ODNs C2(TA)13C2 and (AT)6AG4T(AT)6 did not result in induction of IFNα in 
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CQ-blocked PBMCs, while transfection of the double strand did induce IFNα (see Fig. 3.7B). 
Transfection of self-hybridized G2(TA)13G2, and (AT)6AC4T(AT)6 yielded an unexpected 
result; the single ODN G2(TA)13G2 could induce a remarkably strong IFNα response 
(Fig. 3.7B), which was the reason for further investigation of the G-ended motif. Curiously, 
the single stranded (AT)6AG4T(AT)6 showed two bands when run on a PA gel, one at the 
ssDNA height and one significantly further up. This band did not disappear once 
(AT)6AG4T(AT)6 was hybridized to C2(TA)13C2 (Fig. 3.7C). The IFNα induction was still 
dependent on the double-stranded structure; (AT)6AG4T(AT)6 by itself, even though it 
multimerized into a higher-MW band, did not result in an IFNα response.  
 
Murine BM-DCs have a lower sensing threshold for cytosolic ODNs 
Murine immune cells have long been used for investigations concerning cytosolic nucleic acid 
recognition (Hemmi, Takeuchi et al. 2000; Takaoka, Wang et al. 2007). As differences in PRR 
expression such as TLR9 are already known to exist between human and murine immune cells 
(reviewed in (Barchet, Wimmenauer et al. 2008)), ODNs shown to induce IFNα in PBMCs 
were transfected into  murine BM-DCs. Cells were isolated from C57BL/6 and cultivated for 
7 days in media containing GM-CSF. As can be seen in Fig. 3.8A, the ODN ladder of 24-
84bp induced a mIFNα response starting from 44bp instead of 64-84bp, as for PBMCs 
(Fig. 3.5A). In Fig. 3.8B, ODNs C2(TA)13C2 and (AT)6AG4T(AT)6 induced mIFNα when 
transfected as a concatemer, similarly to IFNα induction in PBMCs. (AT)6AG4T(AT)6 , 
however, also induced a mIFNα response without hybridization with C2(TA)13C2. This 
induction could not be observed in PBMCs (Fig. 3.7B). This species-derived difference in 
length-dependent sensitivity to dsODN transfection is an example of why results obtained in 
using murine parameters cannot be transferred to the human system. Curiously, the single 
stranded (AT)6AG4T(AT)6 showed two bands when run on a PA gel, one at the ssDNA height 
and one significantly further up. This band did not disappear once (AT)6AG4T(AT)6 was 
hybridized to C2(TA)13C2 (Fig. 3.7C).  
 
3.1.5. dsODN with protruding G ends induce IFNα  in PBMC 
As discussed in section 3.1.4., the IFNα-inducing activity of G2(TA)13G2 was similar or better 
than tandem matching ODN combinations. Further analysis of length and composition 
revealed strong IFNα inducing activity of ODNs with two mismatched protruding G at the 5’ 
and 3’ ends (see Fig. 3.7.B).  
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Fig. 3.7: ODNs need to be double-stranded for IFNα induction. A) CQ-blocked PBMCs were transfected with 
hybridized ODNs CG(TA)13GC, (AT)6ACGGCT(AT)6, (AT)6AGCCGT(AT)6 and GC(TA)13CG. Each 
ODN transfected by itself did not induce an IFNα response, while the concatemerizing ODNs transfected 
together did induce a strong IFNα response. B) IFNα response after replacing GC pairings with only G or C 
sequences. The G2(TA)13G2 ODN induced and IFNα response when self-hybridized, the other pairings only 
induced IFNα when concatemerized.  
 
G3 induces a robust IFNα response, although C3, A3, T3 do not 
Three protruding Gs exhibited the most robust IFNα inducing activity. Substitution of G3 
with A3, T3 or C3 led to the complete loss of IFNα activity. Interestingly, the effect of G3 
overhangs could be neutralized by pairing the G3 ODNs with their C3 complements. 
Permutation of unpaired overhangs showed that substitution of single Gs by A, T or C are 
gradually tolerated but confirmed that G3-ended ODNs mount the most robust type I IFN 
response (Fig. 3.10C). 
 
The crucial element of IFNα induction in the G-ended nucleotides is the barbell end 
Sequences based on the core sequence of G2(TA)13G2 were transfected onto CQ-blocked 
PBMCs  in order to assess the length dependence of the stimulatory motif. G2(TA)9G2 still 
induced a substantial amount of IFNα (see Fig. 3.9 B). This would indicate that the length of 
the (TA) sequence is not the section of the ODN critical for recognition.  
0 5 10
 (AT)6 ACGGCT(AT)6 
  
CG(TA)13GC
 (AT)6 ACGGCT(AT)6     +CG(TA)13GC
(AT)6 AGCCGT(AT)6
GC(TA)13CG
 (AT)6 AGCCGT(AT)6
    +GC(TA)13CG
 (AT)6 ACGGCT(AT)6 
+(A T)6 AGCCGT(AT)6
GC(TA)13CG
+CG(T A)13GC
(AT)6 AGCCGT(AT)6
+CG(T A)13GC
 (AT)6 ACGGCT(AT) 6
    +GC(TA)13CG
dAdT
CpG
CpG - CQ
Medium
IFN- a (ng/ml)A
0 2 4 6
CC(TA)13CC
(AT)6 AGGGGT(AT)6 
GG(TA)13GG 
(AT)6 ACCCCT(AT) 6 
   CC(T A)13 CC+GG(T A)13GG
   (A T)6 AGGGGT(AT)6
+(A T)6 ACCCCT(AT)6
(AT)6 AGGGGT(AT)6
   +CC(TA)13CC 
(AT)6 ACCCCT(AT)6 +GG(T A)13GG 
dAdT 
CpG 2216  
Medium
IFN-a (ng/ml)
CpG 2216(-CQ)  
B
Results  3.10 
___________________________________________________________________________ 
 
Fig. 3.8: Murine BM-DC mIFNa response to DNA ODNs. A), B): mIFNα ELISA of BMDCs stimulated 
with the dsDNA ODNs. BM-DCs from C57BL/6 mice were isolated and cultivated for a week in RPMI 
supplemented with GM-CSF. Cells were plated at 105 cells per well in a 96-well plate, then transfected with 
0.5µL Lipofectamine complexed with 0.2µg DNA. Supernatants were removed after 24 hours incubation and 
mIFNα measured. A) Transfection of 24bp-84bp ODN ladder. The cutoff point for cytosolic dsDNA 
recognition starts much lower in murine BMDCs, indicating that results obtained in the murine system cannot 
be blindly transferred into the human one. B) ODNs C2(TA)13C2 (40) and (AT)6AG4T(AT)6  (39) were self-
hybridized or concatemerized, then transfected on BM-DCs. (AT)6AG4T(AT)6 induced a mIFNα response 
without hybridization to its C-ended counterpart.C) An indication for this induction of mIFNα may lie in the 
fact that (AT)6G6(AT)6 complexes by itself into a multimer: ODNs 139 and 140 were loaded and run on a 8% 
PA-gel.  
 
PBMCs were also transfected with variations of the G3(TA)4NNNN(TA)4G3 core sequence: 
As can be seen, no homogeneous (TA) sequence is needed of IFNα induction. All 
combinations of nucleotide pairings in the sequence between the (TA) segments induced 
type I IFN. 
 
3.1.6. Bar-bell dsODNs are recognized by DNAR 
Since the (TA) sequence can not be present as ssDNA strands, a nonpalindromic core sequence 
was designed, together with its equally nonpalindromic counterpart (G3NonPalin1G3 and 
G3NonPalin1G3’, respectively). This way, double-stranded ODNs would occur only in presence 
of both ODN strands and self-hybridization could be ruled out.  
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Fig. 3.9: Only G-ended oligos induce type I IFN in CQ-blocked PBMCs. A) CQ-blocked PBMCs were 
transfected with ODNs containing a core sequence of (TA)10 and end sequences of G3, A3, T3 and C3, 
respectively. Only G3(TA)10G3 transfection resulted in a type I IFN response. B) PA-gel of ODNs with a 
(TA)10 core sequence and G3, A3, T3 and C3 ends, respectively. As can be seen, no structural or multimerization 
differences can account for the disparate IFNα induction. 
 
Nonpalindromic DNA sequences 
PBMCs were blocked with CQ and then transfected with different combinations of the 
nonpalindromic core sequence. When transfected with these nonpalindromic ODNs, PBMCs 
responded with IFNα induction only in the case of dsDNA ODNs. Each strand for itself did 
not induce IFNα (Fig. 3.10A). Human cell lines THP-1, HEK293T, A498, A549, FaDu and 
HepG2 were transfected with various RNA and DNA stimuli and IP-10 quantities measured. 
RIG-I ligand 3P-dsRNA, RIG-I and DNAR ligand dAdT and DNA stimuli genDNA, 
pDNA, phage DNA, CpG 2216 and G3NonPalinG3 showed a varied cytokine response. 
Apart from THP-1, no human cell line induced IP-10 in response to G-ended barbell ODN 
(Fig. 3.11C). 
 
IFNα induction by nonpalindromic DNA with missing G3 barbell ends 
Hybridizing two complementary core sequences with different 5’ and 3’ ends was done in order 
to identify on which end, if any, the G3 overhang or mismatch is essential. The experiments 
showed that at least one 5’ and one 3’ G3 overhang per double strand must be present for IFNα 
induction to proceed. In general, the amount of G3 overhangs corresponded to the IFNα 
response. Interestingly, two mixed ODN with either a single 5’ G3-overhang or a single 3’ 
overhang cooperated inducing IFNα in monocytes (Fig. 3.12B). 
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Nonpalindromic DNA with inosine insertion 
In order to test if the IFN induction was purely due to the structural singularities of guanosine, 
new ODNs were designed incorporating inosine at their 5’ and 3’ ends. The inosine nucleoside 
has a ribose ring attached to hypoxanthine using a β-N9-glycosidic bond. It can pair with 
adenine, cytosine, and uracil. The DNA ODNs designed with inosine continued to use the 
nonpalindromic core sequence mentioned previously.  
Inosine-containing barbell double strands induced IFN in a comparable amount to G3(TA)10G3 
ODNs. Inosine replacement of only one strand did not abrogate the effect that the G ends on 
the other strand had on IFN induction (Fig. 3.13B). The nonpalindromic core sequence and its 
corresponding antisense sequence were outfitted with I, G, A, T or C overhangs on both 5’ and 
3’ ends, in addition to an ODN without overhangs, i.e. the naked core sequence. All 
nonpalindromic sequences were hybridized with their antisense sequences, meaning 
IINonPalinII was hybridized with GGNonPalinGG, AANonPalinAA, and so on. This showed 
that inosine had a stimulatory effect comparable to guanosine; as long as only one of the strands 
contained inosine overhangs this resulted in an IFNα response in CQ-blocked PBMCs. 
Hybridization of IINonPalinII with NNNonPalinNN induced even more IFNα when N was 
T, A, or C.  
The only exception to this was when IINonPalinII was hybridized with the ODN sequence 
without overhangs; this hybridization induced no IFNα. Guanosine overhangs induced at least a 
modicum of IFNα as long as no blunt ends resulted in the pairing (Fig. 3.13B).  
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Fig. 3.10: Evaluation of (TA) length dependency on IFNα induction. A) The (TA) core sequence was further 
decreased by inserting different 4nt sequences. An unbroken (TA) length was therefore not necessary for an 
IFNα response in CQ-blocked PBMCs. Even though the TA-rich central repeat sequence appears to represent 
an excellent recognition motif, non-palindromic central sequences with low TA-content also induce substantial 
amounts of IFNα. B) Length of (TA) sequence is not important as long as Gs present on the ends. PBMCs 
were blocked with CQ and transfected with ODNs containing 2 guanosines on the ends but differing lengths of 
the (TA) core sequence. Differing lengths of the core sequence were diminished at (TA)9 concerning the amount 
of type I IFN induced. An ODN containing no TA sequence, but G3 ends, was also transfected and induced 
IFNα in the range of the (TA) sequence-containing ODNs. C) Substitution of one or more Gs by A, T, or C 
did not result in abrogation of the type I IFN response. 
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Fig 3.11: Analysis of G3NonPalin1G3 ODN characteristics. Because the sequences used previously could not 
guarantee a single-stranded state due to their palindromic sequences, ODNs were developed using the 
nonpalindromic core sequence of GGGCAATGGTCCTGCTGGAGTTCGGG (G3NonPalin1G3) and its 
corresponding antisense strand, GGGGAACTCCAGCAGGACCATTGGGG (G3NonPalin1G3’). They would 
not be able to form double strands by themselves, only when hybridized to their counterparts. A) CQ-blocked 
PBMCs were transfected with either only one half of the NonPalin couplet or with both strands hybridized. 
Only the double strand managed to induce an IFNα response, indicating that the IFNα measured after earlier 
transfections could be due to palindromic double-stranded sequences. Transfection of CQ-blocked PBMCs with 
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either one of the two ISD strands or the double strand hybridized showed only mild induction of IFNα. B) PA 
gel of G3NonPalin1G3 and G3NonPalinG3’. No multimeric complexes were formed. C) IP-10 ELISA of cell 
lines THP-1, HEK293T, A498, A549, FaDu and HepG2 transfected with RNA and DNA stimuli. Although 
all cell lines reacted to RIG-I ligand 3P-dsRNA and DNAR/RIG-I ligand dAdT, none reacted to DNA 
ODNs and CpG 2216. Although A498 responded to lambda phage DNA and genomic DNA, only THP-1 
responded to G3-barbell ODNs. 
 
 
Fig. 3.12: Nonpalindromic barbell oligos induce IFN in CQ-blocked PBMCs in a barbell dependent manner. 
A) Double-stranded ODNs were transfected according to their G-ended overhangs. Blunt-ended nonpalindromic 
double strands do not induce IFN, so even if one of the strands of the double-stranded sequence has G ends, if 
the whole double strand has a blunt-ended motif, the IFN induction is abrogated. B) ODNs transfected together 
in order to assure a 5’ and 3’ overhang induce type I IFN; when tranfected alone, this effect could not be 
observed. C) Gel of the different G3-ended double stranded permutations. The double strands do not form 
concatemers. 
 
3.1.7. Bar-bell ODN are active as monomers 
Multiple nucleotides are capable of interacting via a quadruplex formation. There was, 
therefore, a distinct possibility that ODNs with overhanging G-rich ends interact via 
intermolecular G-quadruplex interplay, forming long chains recognized by virtue of their 
length. These so-called G tetrads are also present in telomeres: in mammalian cells, telomeres 
consist of hexanucleotide (TTAGGG) repeats, thus providing a possible answer for the 
immunogenicity of G-ended overhangs (Wallace, Salonen et al. 2000; Gursel, Gursel et al. 
2003). Using native gel electrophoresis, it could be shown that ODNs with G4 and G5 ends 
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form high molecular weight bands typical for G quadruplexes, while G2 and G3-ended ODNs 
migrated as a simple low molecular weight band (see Fig. 3.14B). 
 
Fig, 3.13: Effect of Inosine on nonpalindromic ODN sequences. A) PBMCs were transfected with the 
abovementioned ODN sequences. G3- and I3-ended ODNs induced IFNα. B) Nonpalindromic core sequences 
with I, G, C, T or A ends were paired with the corresponding strands. Inosine-containing barbell double 
strands induced IFNα in a comparable manner to G-ended barbell double strands. 
 
PAGE gels show a single band of G2, G3 
Oligonucleotides were loaded on a non-denaturing PA-gel using KCl as a buffer instead of 
TBE. The gel was run for 14 hours at 4°C, so any complex formation of the ODNs would not 
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be disturbed. Two different core sequences were used; G overhangs were added to core 
sequences of (TA)4TGCA(TA)4 and (TA)10. As can be seen in Fig 3.14, ODNs G2(TA)10G2, 
G3(TA)4TGCA(TA)4G3 and G3(TA)10G3 did not show multiple bands on PA gels. ODNs 
with longer overhangs such as G5(TA)4TGCA(TA)4G5, G4(TA)4TGCA(TA)4G4 and 
G4(TA)10G4 did. The power of multimer formation did not, however, have any influence on 
IFNα induction in CQ-blocked PBMCs. All G-ended ODNs had similar IFNα-inducing 
properties (see Fig 3.14A). 
 
Circular Dichroism spectra show no tetramer formation 
Because a native electrophoretic gel may interrupt weak interactions because of its strong 
electric field, the molecular interactions were investigated in a physiological solution; 150mM 
NaCl, 30°C starting temperature. To this end, CD spectroscopy was used. A G quadruplex is 
arranged chirally (Fig. 3.15A), which enables it to be detected by CD spectroscopy, where the 
difference of absorption between circularly left and right polarized light is measured. In contrast 
to dsDNA, G tetrads show a unique optically active melting curve at 295nm (Fig. 2.4). CD 
spectra melting curves were measured from 30°C to 70°C using the ODNs listed in table 6.4. 
While G4 and G5-ended ODNs showed a clear melting curve, all of the other ODNs, 
including the G2 and G3-ended ones, exhibited no optical activity at 295nm (Fig. 3.15C). This 
is a strong indication that these immune stimulatory ODNs are also present as monomers 
under physiological conditions. In order to exclude a G quartet interaction under unknown 
parameters, ODNs were tested with the protruding 5’ and 3’ Gs subsequently replaced by 
7-deaza-guanosine (Fig. 3.15D). Replacement of N7 by a C-H group disables tetrad 
formation. As the non-modified ODN demonstrates the same immune stimulatory ability as 
the modified ODN (Fig. 3.15E), it is to be assumed that G quartet formation, and, 
accordingly, polymerization is not necessary for immune recognition. This could, therefore, be 
considered a new sequence motif. 
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Fig. 3.14: G-ended ODNs induce IFNα in CQ-blocked PBMCs regardless of tetramer formation. A) CQ-
blocked PBMCs were transfected with ODNs containing G ends of different lengths. All ODNs proceeded to 
induce a type I IFN response independent of tetramer formation. B) PA-gel of ODNs with different lengths of 
G ends. Only ODNs with 4 or 5 Gs showed tetramer formation; 3 Gs did not show the typical multimer 
formation seen in tetramer complexes. 
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Fig. 3.15: IFNα-inducing characteristics and CD melting curves of G-ended and deaza-G-ended ODNs. CD 
spectra were used for observation of G tetrad formation in G-ended barbell ODNs. A) Arrangement of a G 
tetrad. B) IFNα induction in CQ-blocked PBMCs after transfection with deaza-G containing ODNs. C) CD 
measurement. ODNs were resuspended in a buffer using physiological pH and salt concentrations, then melted 
over a temperature course from 30 to 70°, with their CD spectra measured at 295nm D) Structure of deaza-G. 
N7 has been replaced by a C-H group. E) CQ-blocked PBMCs were transfected with G-ended ODNs, one of 
them containing deaza-G instead of G. No difference of IFN induction could be observed.   
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3.1.8. ODN are degraded in the cytosol 
If the reason for different IFNα response to bar-bell ODNs does not lie in a polymerizing 
structural motif such as a G tetrad, maybe the key to the difference between G3 ODNs and 
their counterparts, such as A3, T3 and C3-ended ODNs, lies in their processing once they reach 
the cytosol. There are various DNases in mammalian cells, both endo and exonucleases. It could 
therefore be due to their delayed processing of G-ended ODNs.  
 
Characterization of G3(TA)10G3 vs C3(TA)10C3 treatment 
ODNs containing the G3-ended nonpalindromic core sequence were used with a 5’- fluorescent 
FAM molecule, as well as a quenching 3’ molecule. The idea was that the fluorescence would 
only be visible once cytosolic DNases had digested part of the sequence, thus freeing the FAM 
from the quencher. (see Fig 3.16). The assay was performed in 96-well plates; THP-1 cells 
were transfected with the ODNs, then incubated for different time points. In order to ascertain 
a transfection efficiency-independent readout, cells were also transfected with a Cy5-tagged 
control ODN, albeit at 1/10th the concentration of the nonpalindromic ODN of interest.  
 
 
Fig. 3.16: Principle of the FAM-ODN transfection. A simple, FAM-tagged ODN would fluoresce regardless 
of its location. Coupling the FAM tag with a quencher on the 3’ end of the ODN ensures fluorescence only 
when inside the target cell and enzyme activity separated the FAM molecule from the quenching molecule, an 
indication of intracellular localization of the ODN.  
 
THP-1 cells were then investigated via FACS analysis, as well as measuring their fluorescence 
in the Perkin-Elmer luminometer. (see Fig 3.17A, C, D and 3.18C). The percentage of Cy5 
and FITC-positive cells were entered into a table. No significant difference between C3 and 
G3- ended sequences could be observed up to 6 hours’ post transfection time (Fig. 3.17A). 
G3-nonpalin ODNs were still capable of inducing and IFN response when transfected as a 
double strand (Fig. 3.17B.) 
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Fig 3.17: Fluorescence and IFNα induction of FAM-tagged ODNs. A) Percentage of FITC, Cy5 positive cell 
population over time. The percentage of positive cells steadily increases with time over the 12-hour timecourse. 
B) IFNα ELISA of CQ-blocked PBMCs. FAM-tagged ODNs possess no IFNα induction properties when 
transfected alone, only when tranfected as a double strand. FACS analysis of FAM fluorescence 12 hours after 
transfection with FAM-tagged ODNs hybridized with C) G3 or D) C3 strands. 
 
There is no sequence specificity concerning transfection efficiency with nonpalindromic ODNs. 
(Fig. 3.17C, D) ODNs with barbell or blunt ends were transfected into THP-1 cells, with 
fluorescence measured via FACS analysis. All cells showed comparable transfection efficiencies 
12 hours after transfection (Fig. 3.17C, D). There was also only a slight sequence specificity 
concerning fluorescence induction at early time points; all sequences were similarly fluorescent 
at later time points (Fig. 3.17A). Barbell sequences containing one FAM-tagged strand induce 
IFNα in CQ-blocked PBMCs. Single-stranded 314 was transfected into PBMCs, as well as 
the barbell combination of 314+111 and the blunt-ended dsODN of 314+313. Of the three 
sequences, only the barbell dsODN could induce type I IFN. All together, these date implicate 
a G3-dependent recognition of dsODN which does not depend on dsODN translocation into 
or stability in the cytosol of cells. 
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Fig. 3.18: Properties of FAM-tagged ODNs A) Mean density of gel bands of G- and C-ended ODNs 
incubated in PBMC lysate. PBMCs were lysed and incubated for the indicated timepoints with 10µg ODNs. 
Density of the gel bands in B) were then measured with gel analysis software. B) PAGE-gel of PBMC lysate 
incubated with G-ended and C-ended ODNs for the indicated timepoints. Gel band density decreases over time. 
C) FAM-tagged ODNs coupled with a quenching molecule fluoresce when incubated with DNase I. 1µg DNA 
was resuspended in 9µL DNAse I buffer and 2U DNaseI, then incubated at 37° for time spans from 30sec to 8 
hours and fluorescence was measured in a Perkin-Elmer luminometer. Fluorescence sharply increased within the 
first five minutes after addition of the DNase, then slowly decreased over time. As a proof of principle, this 
shows that digestion of the DNA sequences does indeed enable unquenched  fluorescence. 
 
3.1.9 ODN induce IFN only if in cytosol 
In order to visualize internalization of fluorescent ODNs into THP-1 cells and monocytes, 
fluorescent ODNs were complexed with either Lipofectamine or poly-L-arginine, then 
transfected into the abovementioned cells.   
Cells were incubated with the ODNs for 2 hours, then fixed, permeabilized and stained for 
DAPI. ODNs transfected with poly-L-arginine showed punctate green fluorescence coinciding 
with endosomal delivery of the ODNs. Using Lipofectamine for transfection delivers the 
ODNs into the cytosol of the cells. As can be seen below (Fig. 3.19), Lipofectamine-
complexed ODNs resulted in a fluorescent staining of the whole cytosol, while poly-L-arginine 
transfection of ODNs did not show this fluorescence.  
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Fig. 3.19: Fluorescence microscopy images of FAM-tagged ODNs Monocytes were seeded at 200 000 cells per 
well of a 96-well plate, then transfected with Lipofectamine complexed to DNA ODN with either A) C3 or B) 
G3 ends, then washed and stained with DAPI after two hours’ incubation. C) Monocytes were transfected with 
0.2µg DNA complexed to 0.18µL poly-L-arginine. After two hours, cells were washed, incubated with DAPI, 
then resuspended in mounting medium and pipetted under a coverslip. Only punctate green specks are visible. 
An equally diffuse green staining is visible for both G3 and C3 sequence combinations. 
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3.2. MITA- or autophagy- dependent type I IFN response 
MITA, or STING contains multiple transmembrane domains and colocalizes with the RIG-I 
adaptor protein IPS-1 (Ishikawa and Barber 2008; Zhong, Yang et al. 2008). Originally found 
to interact with IPS-1, it was also mentioned that the IFN response to cytosolic dsDNA was 
abrogated when MITA was inhibited. Further publications then cemented the necessity of 
MITA presence for cytosolic dsDNA-induced IFN (Ishikawa, Ma et al. 2009). It is not 
involved in the TLR pathway (Ishikawa and Barber 2008) and is critical for virus-induced 
activation of IRF 3 (Zhong, Yang et al. 2008). IFNα production in MITA-deficient MEFs is 
abrogated in response to ODN dsDNA, viral DNA and L. monocytogenes (Ishikawa, Ma et al. 
2009). 
The localization of MITA between the ER and the mitochondria would imply MITA to be a 
junction point linking RIG-I and dsDNA-mediated innate immune responses. This way it 
could detect viral RNAs in translation in addition to DNAs, inducing antiviral immunity via 
TBK1. A MITA/TBK1 complex is formed following transfection with DNA and then 
shuttled to endosomal compartments leading to a robust innate immune response (Ishikawa 
and Barber 2008; Zhong, Yang et al. 2008; Ishikawa, Ma et al. 2009).  
Using adenoviral-induced knockdown of MITA, shRNA-mediated knockdown was 
accomplished in THP-1 cells and the cytokine responses to lipofection of ODNs observed 
(Fig. 3.20B). 
 
3.2.1. The role of MITA in the type I IFN response 
THP-1 cells were infected with a lentivirus encoding for MITA-shRNA, then stimulated with 
ODNs proven to induce a type I IFN response in CQ-blocked PBMCs. Type I IFN response 
is similar to the CQ-blocked PBMC response, with the added advantage of THPs being a cell 
line, not primary cells, and therefore not subject to the donor-induced variations normally 
found in PBMC-based experiments.  
As can be seen in Fig. 3.20A, CQ-blocked PBMCs and THP-1 cells responded to DNA 
stimuli in a comparable manner. Both cell types induced type I IFN in response to G3(TA)10G3, 
but not to ODNs with A, C or T ends. THP-1 cells were then transduced with lentivirus 
containing shRNA with a scrambled sequence, knocking down MITA, or left untreated. The 
type I IFN response to RNA did not greatly differ between conditions. The reaction of THP-1 
cells treated with MITA-shRNA to cytosolic DNA stimuli such as G3(TA)10G3, genomic 
DNA from Listeria and plasmid DNAand THP-1 cells left untreated did, however, differ.  
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Fig. 3.20: Role of MITA in the Type I IFN response to DNA. A) Type I IFN response of PBMCs and THP-
1 cells to various ODN combinations, pDNA and dAdT. PBMCs and THP-1 cells react in a comparable way 
to DNA stimuli. B) Transfection of RNA and DNA stimuli in THP-1 cells. THP-1 cells were either left 
unmodified or transduced with lentivirus carrying MITA or scrambled shRNA. Once MITA has been knocked 
down with lentiviral shRNA transduction, the type I IFN response to DNA stimuli was reduced in THP-1 
cells. Transfection with dAdT resulted in similar type I IFN responses, which demonstrated the MITA-
dependent recognition of cytosolic DNA stimuli. pDNA, plasmid DNA. genDNA, genomic DNA from 
Listeria.  
 
THP-1 cells not transduced or transduced with scrambled shRNA lentivirus retained their 
ability to induce type I IFN production in response to G3(TA)10G3, genDNA and pDNA, in 
contrast to THP-1 cells transduced with MITA shRNA lentivirus (see Fig. 3.20B). 
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3.2.2. The role of autophagy in the type I IFN response 
The cellular mechanism of autophagy shuttles cytoplasmic components to the lysosome. The 
autophagosome, a double-membraned structure, becomes an amphisomes. The pH of the 
vesicle is lowered, enabling hydrolase-mediated degradation (reviewed in (Mizushima, Ohsumi 
et al. 2002). Autophagy has been implicated in the innate and adaptive immune responses: It 
degrades intracellular microbes in autolysosomes and can present cytosolic microbial products 
to PRRs.  
Although type I IFNs are not thought to induce autophagy (Delgado, Elmaoued et al. 2008), 
the influence of autophagy on TLR and RLR signaling is not to be neglected. TLR7 interacts 
with autophagy to recognize the vesicular stomatitis virus; without Atg5 expression, IFN 
induction is abrogated (Lee, Lund et al. 2007). The Atg5-Atg12 complex inhibits RIG-I 
activation by blocking RIG-I from binding to IPS-1 (Jounai, Takeshita et al. 2007). This 
already enmeshed signaling between autophagy and the innate immune response does suggest 
an involvement of cytosolic DNA recognition. Recently, it has been found that Atg9 influences 
dsDNA-induced MITA translocation. Saitoh et al (Saitoh, Fujita et al. 2009) describe the 
translocation of MITA and TBK-1 after dsDNA sensing. MITA was shown to colocalize with 
autophagy proteins LC3-II and Atg9 after dsDNA stimulation. Once Atg9 was inhibited, the 
innate immune response was enhanced, suggesting Atg9 to function as a regulator of dsDNA 
sensing (Saitoh, Fujita et al. 2009). In this thesis, the role of autophagy-related genes, inhibitors 
and inducers in dsDNA stimulation and IFN response will be investigated for monocytes and 
monocyte-derived cell lines. 
Preliminary results show a wortmannin-dependent IP-10 response to DNA stimuli in THP-1 
cells (Fig. 3.21). THP-1 cells were either left untreated, incubated with wortmannin or 
rapamycin. THP-1 cells with a lentiviral knock-down of MITA, autophagy-associated protein 
Atg5, or the control scrambled shRNA sequence were also transfected with DNA and RNA 
stimuli. Wortmannin is used as an autophagy inhibitor (Blommaart, Krause et al. 1997), 
rapamycin is used to upregulate autophagy (Kamada, Funakoshi et al. 2000). Application of 
wortmannin, rapamycin and shRNA against Atg5 can give an approximation to autophagy 
induction or inhibition. In Fig 3.21, wortmannin diminished the IP-10 response to DNA 
stimuli G3(TA)10G3 and pDNA, but not to dAdT and the RNA stimulus 3P-dsRNA. As 
wortmannin functions as a PI3K inhibitor, the decrease of the IP-10 response could also be due 
to wortmannin interference in other cellular pathways. Application of rapamycin did not 
increase the IP-10 response. Interactions between MITA, autophagy, and the type I IFN 
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response to intracellular pathogens or cytosolic nucleic acids promise to be an interesting 
endeavour. 
 
Fig. 3.21: IP-10 Elisa of THP-1 cells treated with autophagy-associated molecules. 8x105 THP-1 cells were 
either left untreated (wt), incubated with 0.1 µM autophagy inhibitor wortmannin, 0.1µM autophagy inducer 
rapamycin, transduced with shRNA for MITA, Atg5 or a scrambled shRNA. Cells were then transfected with 
dAdT, 3P-dsRNA, G3(TA)10G3, C3(TA)10C3, plasmid DNA (pDNA) or left untransfected (empty).  
 
3.3. The Listeria-induced IFN response 
Listeria monocytogenes is a facultative intracellular bacterium that is the causative agent of 
Listeriosis. It is a foodborne pathogen and especially dangerous for immunocompromised 
individuals, such as the elderly, the young, or pregnant women (Ramaswamy, Cresence et al. 
2007).  
Primarily, Listeria infects the host via the intestinal epithelium where the bacteria invade non-
phagocytic cells. Induction of uptake occurs by the binding of listerial internalins (Inl) to host 
cell adhesion factors such as E-cadherin. L. monocytogenes uses internalins only for invasion of 
non-phagocytic cells; invasion of macrophages, their preferred host cell, does not require 
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internalin use. Secretion of LLO creates holes in the vacuolar membrane and allows the 
bacterium to escape into the cytoplasm, where it can reproduce (Reviewed in (Kayal and 
Charbit 2006)). 
Elucidating the host response to Listeria had been though to have been explained in 2006, when 
Decker et al described an IPS-1 independent response to Listeria. They used siRNA-mediated 
knock-down in macrophages to show that IFNβ synthesis in response to intracellular dsRNA 
decreased in absence of IPS-1. In their case, it was shown that Listeria infection targeted the 
IFNβ gene without detectable IPS-1 requirement (Soulat, Bauch et al. 2006). Later on in the 
same year, Medzhitov et al identified an IRF-3 dependent response to Listeria infection. They 
presented evidence that cytosolic DNA could induce a potent type I interferon response to 
Listeria. This activation of type I interferons was TLR independent and required IRF3 but 
occurred without detectable activation of NF-κB and MAP kinases (Stetson and Medzhitov 
2006). However, evidence exists to suggest that Listeria, like Legionella, also take the RIG-I 
pathway. Maybe not uniquely, but RNA definitely plays a role in the innate immune response 
of A549 cells. In this section, the innate immune response to Listeria in phagocytic and non-
phagocytic cells will be investigated.  
 
3.3.1. Listeria induce various cytokine responses in monocytes and THP-1 cells 
Bacterial RNA of various species induces a type I IFN response in chloroquine-blocked PBMCs  
PBMCs were isolated and blocked with CQ in order to eliminate TLR9-dependent 
recognition. Bacterial RNA was isolated from different species by lysozyme treatment and 
according to manufacturer’s instructions (Qiagen). RNA was treated with DNAse for 30 min 
at 37°C, then complexed with Lipofectamine and transfected into PBMCs. Bacterial DNA 
from the same species was also isolated and transfected into CQ-blocked PBMCs. Treatment 
with DNaseI did not impact IFNα induction by bacterial RNA (Fig. 3.21A). Bacterial RNA 
from various species was incubated with CIAP and then transfected into CQ-blocked PBMCs.  
3P-dsRNA was used as a control. As soon as the bacterial RNA was treated with CIAP, a 
sharp decrease of the IFNα response could be observed. (Fig 3.21B) This shows that all 
bacterial RNA, regardless of strain or species, is capable of inducing a type I IFN response in a 
phosphorylation-dependent manner. Listeria monocytogenes infection has been linked to 
cytosolic nucleic acid sensor-dependent type I IFN induction. Listeria represents a well-
characterized model organism for intracellular host-bacteria interaction; it is an opportunistic 
bacterium responsible for infections leading to meningitis and miscarriages. In this thesis, cell 
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lines used as target cells for Listeria infection were chosen because of their involvement in 
Listeria infections in vivo.  
 
Fig. 3.22: Type I IFN response to bacterial RNA in PBMCs. A) RNA from the pathogens S. aureus, E.coli and 
L. monocytogenes was isolated and treated with DNase. Genomic DNA was also isolated and transfected into 
CQ-blocked PBMCs. DNase treatment did not lessen the IFNα response. B) RNA isolated from the indicated 
bacteria species was treated with DNase and CIAP, then transfected into CQ-blocked PBMCs. Only the 
treatment with CIAP abrogated the IFNα response, indicating that the phosphorylation state of the RNA was 
the key factor for the IFNa induction. RNA from Gram positive and negative bacterial strains showed the same 
IFN induction pattern.  
 
Cytokine responses of THP1 and CD14+ monocytes occur in a localization-dependent manner 
Listeria monocytogenes wt and Δhly strains were used at different MOIs in order to infect 
CD14+ monocytes and the THP-1 monocytic cell line, the supernatants removed after 20 
hours and cytokine leves measured. MTT assays for viability could not be performed because 
the MTT reaction also gives a false positive in the presence of bacteria.  
MOI titrations of MOI from 0.25 to 50 were carried out; MOIs higher than 20 tended to 
abrogate the cytokine response in monocytes and THP-1 cells, most likely due to cell death in 
response to microbe overload.  
In Fig 3.22, CD14+ cells were isolated from PBMCs and then infected with Listeria 
monocytogenes wt and Δhly at the indicated MOI. The IFNα response corresponded to the 
MOI used for infection as long as bacteria were used that could express LLO in order to escape 
into the cytosol (L. monocytogenes wt). When the Δhly mutant was used, only a small amount 
of IFNα could be induced regardless of MOI applied, indicating that the cytokine response was 
due to the bacterial presence outside of the lysosome (Fig. 3.22A) and inside the cytosol. The 
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supernatants from CD14+ cells were then also used to measure IL-1β and IL-6, both 
proinflammatory cytokines (Fig 3.22B, C). The IL-6 response was very robust even at quite 
low MOIs, indicating that the pathogen induced IL-6 both when in the cytosol and constrained 
to the lysosome.  
 
Fig. 3.23: Cytokine responses to Listeria infection. Monocytes were infected at the indicated MOIs (8, 6, 4, 2, 
0.5, 0,25) with Listeria wt and Δhly. Supernatants were collected after 20h (for IFNα and IL-6 ELISAs) and 6h 
(IL-1β ELISAs). A) IFNα ELISA of monocytes infected with Listeria monocytogenes. The cytokine response 
was cellular localization-dependent, as the Δhly mutant induced a subdued IFNα response. B) IL-1β ELISA of 
monocytes infected with Listeria. No difference could be observed between wt and Δhly mutants. C) IL-6 
ELISA of monocytes infected with Listeria. The IL-6 response is highly sensitive, as a robust response could 
be observed at MOI 0.25.  
 
Induction of IL-1β, while not dependent of cellular localization of the bacteria, did correspond 
to the amount of bacteria used for infection, indicating that IL-6 can serve as a sign for 
pathogen infection. Monocytes were purified from healthy donor buffy coats by MACS beads 
for CD14, then infected with either wt L. monocytogenes or the Δhly mutant. The supernatants 
were removed after 6 hours (for IL-1β measurement) or 20 hours (for IL-6 and IFNα 
measurements). THP-1 cells were infected at rising MOIs, using RIG-I ligand 3P-dsRNA, 
RIG-I and DNAR dAdT and DNAR ODN 122 as positive controls. The IFNα response 
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occurred in a MOI- and mutant-dependent manner, with the response to Δhly-Listeria 
infection abrogated in comparison to the wt cytokine response. The IL-6 levels were the same 
for both Listeria types, indicating that the IL-6 response occurs independently from pathogen 
localization in the host cell.   
 
THP-1 cells were also infected with wt and Δhly Listeria strains at the indicated MOI 
(Fig. 3.23A-C). The IP-10 response to wt Listeria corresponded to the MOI of the pathogens 
used up to MOI 5. The tapering off of the IP-10 response at higher MOIs indicates that IP-10 
is not an adequate tool for measuring the immune response to Listeria infection (Fig. 3.23A). 
IL-1β induction after Listeria infection was not localization dependent in THP-1 cells, similar 
to the response observed in PBMCs (Fig. 3.23B). The IL-6 response to Listeria showed a slight 
correlation to MOI for both wt and Δhly infections (Fig. 3.23C);  
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Fig. 3.24: THP-1 cytokine responses to Listeria infection. 105 THP-1 cells were infected with Listeria wt and 
Δhly and then IL-1β, IL6 and IP-10 responses measured. A) THP-1 cells were infected with Listeria at the 
MOI indicated and IP-10 production analyzed. The signal tapered off at higher MOIs. B) IL-6 ELISA of 
THP-1 cells infected with wt and Δhly Listeria. Cells infected with both Listeria strains produced IL-6. 
C) IL-1β ELISA of THP-1 cells infected at the indicated MOI with wt and Δhly Listeria. Both Listeria strains 
induced an IL-1β response, indicating a localization-independent response for both IL-6 and IL-1β. 
 
3.3.2. Cytosolic Listeria induce IP-10 and type I IFN in A549 cells 
A549 lung carcinoma cells are routinely used as host cells for Legionella infection. In infants and 
immunocompromised individuals, Listeria can populate and infect host alveolar macrophages 
via the lung (reviewed in (Campbell 1993), (Munder, Zelmer et al. 2005)). A549 cells were 
infected with Listeria in rising MOI concentrations, as well as the RIG-I ligands IVT2, IVT4, 
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and the DNAR- and RIG-I ligand dAdT. As controls, DNAR ligands ODN 122, pDNA, 
genDNA, as well as Listeria RNA were used.  
As can be seen in Fig 3.24A, A549 cells do not react to the DNA stimulus genomic DNA. 
They do react to 3P-dsRNA and live Listeria. This would indicate that in A549 cells, the 
DNAR is not a component of the IFN pathway, as can be found in monocytes and monocytic 
cell lines.  
 
Fig. 3.25: Type I IFN and IL-1β responses to infection by Listeria wt and Δhly. A) There was a strong A549 
type I IFN response to known RIG-I ligand 3P-dsRNA transfected into the cytosol by lipofection. The type I 
IFN response to wild type Listeria showed a definite difference between wt Listeria and the Δhly mutant. B) 
IL-1β ELISA of A549 cells shows no localization-dependent distinction of the IL-1β response. 
 
A549 cells were infected with live Listeria from wt and Δhly strains. As was the case for the 
type I IFN response in THP-1 cells, Δhly Listeria did not induce a type I IFN response in A549 
cells. As wt Listeria infection did result in production of type I IFN, this demonstrates a 
localization-dependent type I IFN response (Fig. 3.24A). 
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Supernatants from infected A549 cells were also used to measure IL-1β induction. In contrast 
to the type I IFN response, both Listeria strains were able to induce IL-1β, showing that IL-1β 
is a sign of infection, but not an indication of pathogen localization (Fig. 3.24B). 
 
FACS of FITC-Listeria infection in THPs 
In order to determine if Listeria elicited the cytokine responses due to their presence in the 
cytosol, FITC-tagged Listeria were added to THP-1 cells and A549 cells. The cells were 
washed after 1 and 4 hours of infection, then fixed and permeabilized with PFA. FACS analysis 
showed a fluorescence shift in all infected cells, irrespective of the Listeria type used. This assay 
confirmed equal uptake of Listeria into the host cells. 
 
 
Fig. 3.26: FACS of A549 and THP1 infection with Listeria wt and Δhly. A) THP-1 cells were infected with 
Listeria wt and Δhly at the MOIs indicated. No difference in internalization can be seen between the uptake of 
wt and Δhly. B) A549 cells were infected with Listeria wt and Δhly at the MOIs indicated. Listeria were 
opsonized with human serum incubation for 30min at 37°C. Both Listeria types were equally internalized. 
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Listeria enter the cytosol of host cell, with listeria wt polymerizing actin 
Listeria could still induce an innate immune response by clinging to the cell membrane and 
Listeria cell wall components binding to TLR receptors on the host cell membrane. THP-1 
cells were infected with Listeria, then stained for phalloidin in order to visualize actin strands. 
(see Fig. 3.26A). Z-stacks were photographed in 1.6µm increments. FITC-stained Listeria 
were visible not only on the outside of the cell, but also inside the cell, showing polymerization 
with actin strands and presence in the same plane as the THP-1 nuclei.  
As can be seen in the figures below (Fig 3.27B), actin colocalization with FITC-stained Listeria 
occurred only with wt Listeria, showing that Listeria did indeed enter the host cells cytosol and 
proceed with the infection cycle. Listeria with the Δhly mutation showed no colocalization with 
the phalloidin staining. Type I IFN responses after Listeria infection can therefore be considered 
to occur due to receptor interaction in the cytosol. 
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Fig 3.27: Z-stack images of Listeria-infected THP-1 cells. THP-1 cells were treated with PMA for four hours, 
adhered to coverslips and then infected with either wt or Δhly Listeria for 2 hours. Cells were then washed and 
fixed with 4% PFA, actin stained with phalloidin and observed under fluorescence microscopy. A) Images were 
taken, starting at the apical side of the cells, every 1.6µm, travelling towards the basal side until cell membranes 
were no longer in focus. Listeria show colocalization with phalloidin staining at multiple points. B) Zoom 
image of wt-Listeria infected THP1 cells at 12.8µm and C) Zoom image of hly-Listeria infected THP-1 cells. 
 
3.3.3. Listeria – dependent induction of type I IFN is RIG-I dependent 
A RIG-I knock-down using lentiviral delivery of RIG-I shRNA into A549 was used to observe 
the dependency of RIG-I presence for type I IFN response to Listeria infection. Using lentiviral 
knockdown ensured the genesis of a cell line that demonstrated knock down of RIG-I for 
upwards of 10 cell passages. Unmodified and knockdown cells were infected with wild-type and 
Δhly Listeria, 3P-dsRNA, dAdT, RNA gained from Listeria and RNA isolated from E.coli 
(Fig. 3.28A). The IP-10 ELISA showed no cytokine induction in response to Listeria or E.coli 
RNA. The response to live wt and Δhly Listeria was also reduced in RIG-I k.d. cells. The IP-10 
response to both wt and Δhly Listeria in unmodified A549 cells is due to IP-10 not being a the 
sole indicator for type I IFN induction, which is why type I IFN assays were performed as well 
(Fig. 3.28B). THP-1 cells were also knocked down using the lentivirally-mediated shRNA 
system. Both A549 and THP-1 cells were transfected with 3P-dsRNA, Listeria RNA, Listeria 
DNA, and different MOIs of Listeria wt as well as Δhly. As can be seen in Fig. 3.28B, RIG-I 
knock-down in THP-1 cells reduced the type I IFN response to 3P-dsRNA and Listeria RNA, 
but only slightly lessened the type I IFN response to live Listeria infection. This differed from 
the changes in the type I IFN response between unmodified and RIG-I knocked down A549 
cells, in which the induction of type I IFN after Listeria infection was sharply reduced. As 
THP-1 cells possess both cytosolic RNA and DNA receptors leading to induction of type I 
IFN, it is possible that Listeria are recognized by both pathways. This is not the case in A549 
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cells, as they do not respond to cytosolic DNAR stimuli and would therefore rely solely on 
cytosolic RNA as a type I IFN inducer.  
  
Fig. 3.28: Lentiviral knockdown of RIG-I in A549 and THP-1 cells. Cells were transfected with the indicated 
stimuli or live Listeria at various MOI. Antibiotics were added 4 hours post infection and supernatants removed 
after 20 hours incubation. A) IP-10 ELISA of A549 cells. Cells were transfected with bacterial RNA, genomic 
DNA, 3P-dsRNA and dAdT. Knock-down of RIG-I resulted in a decreased signal in response to RNA and 
bacterial stimuli. B) Lentiviral knockdown comparison of A549 cells with THP-1 cells, also with RIG-I 
lentiviral knockdown. Cells were transfected with 3P-dsRNA, Listeria RNA, Listeria DNA, live Listeria of wt 
and Δhly strains. The RIG-I-dependent type I IFN response to live Listeria was more pronounced in A549 cells 
than THP-1 cells. 
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Fig. 3.29: IL-1β Elisa of A549 lentiviral kd of RIG-I. IL-1β ELISA showed no k.d. effect between the A549 
wt and A549 RIG-I k.d., suggesting that the IL-1β induction pathway is not influenced by signals from the 
RIG-I pathway in response to Listeria infection. 
 
The supernatants from infected A549 cells were also used for analysis of IL-1β response, but no 
difference could be observed, either between Listeria wt and Δhly or between A549 wt and 
A549 RIG-I k.d. (Fig. 3.29). This would indicate that Δhly are capable of inducing an immune 
response, just not type I IFN, and that A549 RIG-I k.d. is capable of producing an immune 
response, just not via RIG-I.  
Because lentiviral knockdown of RIG-I was not performed for proteins in the RLR pathway, 
notably IPS-1 and IRF3, siRNA-mediated knockdown of A549 cells was attempted in order to 
have a comparable protocol between proteins. As can be seen, the knock-down extent is similar 
in lentivirally abrogated RIG-I and siRNA-mediated inhibition of RIG-I (Fig 3.28A, B and 
Fig. 3.30). Cells were transfected with dAdT, Listeria RNA, 3P-dsRNA, and infected with 
both wt and Δhly Listeria. Positive controls that would elicit the same type I IFN response in 
both wt and kd cells would be difficult to come up with, as A549 cells do not react to DNA 
with type I IFN production, and the cytosolic response to RNA seems to go only via RIG-I. 
The Hiperfect-mediated siRNA knock-down of RIG-I necessitated a protocol in order to 
determine the best amounts of siRNA and Hiperfect reagent. Knock-down in A549 cells was 
greatest 48 hours after transfection and using 0.1µg RNA with 1.5µL Hiperfect (Fig 3.30A). 
A549 cells were treated with siRNA against RIG-I, IPS-1, Luciferase and a double knock-
down of both RIG-I and IPS-1. After 48h, the cells were infected with Listeria wt and Δhly at 
different MOIs or transfected with 3P-RNA, Listeria RNA, and Listeria DNA. Both RIG-I 
and IPS-1 decreased the type I IFN response to 3P-dsRNA, wt Listeria and Listeria RNA. A 
cumulative effect was not always discernible in the cells subjected to a double knock-down. 
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Fig. 3.30: A549 cells with siRNA mediated knockdown of RIG-I and cytokine responses of type I IFN. A) 
Titration of Hiperfect and siRNA in A549 cells. The best results were obtained after 48h incubation with 
siRNA+Hiperfect, using 0.1µg siRNA and 1.5µL Hiperfect. B) siRNA-mediated knock-down of A549 cells 
using siRNA against RIG-I, IPS-1, Luciferase and a double knock-down of  RIG-I and IPS-1. Reduction in 
the type I IFN response to wt Listeria and cytosolic RNA stimuli could be seen in the knock downs of RIG-I, 
IPS-I, RIG-I+IPS-1, but not Luciferase. 
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Fig. 3.31: HepG2 cytokine responses to Listeria infection. A) HepG2 cells were incubated with antibiotic-free 
medium for 24 hours prior to infection, then infected with different MOIs of Listeria wt and Δhly. A robust 
type I IFN response was only visible for MOI>25. Δhly did not induce a strong type I IFN response.  
 
 
Fig. 3.32: Relative luminescence units in primary mouse hepatocytes and the αML mouse hepatocyte cell line. 
Primary mouse hepatocytes were isolated and infected with Listeria, as well as transfected with different RNA 
stimuli. The murine hepatocyte cell line αML was treated in a similar manner. Supernatants from both 
experiments were given to L929 cells expressing IFNβ-Luciferase and total luminescence then measured. 
 
With this comparison, HepG2 cells were transfected and infected with known RNA and DNA 
stimuli, as well as different MOIs of Listeria, both wt and Δhly (Fig. 3.31A). HepG2 cells did 
not respond as readily to Listeria as THP-1 cells, which is to be expected; HepG2 cells showed 
a type I IFN response only at MOI > 25. They did not react to lower concentrations of 
3P-dsRNA, nor did they respond to DNA stimuli like plasmid DNA, genomic DNA, or 
ODNs shown to induce type I IFN in THP-1 cells and PBMC (Fig. 3.31B). Due to the 
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inavailability of primary human hepatocytes, C57BL/6 mice were sacrificed and hepatocytes 
isolated, then kept in culture for 3 days to allow for differentiation. αML cells, a murine 
hepatocyte cell line, were used as well. Both types of cells were transfected with different types 
of RNA/DNA stimuli; Listeria RNA, 3P-dsRNA, genDNA and only Lipofectamine as a 
control. Both hepatocyte cell types reacted to 3P-dsRNA and bacterial RNA, but not 
genDNA. Luminescence could be observed only at high MOIs>25, a characteristic also true of 
the human HepG2 cells.  
 
3.3.4. Listeria RNA present in the cytosol after infection 
After having demonstrated that Listeria not only enter the cell, but also induce type I IFN in a 
localization-dependent manner, a system for visualizing the Listeria RNA in the host cell 
cytosol was implemented.  
In order to visualize transfer of bacRNA into the cytosol of cells a recently developed sensitive, 
non-radioactive but non-toxic method was used to label RNA in living cells (Jao and Salic 
2008) (Fig. 3.33): 5-ethynyluridine (EU) was shown to be incorporated into RNA transcripts 
generated by RNA polymerases I, II and III in mammalian cells but not into DNA (Jao and 
Salic 2008). Listeria were grown in medium containing EU and labeled with FITC. The host 
cells were then infected with labeled bacteria. One or four hours post infection, host cells 
containing Listeria in the cytosol were fixed, permeabilized and incubated with fluorescence dye 
coupled to a reactive azide group (Alexa594-azide). In this setting, the azide selectively couples 
to the ethynyl group of EU incorporated into the bacRNA. Whole Listeria are labeled green 
with FITC and RNA is visible as red fluorescence (Alexa594), nuclei are stained by DAPI 
(blue). As evident from fluorescence images, the cytosol of THP-1 cells was clearly labeled for 
EU-containing RNA when infected with wild type (wt) Listeria monocytogenes (Fig. 3.33A left 
and middle panel) but not when infected with a mutant lacking LLO (Δhly) (Fig. 3.33A right 
panel) which is not able to escape from the endosome. Bacterial RNA accumulated in the 
cytosol host cells upon prolonged infection time with wt L. monocytogenes (Fig. 3.33A, left and 
middle panel). In concordance with findings from THP-1 cells, similar results were obtained 
with epthelial  (A549, Fig. 3.33B ) and hepatocarcinoma cell lines (HepG2, Fig. 3.33C).  
Labeled RNA was absent within Listeria because Alexa594-azide either cannot penetrate the 
cell wall or is inactivated within Listeria, as direct labeling of Listeria from bacterial culture is 
not possible (data not shown). By contrast, direct labeling of RNA from gram negative E. coli 
and from L. monocytogenes protoplasts, which lack the cell wall, was possible (Fig. 3.34A, B). 
Therefore, during Listeria infection only cytosolic bacRNA could be detected. The absence of 
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labeled RNA in the host cell nucleoli, the site of ribosomal RNA production, excluded transfer 
of EU nucleotides from Listeria with subsequent incorporation into the host. In fact, direct 
labeling of cells in conditioned culture medium led to strong staining of the nucleoli (Fig. 3.35, 
left panel). Of note, EU labelings were performed in starvation medium that allows the 
incorporation of EU. Indeed, EU is not quantitatively incorporated in standard culture medium 
(Fig. 3.34, right panel). Since we used standard medium during infection, we additionally 
excluded the possibility that host cell RNA is stained by non-incorporated EU diffusing from 
Listeria. Altogether, we conclude from the data that during infection significant amounts of 
bacRNA are transferred into the cytosol of cells where it is accessible for cytosolic immune 
receptors. 
As Listeria appeared to be intact, we wondered, if occurrence of bacterial RNA in the cytosol 
of cells might be a result of an active release process. As a preliminary experiment it was 
examined if such a release could be provoked by stress conditions. Listeria were incubated in 
either full media, Fraser Half Medium (FHM), or starvation media (HTM). Supernatants 
were collected and nucleic acids isolated via phenol-chloroform precipitation. These were then 
incubated with either DNase, RNase, or left untreated and loaded on agarose gels. As can be 
seen in Fig. 3.36, a band appeared when bacteria were grown in starvation media. This band is 
RNase-sensitive, although the entire band is not gone after RNase incubation. This could be 
due to protein contamination of the supernatant, i.e. bacterial proteins binding to the RNA and 
encumbering RNase activity or presence of bacterial DNA. By contrast, incubation with 
DNase did not degrade any nucleic acid visible in the gel. This finding suggests an active release 
of bacteria RNA from Listeria. However, it is unclear, if RNA is released because of cell death 
leading to limited perforation of the bacteria membrane and “secretion” of small but large 
molecules. To estimate this scenario the identity of RNAs and the viability of Listeria need to 
be examined. 
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Fig. 3.33: EU staining of Listeria RNA after infection in A549 cells. Cells were infected with FITC-labeled 
and EU-incorporated Listeria for either 1 or 4 hours, then fixed and stained with DAPI and Alexa 594. The red 
staining of Listeria RNA can be seen to increase over time. THP-1 cells were infected with wt FITC-tagged 
Listeria for 1 and 4 hours, then fixed and stained with DAPI and Alexa 594. Due to their phagocytic nature, 
THP-1 cells manage to incorporate more Listeria than non-phagocytic cells such as A549 and HepG2 cell 
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infection of Listeria. HepG2 cells were infected with wt Listeria for 1 and 4 hours. A very slight red staining 
could be seen after 1 hour of Listeria infection. Listeria had been internalized after opsonization with human 
serum for 30 min at 37°C. Δhly Listeria infection of HepG2, A549 and THP1 cells, showing no red 
fluorescence of EU staining with alexa 594. 
 
 
Fig. 3.34: EU stain in E.coli and L.monocytogenes protoplasts. A) E.coli and B) L.monocytogenes protoplasts were 
incubated with EU for 2 to 4 hours during log phase growth, pelleted, fixed and stained with Alexa fluor 488. 
E.coli readily showed EU staining during log phase, while L.monocytogenes had to be incubated in starvation 
medium or cultured as protoplasts for successful EU-Alexa azide staining. 
 
 
Fig. 3.35: EU incorporation into the host cell. THP-1 cells were incubate with EU for 4 hours, then fixed and 
stained with DAPI and Alexa 488. Only cells grown in starvation medium incorporated the EU into their own 
machinery (left), while cells grown in full RPMI medium showed only weak fluorescence (right).  
Alexa Fluor  488                            Light microscopy
Alexa Fluor  488                             Light microscopy
Listeria monocytogenes (protoplasts)
Escherichia coliA
B
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Fig. 3.36: Agarose gel of Listeria supernatant. Listeria were incubated in either full (FHM) or starvation 
(HTM) media. Supernatants were precipitated and treated with DNAse, RNAse, or left untreated then loaded on 
agarose gels. The band only appeared in HTM-grown Listeria and was RNase sensitive. 
 
contr +RNase +DNase    contr   +RNase +DNase
           FHM                              HTM
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4. Discussion 
 
4.1. Cytosolic recognition of DNA 
Pathogen-derived nucleic acids are a highly important PAMP and play a central role during the 
innate immune response. TLR9 recognizes unmethylated CpG dsDNA located in the endosome 
of PDCs. In a healthy cell, DNA should not be present in the endosome. In the cytosol, the 
exact mechanism of dsDNA recognition is not yet fully elucidated and a bit more complicated. 
This is why a minimal DNA motif is of such interest; using a short well-defined dsODN in 
order to investigate the characteristics of the DNAR guarantees reproducible results. In this 
thesis, recognition motifs of short dsDNA ODNs were analyzed in monocytes, murine BM-
DCs and assorted cell lines. Two classes of immune stimulatory ODNs could be determined. 
This is of great clinical interest because of the therapeutic options made available once PRR 
ligands can be accurately determined. With the possibility of activating the innate immune 
system without pathogen implementation, an immune response can be mounted resulting in 
induction of only specific cytokines.  
 
4.1.1. PBMCs recognize DNA dependent of its localization 
Once thought to be the gold standard of cytosolic DNA recognition, poly dAdT was recently 
determined to be a ligand for RIG-I (Ablasser, Bauernfeind et al. 2009). In this paper, dAdT 
was shown to serve as a template for the formation of an endogenous RIG-I ligand via RNA 
polymerase III. The TLR9-independent type I IFN response to random long dsDNA 
molecules, however, still induced type I IFN without involvement of RIG-I: dsDNA molecules 
in the size range of dAdT still induced a type I IFN response in human MoDC in which RIG-I 
was silenced. In Fig. 3.2, PBMCs were either left untreated, treated with CQ, which inhibits 
endosomal acidification, or alternatively depleted of PDCs, the main TLR9-expressing cell 
population. The three cell populations were then transfected with CpG 2216, genomic DNA 
from PBMCs, plasmid DNA, dAdT and a Lipofectamine control. CpG 2216, a well-known 
ligand for TLR9, failed to induce an IFNα response in all cell populations except in untreated 
PBMCs, where the endosomes were allowed to mature and PDCs had not been depleted. 
Together with the results from Fig. 3.3 and 3.4, this demonstrates that the main part of the 
cytosolic dsDNA-induced type I IFN response is produced by monocytes. Although PDCs are 
considered as the main IFNα producing cell population, this holds true only for endosomal 
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stimuli of TLR9. This is of great importance as the percentage of monocytes in the peripheral 
blood cells is much higher than that of PDCs (15 to 1%, respectively). Targeting monocytes for 
cytokine production with a monocyte-specific recognition mechanism would therefore be much 
more promising for therapeutic approaches. 
 
4.1.2. Tandem dsODN are recognized by the DNAR in a length, then sequence-
dependent manner 
With the knowledge that PBMCs treated with CQ show a cytokine pattern derived almost 
exclusively from the monocyte response to stimuli, further experiments were carried out with 
PBMCs blocked with CQ. Building on results obtained in the murine system, ODNs of 
different lengths were designed in order to deduce the minimal length requirement needed to 
induce an IFNα response in monocytes (Stetson and Medzhitov 2006). Medzhitov et al. had 
established a dsODN that, when transfected as a single strand, did not induce an IFN response 
in murine macrophages. Transfected as a double strand, however, induced a robust type I IFN 
response. This dsODN was dubbed IFNstimulatory DNA, or ISD. Working from this length, 
ladders were designed in order to determine the minimal length requirement for human 
monocytes. The mIFNα response to dsODNs, however, was much more sensitive, reacting to 
dsODNs at much shorter lengths than in human monocytes. Our findings show that ISD only 
mildly induces type I IFN response in human monocytic cells (Fig. 3.11A). As could be seen in 
Fig 3.10 C, blunt-ended dsODN only induced an IFN response in human monocytes and 
monocytic cell lines, but not in cell lines derived from other cell populations, i.e. HEK293T, 
Hela, FaDu, A549, A498 or HepG2. This indicates that the ability to recognize dsODNs is 
restrained to cells of the immune system, both primary and cell line-derived. Because of this, 
further experiments to determine the DNAR ligand were carried out in THP-1 cells or primary 
monocytes in PBMCs.  
Once the minimal length had been determined for monocytes/PBMCs, concatemerizing ODNs 
were designed. This way, each ODN by itself would not fulfill the minimal length requirement, 
while both together would hybridize into longer dsDNA strands (Fig 3.6). ODNs possessed 
switched corresponding sequences, so that once hybridized together, they would not form blunt-
ended dsDNA but rather a self-multimerizing dsDNA strand with half the sequence always an 
overhang. When transfected into CQ-blocked PBMCs, the single strands indeed did not induce 
an IFNα response, while both strands hybridized together and transfected could elicit a very 
strong IFNα response. This principle was applied to various ODN including AT-poor 
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sequences (Fig. 3.10A), with the same cytokine induction pattern as a result. This would mean 
that for long dsODN sequences, the sequence is not relevant for cytokine induction, an effect 
that could also be seen for transfected plasmid DNA, where the signal was only partly abrogated 
after endosomal blockage by addition of CQ. This sequence vagueness is possibly due to the fact 
that healthy cells do not display any cytosolic DNA, so a cytosolic DNA receptor would need to 
respond to all types of DNA it encounters, no matter the methylation or PTO status. One of the 
concatemerizing double-stranded ODNs designed possessed a G-ended sequence which, 
surprisingly, induced IFNα when transfected as a single strand. This GG(TA)13GG ODN was 
used as a template sequence to better determine the reason for the IFNα inducing characteristics 
of this short ODN (Fig. 3.7). Working with the different permutations of the base construction 
of the ODN, C-ended ODNs were also developed, this time with G-rich sequences in the 
middle of the ODNs. Interestingly, these G-rich core sequences failed to induce hIFNα but 
induced quite a lot of mIFNα when transfected into murine BM-DCs. Analysis by PAGE 
revealed that this G-rich core sequence could polymerize into a band that was quite a bit higher 
than its ssDNA length. This would mean that G-rich core sequences induced IFNα only in the 
murine system and G-rich end sequences could induce IFNα in both human and murine 
systems. 
A new basic sequence was designed, with the (TA) amount cut down and more Gs added on the 
ends in order to assure the same ODN length. This basic sequence was then modified with 
different nucleotides added to the ends in order to guarantee the same basic barbell structure, 
only alternating barbell components (Fig. 3.10B). Only the G-ended barbell ODNs could 
induce an IFNα response in CQ-blocked PBMCs, indicating a highly sequence-specific 
induction motif. This significantly facilitates the directed induction of IFNα; a short, well-
known ODN sequence has more therapeutic uses than a long dsDNA sequence with unknown 
structural possibilities and conformations. Although easy recognition of long dsDNA present in 
the cytosol is due to the fact that the mere presence of cytosolic DNA could be an indication for 
infection, the recognition motif of short, sequence-specific dsDNA ODNs has the advantage of 
easier handling.  
Further experiments concerning the necessity of the (TA)10 segment in the middle of the ODN 
sequence were performed, demonstrating that an unbroken (TA) length does not correlate with 
augmented IFNα induction (Fig 3.10A). Working with this finding, ODNs were designed 
containing G-ended barbells and varying lengths of (TA) sequences. There was no strong 
difference visible between sequences containing longer stretches of (TA) and those of a shorter 
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length, once the length-dependency was factored out: Sequences under 24bp elicited little type I 
IFN, but once the threshold of 26bp had been breached, no length-dependent difference in type 
I IFN induction could be observed (Fig. 3.5). This would indicate a prompt saturation of type I 
IFN induction.  
Nonpalindromic DNA sequences were implemented in order to abolish the possibility that the 
dsODN strands were formed because the ssDNA segments folded in on each other. As shown in 
Fig. 3.11A, G-ended barbell sequences were ordered and transfected on CQ-blocked PBMCs. 
Each ODN transfected by itself could not induce IFNα; both ODNs transfected to a bar-belled 
dsDNA strand, however, could. PA gels were run to show that no multimerization had taken 
place. This of course raised the question that if a barbell formation was necessary for IFNα 
induction in CQ-blocked PBMCs, how much of a barbell could be removed before the 
induction potential was abrogated. In Fig. 3.12, ODN sequences containing reduced numbers of 
G ends were paired with the original nonpalindromic G-ended strands. This resulted in IFNα 
abrogation as soon as both ends of a barbell were missing. Having only half a barbell was 
sufficient for IFNα induction; having a complete barbell on one end of the double strand and no 
G overhang on the other side, however, was not. This indicates that it is merely the G-ended 
overhang that is crucial for recognition by the DNAR or an associated protein, and not the angle 
of the barbell formed when two G overhangs are opposite each other. PA-gel analysis showed 
gel bands traveling at a unified height, demonstrating that the strand combinations were not 
different in their IFNα-induction potential because of varying structural characteristics. 
 
4.1.3. G-ended bar-bell ODN are active as monomers 
 Although the bar-bell formation had been tested for A3, C3, T3 and G3 overhangs, only 
G-ended dsODNs had elicited an IFNα response. A possible explanation for this was thought 
to lie in the unique capacity of guanosine to interact via intermolecular G-quadruplex interplay. 
G-tetrad structures are present especially in telomeres and gene promoters (Huppert 2008), 
which would indicate that cytosolic G tetrads are potential recognition motifs. G quadruplexes 
are formed due to the array of 4 guanosine bases in a nearly planar field. They are more resistant 
to DNase digestion and have higher melting points than their counterparts composed of other 
bases. G quadruplexes are held together via their phosphodiester backbone and further stabilized 
due to their monovalent ion binding (reviewed in (Lane, Chaires et al. 2008)). Gels run with 
dsODNs containing G-ended overhangs of varying length showed a propensity for tetramer 
formation in dsODNs possessing 4 or 5 Gs in their bar-bell sequence (Fig. 3.14). Hybridizing 
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the dsODNs and transfecting them with Lipofectamine on CQ-blocked PBMCs showed a 
robust type I IFN response irrespective of the amount of Gs present on the bar-bell overhang. As 
there was no difference in induction between dsODNs shown to form tetramers on a PA gel and 
those presenting only a single molecular weight band, bar-bell dsODNs were analyzed using 
circular dichroism. CD spectroscopy measures the differential absorption of left- and right-
handed circularly polarized light. It is known that G tetrads have unique melting curves at 
295nm, so G-ended dsODNs were heated and absorbance at 295nm measured. As can be seen 
in Fig. 3.15, CD spectra showed the characteristic G-tetrad melting curve for dsODNs with 4 
and 5-long G ended overhangs, and no melting curve for dsODNs containing 3 or less Gs in 
their bar-bell formation. The final indication against quadruplex formation, even inside the 
cytosol, occurred when dsODNs were designed containing N7-deaza-guanosine in their bar-bell 
overhangs. Due to the replacement of a nitrogen at position 7 by a C-H group, G-quadruplexes 
could no longer be formed. ODNs containing deaza-G ends, however, induced an equal amount 
of IFNα as G ended dsODNs, showing that G quadruplex formation, while an interesting 
phenomenon, was not the source of IFNα induction. 
 
 
Fig. 4.1: Overview of stimulating ODN structures and sequences. In this thesis, various IFN-inducing ODN 
properties were investigated. In summary, G-ended ODNs with G barbells induce type I IFN irrespective of 
tetramer formation. At least two G ends had to be present on the dsODN for type I IFN induction to occur. In the 
case of concatemerizing ODNs, presence of G ends was not a factor in type I IFN induction, as the length was 
enough to trigger a response. Mismatches in G-ended ODN sequences did not abrogate the type I IFN response. 
 
4.1.4. ODN are degraded in the cytosol irrespective of their overhangs 
 Instead of structural differences, the reason G3-ended ODNs manage to induce an IFN 
response and A3/T3/C3-ended ODNs could lie in the processing that occurs once the ODNs 
enter the cytosol of the cell of interest. To this end, ODNs were developed containing 
fluorescent FAM molecules accompanied by a quenching molecule on the opposite end of the 
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single strand, which suppress the fluorescence of the FAM molecule. The theory was that the 
fluorescence could be measured by FACS analysis or by fluorescence input with a Perkin Elmer 
envision reader. Differences between the G3 and C3-ended ODNs would indicate a variation of 
ODN processing in the cytosol. 
In order to obtain a transfection control and possess identical parameters for both sets of ODNs, 
a third ODN was constructed, carrying a Cy5-fluorescent molecule. This ODN was used as a 
transfection control and provided a convenient gating tool for FACS experiments. 
Time course assays were performed to see when, if any, difference in ODN processing was 
visible. As shown in Fig. 3.17, ODN uptake was similar for both bar-bells after 6 hours; C ends 
did, however, show a nearly twofold higher degradation than G for the first six hours post 
transfection. This difference in degradation in the first hours of ODN transfection into cells, 
however is unlikely to explain the IFNα induction ability of the G3-ODN and the lack of IFNα 
induction of the C3-ODN. IFNα is measured after 20-24 hours’ incubation with the stimulus in 
question, and as degradation levels for both ODNs were equal in the later time points, any 
disparity from the first six hours would have evened out. The complete inability of the C3-ODN 
to induce type I IFN is in no proportion to the uptake variation in comparison to the G3-ODN. 
The heightened fluorescence that was observed over time can be explained with the compounded 
transfection rate of the ODNs. The FAM-tagged ODNs were transfected onto CQ-blocked 
PBMCs and showed a similar induction rate to the untagged ODNs, indicating that the 
presence of FAM did not influence the cytokine response of the cells. Incubating the ODNs 
with cytosolic lysate and then loading them onto a gel further demonstrated no disparity between 
barbell sequences and their rate of digestion. So although the ODNs are indeed processed and 
digested once present in the cytosol, it was not the rate of uptake and digestion nor their 
localization that resulted in the different IFNα response. This signifies that an as yet unknown 
processing mechanism, not dependent on ODN uptake nor localization, recognizes short 
dsDNA in a sequence-dependent manner and induces type I IFN induction in monocytes and 
monocyte-derived cell lines.  
There have been many attempts to identify the cytosolic DNA receptor. In recent years, an 
inflammasome-associated cytosolic DNAR had been identified (Burckstummer, Baumann et al. 
2009; Hornung, Ablasser et al. 2009), which did not, however, explain the IFNα induction after 
transfection with dsODNs, as AIM2 induces pro-IL-1β cleavage. For a while, DAI/ZBP-1 was 
thought to be the cytosolic DNA receptor (Takaoka, Wang et al. 2007). ZBP-1 deficient mice 
did not present any immunocompromised phenotype, therefore excluding ZBP-1 from the 
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continuing search for the cytosolic DNAR (Lippmann, Rothenburg et al. 2008). IFI16 has been 
traded as a potential cytosolic DNAR (Bowie 2010). Beyond the IFI16 DNA binding domain 
coprecipitating with 70bp DNA, shorter DNA sequences need to be shown to bind to IFI16 in 
order to give it the title of cytosolic type I IFN inducing DNAR. Knowing the minimal 
recognition motif also enables further therapeutic approaches, such as exploiting type I IFN 
responses of the body to aid the body’s innate immune response in Hepatitis B and C therapies 
or for the treatment of Multiple Sclerosis ((Di Bisceglie, Martin et al. 1989; Di Bisceglie 1995).  
 
4.2. MITA-dependent DNA recognition and the role of autophagy in 
the type I IFN response 
 
MITA-dependent DNA recognition 
Other approaches to the DNAR identification yielded, the adaptor protein MITA (Ishikawa 
and Barber 2008; Zhong, Yang et al. 2008). It is a membrane protein that could activate IRF3 
and, therefore, induce a type-I IFN response to viral infection. 
In order to investigate the role of MITA in PBMCs, specifically monocytes, MITA knock-
down was performed using shRNA in lentiviral vectors, as well as siRNA assays (Fig. 3.20). 
MITA knockdown did reduce the cytokine response to DNA stimuli, such as pDNA, 
G3(TA)10G3, and genDNA. RNA stimuli such as 3P-RNA and bacterial RNA, however, did not 
induce a MITA-dependent IFN response. Various publications had also associated cytokine 
induction in response to pathogens such as Listeria monocytogenes with MITA signaling 
(Ishikawa, Ma et al. 2009; Nakhaei, Hiscott et al. 2009). MITA knockdown in THP-1 cells was 
therefore also used in order to observe possible interaction of MITA with Listeria RNA, 
discussed further down. MITA interaction with Listeria-derived PAMPs has been shown in 
MEFs; this influence could also be seen in THP-1 cells knocked down using an shRNA 
lentiviral vector targeting MITA. This merits further study, not least because of the species 
divergence already seen in TLR9 expression. 
 
The role of autophagy in the type I IFN response 
Autophagy is a mechanism to deliver cytoplasmic components to the lysosome. In autophagy, 
cytoplasmic constituents are surrounded by a sac, which engulfs them and turns into a double-
membraned structure called the autophagosome. (reviewed in (Mizushima, Ohsumi et al. 2002). 
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Autophagy, next to its well-known role in cell growth, homeostasis, and development, also has 
been shown to have an increasingly important role in the innate and adaptive immune responses: 
It helps to directly eliminate intracellular microbes by digesting them in autolysosomes, delivers 
cytosolic microbial products to PRRs and is an anti-microbial effector in TLR and RLR 
signaling.  
Until recently, it had been considered that autophagy was a cellular process more beneficial to 
the pathogen than to the host cell, because the mechanisms of host defense via autophagy had 
not been wholly elucidated. Various pathogens do, indeed, use or block autophagy for their own 
purposes. HSV-1 produces a protein ICP34.5 that interferes with autophagy; Shigella becomes 
susceptible to autophagy as soon as it loses one of its motility proteins IscB, and Listeria can 
block phagosome maturation with LLO, forming pores in the membrane (Ogawa, Yoshimori et 
al. 2005; Birmingham, Canadien et al. 2007; Orvedahl, Alexander et al. 2007). 
THP-1 cells (Fig. 3.21) cells were treated with autophagy inhibitor wortmannin (Blommaart, 
Krause et al. 1997), or autophagy inducer rapamycin (Kamada, Funakoshi et al. 2000) and then 
transfected with DNA stimuli. The IP-10 response occurred in a wortmannin-dependent 
manner. Other parameters included using THP-1 cells with MITA, Atg5, or a control 
scrambled shRNA sequence knocked down using a lentiviral system. Atg5 was considered a 
protein specifically required for autophagy in complex with Atg12, labeling the outer membranes 
of autophagic vacuoles. (Mizushima, Sugita et al. 1998) Newer findings show non autophagy-
related functions for Atg5 (Codogno and Meijer 2006; Sanjuan, Dillon et al. 2007). The only 
definitive measure for autophagy, therefore, is the documentation of double-membrane 
autophagosomes in cells using electron microscopy. The usage of Atg5 knock-down, 
wortmannin, or rapamycin, however, can still be used as an estimation for autophagy 
involvement in cytokine reponses. 
In Fig 3.21, the THP-1 IP-10 response to DNA stimuli G3(TA)10G3 and pDNA, but not to 
dAdT and the RNA stimulus 3P-dsRNA, was reduced in cells pretreated with wortmannin. Of 
course, as wortmannin is a PI3K inhibitor, this decrease could also attributed to interference in 
other pathways dependent on PI3K. On the inductory side of autophagy, rapamycin also was 
added to THP-1 cells in order to observe if this could have an additive effect on the IP-10 
response. This could not be observed. This could be because upregulation of autophagy does not 
automatically deliver more stimuli to the appropriate receptor. THP-1 cells with lentivirally 
knocked down MITA showed a decreased IP-10 response to DNA stimuli, but not dAdT or 
RNA stimuli. Knock-down of Atg5 showed a general decline of the IP-10 response, but as Atg5 
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has an essential role in cell housekeeping (Hara, Nakamura et al. 2006), the diminished IP-10 
response in Atg5 knock-down cells may be due to general impairment of cell homeostasis. In 
general, this experiment indicated a partially autophagy-dependent IP-10 response to DNA and, 
in the case of Atg5 knock down, also RNA stimuli. The interaction of MITA and autophagy in 
the pathogen-dependent immune response remains to be investigated. 
 
4.3. The Listeria-induced IFN response  
RNAs are outfitted with a 5’triphosphorylated nucleotide when transcribed. This aids in 
processing and regulation of mRNA translation in eukaryotes, where the 5’ end is modified to a 
structure called “CAP”. In bacteria, however, one third of mRNA remains 5’triphosphorylated 
(Bieger and Nierlich 1989). The ligand for 5’triphosphorylated RNA has been shown to be the 
cytosolic helicase RIG-I, which is activated upon binding (Hornung, Ellegast et al. 2006; 
Pichlmair, Schulz et al. 2006). The recognition of various negative and positive strand RNA 
viruses is accomplished via RIG-I (reviewed in (Schlee and Hartmann)). The mechanisms, if 
any, of the interaction of RIG-I with bacterial RNA remain less widely elucidated. It has been 
demonstrated that phagosomal, but not cytosolic bacteria are able to induce IFN in dendritic 
cells in a TLR7-dependent manner (Mancuso, Gambuzza et al. 2009). The cytosolic recognition 
of DNA from intracellular bacteria has been well documented (Stetson and Medzhitov 2006). 
Recognition of bacterial RNA in the cytosol, however, is not as clear-cut. It has been proposed 
that Listeria-mediated IFN induction occurs in an IPS-1 independent manner (Soulat, Bauch et 
al. 2006; Sun, Sun et al. 2006). Even so, IPS-1 was demonstrated to be involved in the pathway 
resulting in IFNβ induction in Legionella-infected lung epithelial cells (Opitz, Vinzing et al. 
2006). This was followed up by a study showing transfected crude Legionella RNA to be 
recognized in a RIG-I-dependent manner (Monroe, McWhirter et al. 2009). It is to be noted 
that these experiments were performed in murine macrophages which are equipped with 
multiple type I IFN-inducing receptor systems, not least of which one responsible for DNA 
recognition. This would implicate a certain redundancy for immunrecognition of intracellular 
bacteria in macrophages. Analyzing the part RIG-I plays in the type I IFN response would be 
easier in cells not possessing both branches, DNA and RNA, of the cytosolic nucleic acid 
recognition pathway (Monroe, McWhirter et al. 2009).  
The facultative intracellular bacterium Listeria monocytogenes is a widespread pathogen. As the 
causative agent for listeriosis, it endangers immunocompromised individuals including pregnant 
women. The Listeria infection pathway usually commences in the intestinal epithelium, where 
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the bacteria invade using listerial internalins to induce uptake into non-phagocytic cells such as 
hepatocytes. Originally, it had been thought that, similar to Listeria monocytogenes, Legionella 
DNA was the PAMP that initiated the host response to infection. Recent findings, however, 
suggest a recognition pathway involving the RNA, instead: Monroe et al found that the 
RIG-I/MDA5 pathway, thought primarily to detect viruses, is also involved in the innate 
immune response to an intracellular bacterial pathogen, Legionella pneumophila (Monroe, 
McWhirter et al. 2009). The RIG-I pathway was required for the response to L. pneumophila 
RNA, but not for the response to L. pneumophila DNA. It could be, therefore, that 
L. pneumophila RNA may access the host cell cytosol, where it triggers the RIG-I/MDA5 
pathway. An unexpected finding, since bacteria have not previously been shown to translocate 
RNA into host cells. It was also found that L. pneumophila encodes a secreted bacterial protein, 
SdhA (Monroe, McWhirter et al. 2009), which suppresses the RIG-I/MDA5 pathway, thus 
explaining the supposed redundancy of multiple bacterial proteins for the same function, 
inhibiting the host response. Multiple viral repressors of the RIG-I/MDA5 pathway have been 
published, but bacterial inhibitors of RIG-I/MDA5 had not been, as yet, isolated. 
 
4.3.1. Listeria induce cytokines in a localization-dependent manner 
Listeria monocytogenes invade not only phagocytic cells but can also enter epithelial cells via the 
interaction of the listerial protein internalin and E-cadherin on the surface of epithelial cells. 
The invasin internalin is necessary for successful Listeria invasion of non-phagocytic cells such as 
enterocytes, hepatocytes, fibroblasts, epithelial cells and endothelial cells (Gaillard, Berche et al. 
1991; Mengaud, Ohayon et al. 1996). The immune response has developed its own receptors to 
deal with bacterial invasion. The macrophage type I scavenger receptor recognizes lipoteichoic 
acid from gram positive bacteria (Dunne, Resnick et al. 1994). TLRs 2 and 5, both situated on 
cell membranes, are thought to be involved in Listeria recognition (Hayashi, Smith et al. 2001; 
Seki, Tsutsui et al. 2002). Obviously, bacteria can trigger type I IFN responses through 
stimulation of TLR4 on the cell surface or TLR9 in the endosomal compartment. A coactivator 
of the type I IFN pathway in macrophages, LRRFIP1, is also thought to be involved in Listeria 
recognition (Yang, An et al.). Investigations in the labs of Decker and Portnoy suggested TLR 
independent pathways leading to induction of type I IFN in mouse macrophages infected with 
Listeria monocytogenes (O'Riordan, Yi et al. 2002; Stockinger, Materna et al. 2002). NOD2 and 
NALP3 recognize intracellular Listeria (reviewed in (Zenewicz and Shen 2007)). However, 
type I IFN induction depended on cytosolic localization of the bacteria (O'Riordan, Yi et al. 
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2002; Stockinger, Materna et al. 2002) but was shown to be NOD2 independent (Stockinger, 
Reutterer et al. 2004). IL-1β is an indicator for Listeria infection; blocking the IL-1R 
exacerbates murine listeriosis (Havell, Moldawer et al. 1992).  
RNA was isolated from different bacteria species and transfected onto PBMCs after treatment 
with phosphatase (CIAP) or DNase. As can be seen in Fig. 3.22, the IFNα signal was abrogated 
in all RNA samples after treatment with CIAP. Live Listeria of wt and Δhly strains were then 
used in order to infect monocytes at varying MOIs. Surprisingly, the IFNα, but not IL-6 and 
IL-1β response, was localization dependent, indicating at receptor systems not dependent on 
cytosolic presence of the pathogen.  
 Listeria in possession of LLO induced a type I IFN response in monocytes, while the Δhly was 
only able to induce a rudimentary IFNα response (Fig. 3.23). Since monocytes are non-
proliferating primary cells and it is therefore rather difficult to perform knock-down experiments 
with them, the monocytic cell line THP-1 was used instead. However, both THP-1 cells and 
monocytes possess a cytosolic DNAR, so a clinically relevant cell line only in possession of a 
cytosolic RNA recognition mechanism and not expressing a DNAR was investigated. 
A549 cells represent a well established infection system for intracellular bacteria (Chi, Mehl et al. 
1991; Jones, Beveridge et al. 1996; Talbot, Paton et al. 1996). Therefore A549 cells were used 
for infection and transfection experiments. Cells were infected with varying MOIs of Listeria wt 
and Δhly, then tested for cytokines IP-10 and IL-1β. Fig 3.24 shows the cytokine response of 
A549 cells. There was no reaction to DNA stimuli, with a very robust A549 hIP-10 response to 
RNA stimuli. Having established A549 cells as a system without a cytosolic DNAR, 
experiments were performed to see if Listeria induced an IP-10 response independent of DNA 
stimuli.  
Listeria, wt and Δhly, were then labeled with FITC and infected host cells of both THP-1 and 
A549 strains. These were then investigated with fluorescence microscopy and FACS analysis, 
demonstrating that the bacteria did indeed enter the host cell cytosol (in the case of the wt 
strain).  
 
4.1.3. Listeria-dependent induction of IFN is RIG-I dependent 
Both THP-1 and A549 cell lines were then infected with a lentiviral vector in order to knock 
down RIG-I expression. This method was later amended using siRNA knock-down instead of 
lentivirus-mediated shRNA knock-down. A549 cells with impeded RIG-I expression did not 
mount a hIP-10 response to wt Listeria infection, while wt A549 cells could respond to Listeria 
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infection with secretion of hIP-10 (Fig. 3.27). The secretion of IL-1β, however, did not increase 
or decrease with RIG-I knockdown, indicating that Listeria activate various pathways of the 
innate immune response, one of them being the RIG-I pathway, in A549 cells. This would 
mean that even if the RIG-I dependent type I IFN response is not initiated, the IL-1β response 
still sounds the alarm. Knocking down RIG-I with siRNA yielded comparable results.  
Conventionally, Listeria invade through the gastrointestinal tract, where they subvert epithelial 
cell actin cytoskeleton in order to reach the bloodstream. Listeria then migrate to the spleen and 
the liver, where they infect liver macrophages as well as hepatocytes (reviewed in (Hamon, 
Bierne et al. 2006)) Listeria invasin internalin B (InlB) binds to Hepatocyte Growth Factor 
(HGF) receptor Met (Dramsi, Biswas et al. 1995). Once bound, InlB activates the Ras-MAPK 
pathway, leading to cytoskeletal rearrangements and internalization of Listeria (Shen, Naujokas 
et al. 2000). HepG2 cells are known to secrete type I IFNs in response to pathogen infections 
(Guan, Lu et al. 2007). They are derived from hepatocytes which represent one common in vivo 
target of Listeria infection. HepG2 cells exhibited to be less sensitive to transfection of Listeria 
RNA and infection than THP-1 cells. Even though THP-1 cells secreted type I IFN at very low 
bacterial load, HepG2 cells only started demonstrating cytokine responses beyond MOI 25. The 
responses were, however, localization-dependent, allowing a deduction transfer from the A549 
cell system (Fig. 3.29).  
As HepG2 cells are carcinoma-derived, the same experiment was carried out in primary murine 
hepatocytes obtained from healthy C57BL/6 mice. Hepatocytes responded very well to 3P-RNA 
and RNA from Listeria, but only very sluggishly to Listeria infection – similar to infection of the 
hepatic carcinoma cell line HepG2, murine primary hepatocytes secreted type I IFNs only in 
response to MOIs greater than 30 (Fig. 3.32). This would indicate that the type I IFN response 
to Listeria is not the main defense mechanism of hepatocytes. With a localization-dependent 
immune response to Listeria deducible from ELISA and luminescence data, host cells were 
infected with FITC-tagged Listeria containing RNA which harbored incorporated ethynyl 
uridine. Listeria were allowed to infect the host cells. Cells were fixed and Alexa 594 molecules 
then bound to the ethynyl uridine present in the host cell cytosol. Because of fixing and 
permealization, single EU molecules are removed and only RNA incorporated EU molecules can 
be visualized. 
EU staining increased over time in THP-1, A549 and HepG2 cells, indicating that the duration 
of Listeria infection correlated with the amount of EU visible in the cell. When Δhly Listeria 
were used to infect host cells, there was no EU staining visible, indicating that Listeria had to be 
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present in the cytosol for bacterial RNA secretion to take place. However, one could reason that 
Listeria simply imported EU which is then incorporated into host RNA. However, experimental 
settings excluded this scenario: 
Host cells were incubated in normal RPMI or starvation media, then treated with EU for 
2 hours. After fixation, EU strong fluorescence could only be seen in cells incubated in starvation 
media (Fig. 3.35). As host cells used in infection experiments with Listeria were grown in 
RPMI, EU uptake by host cells should be infringed. Additionally, Listeria were washed multiple 
times after incubation with EU; unincorporated EU molecules should be removed before Listeria 
are added to host cells. Azide staining of Listeria-incorporated EU in infected cells also showed 
exclusion of the nucleus (Fig. 3.33), indicating that EU-containing RNA was produced by 
Listeria.  
With these experiments, it would seem that Listeria infect non-phagocytic cells by using their 
listerial internalins in order to induce uptake, then lyse their phagolysosomes with LLO and escape 
into the host cell cytosol. Recent findings have found that Group B streptococci (GBS) ssRNA, 
once present in the cytosol, activates macrophages by binding to components of the RIG-I like 
pathway and induce cytokine production in macrophages (Deshmukh 2010). As the cytosol is a 
potentially hostile environment, it is possible that Listeria secrete bacterial RNA as a stress signal. 
Starvation medium used for Listeria incubation loaded onto agarose gels showed a band of nucleic 
acids that was sensitive to RNase, but not DNase, degradation. The marine photosynthetic 
bacterium secretes RNAs of the size of fully mature tRNAs as well as 16S and 26S rRNA 
fragments (Ando, Suzuki et al. 2006). Secretion of DNA by Streptococcus pneumoniae and 
Pseudomonas aeruginosa has been tied to usage as donor material for bacterial gene transfer (Lorenz 
and Wackernagel 1994). This is a phenomenon that could well be transferred to Listeria behavior 
in the host cell cytosol; eukaryotic expression plasmid transfer from Listeria to host cells has 
already been documented (Hense, Domann et al. 2001). It is entirely possible that Listeria use this 
secreted RNA as a method of communication inside the cytosol, although this is an approach to 
the matter that must be thoroughly investigated. Very recent papers have described the recognition 
of cyclic-di-dAMP from Listeria in the host cell. Cyclic di-AMP is produced by bacteria and 
serves as a second messenger signaling DNA integrity (Woodward, Iavarone et al. ; Witte, 
Hartung et al. 2008). Further experiments establishing the extent of the involvement of cyclic-di-
AMP in cell lines not possessing a cytosolic DNAR pathway would be of great interest.  
E.coli overexpressing LLO and engineered to produce trans-kingdom shRNA were able to 
mediate RNAi in mammalian cells (Xiang, Fruehauf et al. 2006). In the course of this thesis, 
cytosolic transfer of endogenous intracellular bacterial RNA was visualized. siRNA-mediated 
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knock down of RIG-I in THP-1 cells only partially diminished Listeria-mediated type I IFN 
induction, indicating a redundant role of RIG-I in monocytic cells. A549 epithelial cells, however, 
showed RIG-I to be the main type I IFN inducer. As one possible explanation, Legionella 
recognition was suggested occurring via an indirect DNA template using the RNA 
polymerase III-dependent RIG-I pathway (Chiu, Macmillan et al. 2009). Genetic DNA from 
Listeria, however, failed to induce a type I IFN response in both A549 cells and the HepG2 
hepatocyte cell line, excluding RNA polymerase III involvement. Epithelial cell lack of response to 
genetic DNA notwithstanding, bacterial RNA was shown to be directly recognized in a 
triphosphorylation-dependent manner, with RIG-I essential for type I IFN and IP-10 induction. 
The 5’ triphosphate end of RNA was determined to be associated with protection of mRNA 
from digestion by the bacterial RNase E (Celesnik, Deana et al. 2007). Regulation of the 5’ 
phosphorylation status has been shown to be due to the pyrophosphatase RppH, which mediates 
mRNA decay (Deana, Celesnik et al. 2008; Celesnik, Deana et al. 2007). RppH has been 
demonstrated to preferentially interact with single-stranded triphosphorylated 5’ nucleotides 
instead of base paired ends (Deana, Celesnik et al. 2008). Additionally, bacterial RNA could be 
stablilized by a 5’ terminal stem-loop (Emory, Bouvet et al. 1992; Mackie 2000). This would 
characterize the bacterial RNA PAMP as base-paired and triphosphorylated. The 5’-terminal 
stem-loop RNAs can contain base-paired 5’-triphosphorylated ends, which has been shown to 
be the real ligand for RIG-I (Schlee, Roth et al. 2009).  
 
Fig. 4.2: Listeria recognition in epithelial cells and hepatocytes versus monocytic cells and macrophages. In epithelial 
cells and hepatocytes, the listeria-induced IFN response occurs in a RNA-dependent manner, implicating RIG-I 
and the IRF3 pathway. In monocytic cells and macrophages, DNA-dependent IFN induction also seems to play a 
role.   
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Essentially, the data in this thesis imply that the Listeria-mediated type I IFN and IP-10 response 
in cells without a DNAR mechanism such as A549 and HepG2 occurs via RIG-I (Fig. 4.2.). 
Various publications suggest type I IFN secretion to support Listeria infection; Listeria would 
therefore profit from RIG-I recognition of their RNA (Gregory, Barczynski et al. 1992) 
(Navarini, Recher et al. 2006). On the other hand, Mancuso et al showed type I IFN signaling to 
be crucial for host resistance to different pathogenic bacteria (Mancuso, Midiri et al. 2007). The 
murine system may not be the ideal experimental setup to investigate infection pathways, as 
murine E-cadherin does not bind Listeria internalin due to the mutation of one AA (Lecuit, 
Vandormael-Pournin et al. 2001). Mice are therefore highly resistant to oral Listeria infection, as 
Listeria do not invade the epithelial cells (Lecuit, Vandormael-Pournin et al. 2001). A host defense 
tactic against Listeria infection may be the secretion of the IFN-inducible CXC cytokine IP-10. It 
attracts phagocytic cells and can deliver defensin-like antibicriobial activity at high doses (Cole, 
Ganz et al. 2001). In order to further clarify the issue of the role RIG-I plays during Listeria 
infection, however, a humanized murine RIG-I knock-out model is necessary. 
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6. Appendix 
 
6.1. Table of abbreviations 
 
Table 6.1: Below is a table of abbreviations used in the course of this thesis, accompanied by their definitions.  
 
Abbreviation Definition 
AIM-2 Absent in Melanoma 2 
ASC apoptosis-associated speck-like protein 
Atg Autophagy 
ATP Adenosine Triphosphate 
BDCA-2 Blood Dendritic Cell Ag 
BHI Brain Heart Infusion 
CARD Caspase Recruitment Domain 
CD Circular Dichroism 
CTL Cytotoxic T Cells 
DAI DNA-dependent activator of IRFs 
DMEM Dulbecco's Modified Eagle's Medium 
DMSO dimethylsulfoxide 
DNA Desoxyribonucleic Acid 
EAMG experimental autoimmune myasthenia gravis 
EDTA Ethylenediaminetetraacetic Acid 
EE1 early endosomal protein 1 
eIF-2 Eukaryotic translation initiation factor 2 
ELISA enzyme-linked immunosorbent assay 
FCS fetal calf serum 
FSC Forward scatter 
HRP horseradish peroxidase 
HSV herpes simplex virus 
HTM Hsiang-Ning Tsai medium 
IFN interferon 
IKB inhibitor kappaB 
IKKi IΚB kinase inhibitor 
IL1 interleukin 
IPS-1 IFN promoter stimulating factor-1 
IRAK IL-1R-associated kinase 
IRF-3 Interferon Regulatory Factor 
ISG interferon-stimulated gene 
LB Luria Broth 
LC-3 Light Chain 3 
LRR Leucine Rich Repeats 
M-CSF Macrophage colony stimulating factor 
MACS magnetic-activated cell sorting  
MDC Myeloid Dendritic Cells 
MITA mediator of IRF3 activation 
MYD88 Myeloid differentiation primary response gene 
NFkB Nuclear Factor kB 
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NLPR3 NOD-LRRs containing pyrin domain 3 
NOD nucleotide-binding oligomerization domain 
ODN Oligonucleotide 
Opti-MEM Minimal Essential Medium 
p:IC poly Inosine-Cytosine 
PAMP Pathogen-Associated Molecular Patterns 
PBMC Peripheral Blood Mononuclear Cells 
PDC Plasmacytoid Dendritic Cells 
PLC Phospholipase C 
PRR Pattern Recognition Receptors 
PYD Pyrin Domain 
RANKL receptor activator of NFkB Ligand 
RIG-I Retinoic Acid Inducible Gene I 
RIP Receptor interacting protein 
RNA Ribonucleid Acid 
RPMI Roswell Park Memorial Institute Medium 
SLE Systemic Lupus Erythmatosus 
SSC Sidewards scatter 
STAT Signal Transducer and Activator of Transcription 
STING Stimulator of Interferon Genes 
TAK TGFß-activated kinase 
TBE Tris-Borate-EDTA 
TBK-1 TANK-binding kinase 1 
TIR Toll-IL1 Receptor 
TLR Toll-Like-Receptor 
TRAF TNF-receptor-associated factor 
TREX 1 3’ Repair exonuclease 1 
ZBP-1 Z-DNA Binding Protein 
 
6.2. Figure index 
 
Table 6.2: List of Figures, their definitions and page numbers 
 
Number Title Page 
Introduction   
Fig 1.1 Progenitor cells of the innate immune system 1.2 
Fig. 1.2. Cellular localizations and ligands of human TLRs 1.4 
Fig. 1.3. TLR9 maturation and signaling pathway 1.6 
Fig. 1.4 TLR signaling pathways 1.6 
Fig. 1.5 Cytosolic recognition of RNA 1.8 
Fig. 1.6 Structure and funtion of RIG-I 1.9 
Fig. 1.7 RIG-I/Mda-5 signaling pathway 1.10 
Fig. 1.8 ZBP-1 signaling pathway 1.12 
Fig. 1.9. AIM-2 and and the NALP3 inflammasome 1.14 
Fig. 1.10 MITA signaling pathway 1.16 
Fig. 1.11 DNA virus infection cycle 1.23 
Fig. 1.12 Viral evasion of innate immunity 1.25 
Fig. 1.13 Infection pathways of Listeria monocytogenes 1.27 
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Fig. 2.1 Buffy coat gradient 2.14 
Fig. 2.2 Counting chamber 2.14 
Fig. 2.3 FACS analysis 2.25 
Fig. 2.3 Lentiviral vectors and the shRNA principle 2.20 
Fig. 2.4 G tetrad melting curve 2.22 
Fig. 2.5 Click-it principle 2.23 
Results   
Fig. 3.1 Characterization of methods used in this thesis 3.1 
Fig. 3.2 IFNa induction in PBMCs + CQ 3.3 
Fig. 3.3 IFNa induction in PDCs 3.3 
Fig. 3.4 IFNa induction in monocytes 3.4 
Fig. 3.5 Ladder ODNs 3.5 
Fig. 3.6 Concatemerizing ODNs 3.7 
Fig. 3.7 Core and end ODNs 3.9 
Fig. 3.8 Dependence of TA-length 3.10 
Fig. 3.9 G-ended ODNs  3.11 
Fig. 3.10 TA and G3-dependence in ODNs 3.13 
Fig. 3.11 Analysis of G3NonPalin1G3 ODN characteristics 3.15 
Fig. 3.12 Nonpalindromic truncated barbell ODNs 3.16 
Fig. 3.13 Inosine ODNs 3.18 
Fig. 3.14 Tetramer formation of G-ended ODNs 3.20 
Fig. 3.15 CD-spectroscopy and deaza-ODN 3.21 
Fig. 3.16 Principle of FAM-ODN transfection 3.22 
Fig. 3.17 Transfection control with a Cy5-ODN 3.23 
Fig. 3.18 Timecourse of FAM-tagged ODNs 3.24 
Fig. 3.19 Fluorescence microscopy of FAM-tagged ODNs 3.25 
Fig. 3.20 MITA-shRNA knockdown in THP-1 cells 3.28 
Fig. 3.21 Autophagy involvement in the type I IFN response 3.30 
Fig. 3.22 Type I IFN response to bacterial RNA 3.33 
Fig. 3.23 Monocyte cytokine responses to Listeria 3.35 
Fig. 3.24 THP-1 cytokine responses to Listeria 3.36 
Fig. 3.25 A549 cytokine response to Listeria + RNA 3.38 
Fig. 3.26 FACS of A549 and THP-1 infected with Listeria 3.39 
Fig. 3.27 Z-stacks of THP-1 cells infected with Listeria 3.40 
Fig. 3.28 Lentiviral knockdown of RIG-I in A549 3.42 
Fig. 3.29 IL-1b ELISA of A549 RIG-I knockdown 3.43 
Fig. 3.30 A549 RIG-I siRNA and Hiperfect titration 3.44 
Fig. 3.31 HepG2 cytokine response to Listeria infection 3.45 
Fig. 3.32 Murine primary hepatocyte response to Listeria 3.45 
Fig. 3.33 THP-1, A549, HepG2 EU-click it staining wt Listeria 3.49 
Fig. 3.34 EU staining of E.Coli and Listeria 3.50 
Fig. 3.35 EU staining of host cells with RNA incorporation 3.49 
Fig. 3.36 Gel of Listeria RNA after incubation in starvation medium 3.51 
Discussion   
Fig. 4.1 Summary of stimulatory ODN structures 4.4 
Fig. 4.2. Infection pathways of Listeria in macrophages and epithelial cells 4.15 
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6.3. Table index 
 
Table 6.3: List of tables, definitions and page numbers 
 
Table Content Page 
Table 2.1 siRNA and shRNA sequence list 2.20 
Table 6.1 Index of abbreviations 6.1 
Table 6.2 Index of figures 6.2-6.3 
Table 6.3 Index of tables 6.4 
Table 6.4 ODN list 6.4-6.12 
 
6.4. Synthetic oligonucleotides used in the course of this dissertation 
 
Table 6.4: The synthetic oligonucleotides used in this thesis are listed in table 2. They were chosen according to 
(TA) repetitions, CpG motifs, poly G or poly C ends, palindromic probability and/or structure formation. 
 
Oligo 
Number 
Oligo Name Oligo sequence 
1 GC(AC)10GC GC(AC)10GC 
2 GC(AT)20GC GC(AT)20GC 
3 GC(AT)30GC GC(AT)30GC 
4 GC(AT)340GC GC(AT)340GC 
5 (AT)7GG(AT)7 ATATATATATATATGGATATATATATATAT 
6 C(AT)14C C(AT)14C 
7 (AC)7CC(AT)7 (AC)7CCATATATATATATAT 
8 A4T8A4 A4T8A4 
9 A4T8C4 A4T8C4 
10 core C13  
11 core C6dUC6  
12 core C8TC6  
13 CG(TA)13GC CGTATATATATATATATATATATATATAGC 
14 (AT)6ACGGCT(AT)6 ATATATATATATACGGCTATATATATATAT 
15 GC(TA)13CG GCTATATATATATATATATATATATATACG 
16 (AT)6AGCCGT(AT)6 ATATATATATATAGCCGTATATATATATAT 
17 GC(AT)9CC(AT)9GC 
GCATATATATATATATATATCCATATATATATAT
ATATATGC 
18 GC(AT)9GG(AT)9GC 
GCATATATATATATATATATGGATATATATATAT
ATATATGC 
19 GC(AT)8GCCG(AT)8GC GCATATATATATATATATGCCGATATATATATAT
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ATATGC 
20 GC(AT)8CGGC(AT)8GC 
GCATATATATATATATATCGGCATATATATATAT
ATATGC 
21 GC(AT)8CCCC(AT)8GC 
GCATATATATATATATATCCCCATATATATATAT
ATATGC 
22 GC(AT)8GGGG(AT)8GC 
GCATATATATATATATATGGGGATATATATATAT
ATATGC 
23 GC(AT)19GC-HPLC   
24 GC(AT)19GC-Kart  
25 GC(TA)13CG GCTATATATATATATATATATATATATACG 
26 (AT)6AGCCGT(AT)6 ATATATATATATAGCCGTATATATATATAT 
27 (AT)6ACGGCT(AT)6 ATATATATATATACGGCTATATATATATAT 
28 CG(TA)13GC CGTATATATATATATATATATATATATAGC 
29 CG(TA)13CG CGTATATATATATATATATATATATATACG 
30 (AT)4AGCCGT(AT)8 (AT)4AGCCGTATATATATATATATAT 
31 (AT)2AGCCGT(AT)10 (AT)2AGCCGTATATATATATATATATATAT 
32 AGCCGT(AT)12 AGCCGT(AT)12 
33 CC(TA)13CC CCTATATATATATATATATATATATATACC 
34 GG(TA)13GG GGTATATATATATATATATATATATATAGG 
35 (AT)6ACCCCT(AT)6 ATATATATATATACCCCTATATATATATAT 
36 (AT)6AGGGGT(AT)6 ATATATATATATAGGGGTATATATATATAT 
37 GC(TA)10CG GCTATATATATATATATATATACG 
38 (TA)5GCCG(TA)5 TATATATATAGCCGTATATATATA 
39 CC(TA)13CC CCTATATATATATATATATATATATATACC 
40 (AT)6AGGGGT(AT)6 ATATATATATATAGGGGTATATATATATAT 
41 CG(TA)13GC CGTATATATATATATATATATATATATAGC 
42 CC(TA)13CC CCTATATATATATATATATATATATATACC 
43 GG(TA)13GG GGTATATATATATATATATATATATATAGG 
44 (AT)6ACCCCT(AT)6 ATATATATATATACCCCTATATATATATAT 
45 (AT)6AGCCGT(AT)6 ATATATATATATAGCCGTATATATATATAT 
46 (AT)6ACGGCT(AT)6 ATATATATATATACGGCTATATATATATAT 
47 (TA)6GGGGGG(TA)6 TATATATATATAGGGGGGTATATATATATA 
48 CCC(TA)12CCC CCCTATATATATATATATATATATATACCC 
49 CC(TA)10CC CCTATATATATATATATATATACC 
50 (TA)5GGGG(TA)5 TATATATATAGGGGTATATATATA 
51 CC(TA)5GGGG(TA)5CC CCTATATATATAGGGGTATATATATACC 
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52 CC(TA)4GGGG(TA)4CC CCTATATATAGGGGTATATATACC 
53 GG(TA)13GG GGTATATATATATATATATATATATATAGG 
54 GG(TA)11GG GGTATATATATATATATATATATAGG 
55 GG(TA)10GG GGTATATATATATATATATATAGG 
56 GG(TA)9GG GGTATATATATATATATATAGG 
57 GG(TA)13 GGTATATATATATATATATATATATATA 
58 C3(TA)4G6(TA)4C3 C3TATATATAG6TATATATAC3 
59 C3(TA)3G6(TA)3C3 C3TATATAG6TATATAC3 
60 C4(TA)11C4 CCCCTATATATATATATATATATATACCCC 
61 A(TA)5G8(TA)5T ATATATATATAGGGGGGGGTATATATATAT 
62 CCC(TA)6 CCCTATATATATATA 
63 CCC(TA)12 CCCTATATATATATATATATATATATA 
64 G4(TA)10G4 GGGGTATATATATATATATATATAGGGG 
65 GG(TA)8GG GGTATATATATATATATAGG 
66 GG(TA)7GG GGTATATATATATATAGG 
67 GGG(TA)10GGG GGGTATATATATATATATATATAGGG 
68 C6(TA)12 CCCCCCTATATATATATATATATATATATA 
69 GC(TA)13GC GCTATATATATATATATATATATATATAGC 
70 GG(TA)4GCGC(TA)4GG GGTATATATAGCGCTATATATAGG 
71 (GC)5(TA)10 GCGCGCGCGCTATATATATATATATATATA 
72 C4(TA)3G8(TA)3C4 CCCCTATATAGGGGGGGGTATATACCCC 
73 C5(TA)2G10(TA)2C5 CCCCCTATAGGGGGGGGGGTATACCCCC 
74 G3(TA)10G3 GGGTATATATATATATATATATAGGG 
75 G3(TA)4TGCA(TA)4G3 GGGTATATATATGCATATATATAGGG 
76 G3(TA)4TCGA(TA)4G3 GGGTATATATATCGATATATATAGGG 
77 G3(TA)4TTAA(TA)4G3 GGGTATATATATTAATATATATAGGG 
78 G3(TA)4AATT(TA)4G3 GGGTATATATAAATTTATATATAGGG 
79 G3(TA)4AGCT(TA)4G3 GGGTATATATAAGCTTATATATAGGG 
80 G3(TA)4ACGT(TA)4G3 GGGTATATATAACGTTATATATAGGG 
81 G3(TA)4ATAT(TA)4G3 GGGTATATATAATATTATATATAGGG 
82 G3(TA)4GATC(TA)4G3 GGGTATATATAGATCTATATATAGGG 
83 G3(TA)4GGCC(TA)4G3 GGGTATATATAGGCCTATATATAGGG 
84 G3(TA)4GCGC(TA)4G3 GGGTATATATAGCGCTATATATAGGG 
85 G3(TA)4GTAC(TA)4G3 GGGTATATATAGTACTATATATAGGG 
86 G3(TA)4CATG(TA)4G3 GGGTATATATACATGTATATATAGGG 
87 G3(TA)4CGCG(TA)4G3 GGGTATATATACGCGTATATATAGGG 
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88 G3(TA)4CCGG(TA)4G3 GGGTATATATACCGGTATATATAGGG 
89 G3(TA)4CTAG(TA)4G3 GGGTATATATACTAGTATATATAGGG 
90 C3(TA)5G6(TA)5C3 C3TATATATATAG6TATATATATAC3 
91 G3(TA)4GC(TA)4G8 GGGTATATATAGCTATATATAG8 
93 CpG 2216-AT GGGGG(AT)3CGATCG(AT)3CG6 
94 G3(TA)4TGCA(TA)4G3 GGGTATATATATGCATATATATAGGG 
95 G3(TA)3T(GC)3A(TA)3G3) GGGTATATAT(GC)3ATATATAGGG) 
96 G3(TA)3(GC)4(TA)3G3 GGGTATATA(GC)4TATATAGGG 
97 G3(TA)2(GC)6(TA)2G3 GGGTATA(GC)6TATAGGG 
98 G3(TA)(GC)8(TA)G3 GGG(TA)(GC)8(TA)GGG 
99 G3(GC)10G3 GGG(GC)10GGG 
100 G3-CpG-AT GGG(AT)3(CGAT)2(AT)2CGGGG 
101 (TA)12C3 TATATATATATATATATATATATAC3 
102 (TA)6C3 TATATATATATAC3 
103 GFP A-B CA3C2A3GA2TGG(CAT)2A3... 
  (TA3)2GGGCAGAT2(GT)2GGAC 
104 GFP B'-C GTC(CA)3ATCTGC3T3AT3... 
  A2GTGGAGAGGGTGA2GGTGA 
105 GFP C'-D TCAC2T2CAC3TCTC2ACT2... 
  A3TGTTGGC2ATGGA2CAGGTAG 
106 GFP D'-A CTAC2TGT2C2ATGGC2A2... 
  CAT3(ATG)2C2AT2CT3GGT3G 
108 CpG-2216 AT GGGGG(AT)3(CGAT)2(AT)2CG6 
109 G3 CpG AT GGG(AT)3CGATCG(AT)3CGGGG 
110 G3-PTO GGGTATATATATGCATATATATAGGG 
111 G3NonPalin1G3 GGGCAATGGTCCTGCTGGAGTTCGGG 
112 G3NonPalin1'G3 GGGGAACTCCAGCAGGACCATTGGGG 
113 G3mixPalin1G3 GGGTTGAGCCACATGTGGCTCGTGGG 
114 G3mixPalin1'G3 GGGACGAGCCACATGTGGCTCAAGGG 
115 G3NonPalin2G3 GGGCAATGGACCTGCTGAAGTTCGGG 
116 G3NonPalin2'G3 GGGGAACTTCAGCAGGTCCATTGGGG 
117 G3Palin2-2'G3 GGGATGAGCCACATGTGGCTCATGGG 
118 NonPal EGFP-5' AGGGCGAGGAGCTGTTCA 
119 NonPal EGFP-3' GAACTCCAGCAGGACCATGT 
120 Pal pBKS-5' AAGGGAAGAAAGCGAAAGGA 
121 Pal pBKS-3' AATACGCAAACCGCCTCTC 
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122 G3(TA)10G3 GGGTATATATATATATATATATAGGG 
123 A3(TA)10A3 AAATATATATATATATATATATAAAA 
124 T3(TA)10T3 TTTTATATATATATATATATATATTT 
125 C3(TA)10C3 CCCTATATATATATATATATATACCC 
126 GFP A-C 
CAAACCAAAGAATGGCATCATAAATAGTGGAGA
GGGTGAAGGTGA 
127 GFP C'-A' 
TCACCTTCACCCTCTCCACTATTTATGATGCCAT
TCTTTGGTTTG 
128 GFP D'-B 
CTACCTGTTCCATGGCCAACTAAATAAAGGGCA
GATTGTGTGGAC 
129 GFP B'-D 
GTCCACACAATCTGCCCTTTATTTAGTTGGCCAT
GGAACAGGTAG 
130 (GATC)4 (GATC)4 
131 (AGAGCTCT)2 (AGAGCTCT)2 
132 (GAGCTC)3 (GAGCTC)3 
133 (AGACT)3 (AGACT)3 
139 (TA)6G6(TA)6  
140 C3(TA)12C3  
141 G3nonPalin1 GGGCA2TGGTC2TGCTGGAGT2C 
142 NonPalin1G3 CA2TGGTC2TGCTGGAGT2CGGG 
143 G3-3P P- GGGTATATATATGCATATATATAGGG 
144 3201-3P P-(AT)12GC2GCGGC 
145 GFP-C' 3P P-TCAC2T2CAC3TCTC2ACTAT 
146 GFP C' TCAC2T2CAC3TCTC2ACTAT 
147 GFP A' T2(ATG)2C2AT2CT3GST3G 
148 GFP A' 1 TATGATGC2AT2CT3GGT3G 
149 GFP A' 2 (ATG)2C2AT2CT3GGT3G 
150 G3-3P GGGTATATATATGCATATATATAGGG -3P 
151 D3201-3P (AT)12GC2GCGGC-3P 
152 GFP C' -3P TCAC2T2CAC3TCTC2ACTAT 3P 
153 GFP A'-C' 
TATGATGCCATTCTTTGGTTTGTCACCTTCA 
CCCTCTCCACTATT 
154 D3201 (AT)12GC2GCGGC 
155 NonPalin1 CAATGGTCCTGCTGGAGTTC 
156 NonPalin1'G3 GAACTCCAGCAGGACCATTGGGG 
157 G3NonPalin1' GGGGAACTCCAGCAGGACCATTG 
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158 NonPalin1' GAACTCCAGCAGGACCATTG 
159 GC(AT)10GC GCATATATATATATATATATATGC 
160 N30TGGTCGGC 
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
T 
GGTCGGC 
161 GCCGACCA GCCGACCA 
162 (AT)7A ATATATATATATATA 
163 POLY(AT)(+G+C)1 TATACATGTATACATG 
164 POLY (AT)(+G+C)2 TGTATGTATACATACATA 
165 POLY (AT)(+G+C)3 TATACGTATATACGTA 
166 111G2NonPalin1G2 GGCAATGGTCCTGCTGGAGTTCGG 
167 112G2NonPalin1'G2 GGGAACTCCAGCAGGACCATTGGG 
168 141NonPalin1G2 GGCA2TGGTC2TGCTGGAGT2C 
169 142G2NonPalin1G2 CA2TGGTC2TGCTGGAGT2CGG 
170 155NonPalin1 CAATGGTCCTGCTGGAGTTC 
171 156NonPalin1'G2 GAACTCCAGCAGGACCATTGGG 
172 157G2NonPalin1' GGGAACTCCAGCAGGACCATTG 
173 158NonPalin1' GAACTCCAGCAGGACCATTG 
174 GFP A'-C' G3 
GGGTATGATGCCATTCTTTGGTTTGTCACC 
TTCACCCTCTCCACTATTGGG 
175 G3(TA)6TGCA(TA)6G3 
GGGTATATATATATATGCATATATATATATAGG
G 
176 G3(TA)6GC(TA)6G3 GGGTATATATATATAGCTATATATATATAGGG 
177 G3(TA)5TGCA(TA)5G3 GGGTATATATATATGCATATATATATAGGG 
178 G3(TA)5GC(TA)5G3 GGGTATATATATAGCTATATATATAGGG 
179 G3(TA)4TGCA(TA)4G3 GGGTATATATATGCATATATATAGGG 
180 G3(TA)4GC(TA)4G3 GGGTATATATAGCTATATATAGGG 
181 G3(TA)3TGCA(TA)3G3 GGGTATATATGCATATATAGGG 
182 G3(TA)3GC(TA)3G3 GGGTATATAGCTATATAGGG 
183 G3(TA)2TGCA(TA)2G3 GGGTATATGCATATAGGG 
184 G4(TA)4TGCA(TA)4G4 GGGGTATATATATGCATATATATAGGGG 
185 G5(TA)4TGCA(TA)4G5 GGGGGTATATATATGCATATATATAGGGGG 
186 G3(TA)4TGGA(TA)4G3 GGGTATATATATGGATATATATAGGG 
187 G3(TA)4TCCA(TA)4G3 GGGTATATATATCCATATATATAGGG 
188 G3(TA)4CCCC(TA)4G3 GGGTATATATACCCCTATATATAGGG 
198 G2(TA)13G2 GGTATATATATATATATATATATATATAGG 
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199 XG(TA)13GX 
DEAZAGTATATATATATATATATATATATATAGD
EAZA 
200 111-biotin GGGCAATGGTCCTGCTGGAGTTCGGG 
201 GA2(TA)10A2G GAATATATATATATATATATATAAAG 
202 A2G(TA)10GA2 AAGTATATATATATATATATATAGAA 
203 GAG(TA)10GAG GAGTATATATATATATATATATAGAG 
204 24mer Upper ATGAGTAAAGGAGAAGAACTTTTC 
205 24mer Lower GAAAAGTTCTTCTCCTTTACTCAT 
206 30mer Upper ATGAGTAAAGGAGAAGAACTTTTCACTGGA 
207 30mer Lower TCCAGTGAAAAGTTCTTCTCCTTTACTCAT 
208 44mer Upper 
ATGAGTAAAGGAGAAGAACTTTTCACTGGAGTG
GTCCCAGTTCT 
209 44mer Lower 
AGAACTGGGACCACTCCAGTGAAAAGTTC 
TTCTCCTTTACTCAT 
210 64mer Upper 
ATGAGTAAAGGAGAAGAACTTTTCACTGG 
AGTGGTCCCAGTTCTTGTTGAATTAGATGGCGA
TG 
211 64mer Lower 
CATCGCCATCTAATTCAACAAGAACTGGGACC 
ACTCCAGTGAAAAGTTCTTCTCCTTTACTCAT 
212 84mer Upper 
ATGAGTAAAGGAGAAGAACTTTTCACTGGAGT 
GGTCCCAGTTCTTGTTGAATTAGATGGCGATGT
T 
AATGGGCAAAAATTCTCT 
213 84mer Lower 
AGAGAATTTTTGCCCATTAACATCGCCATCTAA 
TTCAACAAGAACTGGGACCACTCCAGTGAAAA 
GTTCTTCTCCTTTACTCAT 
214 G5(TA)10G5 GGGGGTATATATATATATATATATAGGGGG 
215 AGG(TA)4TGCA(TA)4GGA AGGTATATATATGCATATATATAGGA 
216 TGG(TA)4TGCA(TA)4GGT TGGTATATATATGCATATATATAGGT 
217 CGG(TA)4TGCA(TA)4GGC CGGTATATATATGCATATATATAGGC 
218 GG(TA)4TGCA(TA)4GG GGTATATATATGCATATATATAGG 
219 
AGGGG(TA)4TGCA(TA)4GGG
GA 
AGGGGTATATATATGCATATATATAGGGGA 
220 CGG(TA)4TGCA(TA)4GGC CGGTATATATATGCATATATATAGGC 
221 AG(TA)13GA AGTATATATATATATATATATATATATAGA 
222 GAA(TA)4TGCA(TA)4AAG GAATATATATATGCATATATATAAAG 
223 GAA(TA)4TGCA(TA)4TTG GAATATATATATGCATATATATATTG 
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224 TAA(TA)4TGCA(TA)4AAT TAATATATATATGCATATATATAAAT 
225 CAA(TA)4TGCA(TA)4AAC CAATATATATATGCATATATATAAAC 
226 GTT(TA)4TGCA(TA)4TTG GTTTATATATATGCATATATATATTG 
227 GCC(TA)4TGCA(TA)4CCG GCCTATATATATGCATATATATACCG 
228 NonPalin1 AAG  GAACAATGGTCCTGCTGGAGTTCAAG 
229 G2(TA)10G2 GGTATATATATATATATATATAGG 
230 G2(TA)13G2 GGTATATATATATATATATATATATATAGG 
231 Deaza(TA)13geaza XTATATATATATATATATATATATATAX 
232 C2(TA)13C2 CCTATATATATATATATATATATATATACC 
233 I2(TA)13I2 -inosin IITATATATATATATATATATATATATAII 
234 GI(TA)13IG GITATATATATATATATATATATATATAIG 
235 IG(TA)13GI IGTATATATATATATATATATATATATAGI 
236 I3(TA)13I3 IIITATATATATATATATATATATATATAIII 
237 G3(TA)2GC(TA)2G3 GGGTATAGCTATAGGG 
238 C3(TA)3TGCA(TA)3C3 CCCTATATATGCATATATAC3 
239 G3TAGCATGCATGCTAG3 GGGTAGCATGCATGCTAGGG 
240 G3TAGCTGCAGCTAG3 GGGTAGCTGCAGCTAGGG 
241 GC(AT)4GC(AT)4GC GCATATATATGCATATATATGC 
242 111 1mm GGGCAATGGTCCAGCTGGAGTTCGGG 
243 111 2mm GGGCAATGGTCCACCTGGAGTTCGGG 
244 111 3mm GGGCAATGGTCGACCTGGAGTTCGGG 
245 111 4mm GGGCAATGGTCGACGTGGAGTTCGGG 
246 111 +5mm GGGCTATGGTCCTGCTGGAGTTCGGG 
247 111 +15mm GGGCAATGGTCCTGCTGGAGTACGGG 
248 111 28mer 
GGGTGACCAATGGTCCTGCTGGAGTTCCAGTGG
G 
249 111 26mer GGGTGACAATGGTCCTGCTGGAGTTCAGTGGG 
250 111 24mer GGGTGCAATGGTCCTGCTGGAGTTCGTGGG 
251 111 22mer GGGTCAATGGTCCTGCTGGAGTTCTGGG 
252 111 18mer GGGAATGGTCCTGCTGGAGTTGGG 
253 111 16mer GGGATGGTCCTGCTGGAGTGGG 
254 111 14mer GGGTGGTCCTGCTGGAGGGG 
255 111 12mer GGGGGTCCTGCTGGAGGG 
256 112 28mer 
GGGACTGGAACTCCAGCAGGACCATTGGTCAGG
G 
257 112 26mer GGGACTGAACTCCAGCAGGACCATTGTCAGGG 
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258 112 24mer GGGACGAACTCCAGCAGGACCATTGCAGGG 
259 112 22mer GGGAGAACTCCAGCAGGACCATTGAGGG 
260 112 18mer GGGAACTCCAGCAGGACCATTGGG 
261 112 16mer GGGACTCCAGCAGGACCATGGG 
262 112 14mer GGGCTCCAGCAGGACCAGGG 
263 112 12mer GGGTCCAGCAGGACCGGG 
264 115i no G3 CAATGGACCTGCTGAAGTTC 
265 116a G3 5' GGGGAACTTCAGCAGGTCCATTG 
266 116b G3 3' GAACTTCAGCAGGTCCATTGGGG 
267 GG(TA)13GG GGTATATATATATATATATATATATATAGG 
268 GA(TA)13AG GATATATATATATATATATATATATATAAG 
269 GT(TA)13TG GTTATATATATATATATATATATATATATG 
270 GC(TA)13CG GCTATATATATATATATATATATATATACG 
271 AG(TA)13GA AGTATATATATATATATATATATATATAGA 
272 AA(TA)13AA AATATATATATATATATATATATATATAAA 
273 AT(TA)13TA ATTATATATATATATATATATATATATATA 
274 AC(TA)13CA ACTATATATATATATATATATATATATACA 
275 TG(TA)13GT TGTATATATATATATATATATATATATAGT 
276 TA(TA)13AT TATATATATATATATATATATATATATAAT 
277 TT(TA)13TT TTTATATATATATATATATATATATATATT 
278 TC(TA)13CT TCTATATATATATATATATATATATATACT 
279 CG(TA)13GC CGTATATATATATATATATATATATATAGC 
280 CA(TA)13AC CATATATATATATATATATATATATATAAC 
281 CT(TA)13TC CTTATATATATATATATATATATATATATC 
282 CC(TA)13CC CCTATATATATATATATATATATATATACC 
283 IInonPalin26II IIACTCAATGGTCCTGCTGGAGTTCACTII 
284 GGnonPalin26GG GGACTCAATGGTCCTGCTGGAGTTCACTGG 
285 TTnonPalin26TT TTACTCAATGGTCCTGCTGGAGTTCACTTT 
286 AAnonPalin26AA AAACTCAATGGTCCTGCTGGAGTTCACTAA 
287 CCnonPalin26CC CCACTCAATGGTCCTGCTGGAGTTCACTCC 
288 IInonPalin26'II IIAGTGAACTCCAGCAGGACCATTGAGTII 
289 GGnonPalin26'GG GGAGTGAACTCCAGCAGGACCATTGAGTGG 
290 TTnonPalin26'TT TTAGTGAACTCCAGCAGGACCATTGAGTTT 
291 AAnonPalin26'AA AAAGTGAACTCCAGCAGGACCATTGAGTAA 
292 CCnonPalin26'CC CCAGTGAACTCCAGCAGGACCATTGAGTCC 
293 nonPalin26' AGTGAACTCCAGCAGGACCATTGAGT 
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294 GGG(TA)10GGG GGGTATATATATATATATATATAGGG 
295 GGA(TA)10AGG GGATATATATATATATATATATAAGG 
296 GGT(TA)10TGG GGTTATATATATATATATATATATGG 
297 GGC(TA)10CGG GGCTATATATATATATATATATACGG 
298 GAG(TA)10GAG GAGTATATATATATATATATATAGAG 
299 GAA(TA)10AAG GAATATATATATATATATATATAAAG 
300 GAT(TA)10TAG GATTATATATATATATATATATATAG 
301 GAC(TA)10CAG GACTATATATATATATATATATACAG 
302 GTG(TA)10GTG GTGTATATATATATATATATATAGTG 
303 GTA(TA)10ATG GTATATATATATATATATATATAATG 
304 GTT(TA)10TTG GTTTATATATATATATATATATATTG 
305 GTC(TA)10CTG GTCTATATATATATATATATATACTG 
306 GCG(TA)10GCG GCGTATATATATATATATATATAGCG 
307 GCA(TA)10ACG GCATATATATATATATATATATAACG 
308 GCT(TA)10TCG GCTTATATATATATATATATATATCG 
309 GCC(TA)10CCG GCCTATATATATATATATATATACCG 
310 FAM-G3NonPalinG3 (111) FAM-GGGCAATGGTCCTGCTGGAGTTCGGG 
311 C3NonPalin1'C3 (112 w/C3) CCCGAACTCCAGCAGGACCATTGCCC 
312 G3NonPalin1'G3 (112) GGGGAACTCCAGCAGGACCATTGGGG 
313 C3NonPalin1C3 (111 w/ C3) CCCCAATGGTCCTGCTGGAGTTCCCC 
314 NonPalin1' (112, no G) FAM-GAACTCCAGCAGGACCATTG-BHQ 
 
